<?xml version="1.0"?>
<rdf:RDF
    xmlns="http://www.biopax.org/release/biopax-level2.owl#"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
    xmlns:owl="http://www.w3.org/2002/07/owl#"
  xml:base="http://www.biopax.org/release/biopax-level2.owl">
  <owl:Ontology rdf:about="">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >This is version 0.93 of the BioPAX Level 2 ontology.  The goal of the BioPAX group is to develop a common exchange format for biological pathway data.  More information is available at http://www.biopax.org.  This ontology is freely available under the LGPL (http://www.gnu.org/copyleft/lesser.html).</rdfs:comment>
  </owl:Ontology>
  <owl:Class rdf:ID="dataSource">
    <owl:disjointWith>
      <owl:Class rdf:about="#openControlledVocabulary"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#xref"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#bioSource"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#externalReferenceUtilityClass"/>
    </rdfs:subClassOf>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: The direct source of this data. This does not store the trail of sources from the generation of the data to this point, only the last known source, such as a database. The XREF property may contain a publicationXref referencing a publication describing the data source (e.g. a database publication). A unificationXref may be used e.g. when pointing to an entry in a database of databases describing this database.
Examples: A database or person name.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:allValuesFrom>
          <owl:Class>
            <owl:unionOf rdf:parseType="Collection">
              <owl:Class rdf:about="#publicationXref"/>
              <owl:Class rdf:about="#unificationXref"/>
            </owl:unionOf>
          </owl:Class>
        </owl:allValuesFrom>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#XREF"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="openControlledVocabulary">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: Used to import terms from external controlled vocabularies (CVs) into the ontology. To support consistency and compatibility, open, freely available CVs should be used whenever possible, such as the Gene Ontology (GO) or other open biological CVs listed on the OBO website (http://obo.sourceforge.net/).
Comment: The ID property in unification xrefs to GO and other OBO ontologies should include the ontology name in the ID property (e.g. ID="GO:0005634" instead of ID="0005634").</rdfs:comment>
    <owl:disjointWith>
      <owl:Class rdf:about="#xref"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:allValuesFrom>
          <owl:Class rdf:about="#unificationXref"/>
        </owl:allValuesFrom>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#XREF"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#dataSource"/>
    <owl:disjointWith>
      <owl:Class rdf:about="#bioSource"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#externalReferenceUtilityClass"/>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="sequenceParticipant">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A DNA, RNA or protein participant in an interaction.
Comment: See physicalEntityParticipant for more documentation.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#physicalEntityParticipant"/>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="complexAssembly">
    <rdfs:subClassOf>
      <owl:Class rdf:about="#conversion"/>
    </rdfs:subClassOf>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A conversion interaction in which a set of physical entities, at least one being a macromolecule (protein, RNA, or DNA), aggregate via non-covalent interactions. One of the participants of a complexAssembly must be an instance of the class complex.
Comment: This class is also used to represent complex disassembly. The assembly or disassembly of a complex is often a spontaneous process, in which case the direction of the complexAssembly (toward either assembly or disassembly) should be specified via the SPONTANEOUS property.
Synonyms: aggregation, complex formation
Examples: Assembly of the TFB2 and TFB3 proteins into the TFIIH complex, and assembly of the ribosome through aggregation of its subunits.
Note: The following are not examples of complex assembly: Covalent phosphorylation of a protein (this is a biochemicalReaction); the TFIIH complex itself (this is an instance of the complex class, not the complexAssembly class).</rdfs:comment>
    <owl:disjointWith>
      <owl:Class rdf:about="#biochemicalReaction"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#transport"/>
    </owl:disjointWith>
  </owl:Class>
  <owl:Class rdf:ID="transportWithBiochemicalReaction">
    <rdfs:subClassOf>
      <owl:Class rdf:about="#biochemicalReaction"/>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#transport"/>
    </rdfs:subClassOf>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A conversion interaction that is both a biochemicalReaction and a transport. In transportWithBiochemicalReaction interactions, one or more of the substrates change both their location and their physical structure. Active transport reactions that use ATP as an energy source fall under this category, even if the only covalent change is the hydrolysis of ATP to ADP.
Comment: This class was added to support a large number of transport events in pathway databases that have a biochemical reaction during the transport process. It is not expected that other double inheritance subclasses will be added to the ontology at the same level as this class.
Examples: In the PEP-dependent phosphotransferase system, transportation of sugar into an E. coli cell is accompanied by the sugarâ€™s phosphorylation as it crosses the plasma membrane.</rdfs:comment>
  </owl:Class>
  <owl:Class rdf:ID="physicalEntity">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: An entity with a physical structure. A pool of entities, not a specific molecular instance of an entity in a cell.
Comment: This class serves as the super-class for all physical entities, although its current set of subclasses is limited to molecules. As a highly abstract class in the ontology, instances of the physicalEntity class should never be created. Instead, more specific classes should be used.
Synonyms: part, interactor, object
Naming rationale: Itâ€™s difficult to find a name that encompasses all of the subclasses of this class without being too general. E.g. PSI-MI uses â€˜interactorâ€™, BIND uses â€˜objectâ€™, BioCyc uses â€˜chemicalsâ€™. physicalEntity seems to be a good name for this specialization of entity.
Examples: protein, small molecule, RNA</rdfs:comment>
    <owl:disjointWith>
      <owl:Class rdf:about="#interaction"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#entity"/>
    </rdfs:subClassOf>
    <owl:disjointWith>
      <owl:Class rdf:about="#pathway"/>
    </owl:disjointWith>
  </owl:Class>
  <owl:Class rdf:ID="unificationXref">
    <rdfs:subClassOf>
      <owl:Class rdf:about="#xref"/>
    </rdfs:subClassOf>
    <owl:disjointWith>
      <owl:Class rdf:about="#relationshipXref"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#ID"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A unification xref defines a reference to an entity in an external resource that has the same biological identity as the referring entity. For example, if one wished to link from a database record, C, describing a chemical compound in a BioPAX data collection to a record, Câ€™, describing the same chemical compound in an external database, one would use a unification xref since records C and C' describe the same biological identity. Generally, unification xrefs should be used whenever possible, although there are cases where they might not be useful, such as application to application data exchange.
Comment: Unification xrefs in physical entities are essential for data integration, but are less important in interactions. This is because unification xrefs on the physical entities in an interaction can be used to compute the equivalence of two interactions of the same type. An xref in a protein pointing to a gene, e.g. in the LocusLink database17, would not be a unification xref since the two entities do not have the same biological identity (one is a protein, the other is a gene). Instead, this link should be a captured as a relationship xref. References to an external controlled vocabulary term within the OpenControlledVocabulary class should use a unification xref where possible (e.g. GO:0005737).
Examples: An xref in a protein instance pointing to an entry in the Swiss-Prot database, and an xref in an RNA instance pointing to the corresponding RNA sequence in the RefSeq database..</rdfs:comment>
    <owl:disjointWith>
      <owl:Class rdf:about="#publicationXref"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#DB"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="relationshipXref">
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#RELATIONSHIP-TYPE"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: An xref that defines a reference to an entity in an external resource that does not have the same biological identity as the referring entity.
Comment: There is currently no controlled vocabulary of relationship types for BioPAX, although one will be created in the future if a need develops.
Examples: A link between a gene G in a BioPAX data collection, and the protein product P of that gene in an external database. This is not a unification xref because G and P are different biological entities (one is a gene and one is a protein). Another example is a relationship xref for a protein that refers to the Gene Ontology biological process, e.g. â€˜immune response,â€™ that the protein is involved in.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#ID"/>
        </owl:onProperty>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#unificationXref"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#DB"/>
        </owl:onProperty>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#xref"/>
    </rdfs:subClassOf>
    <owl:disjointWith>
      <owl:Class rdf:about="#publicationXref"/>
    </owl:disjointWith>
  </owl:Class>
  <owl:Class rdf:ID="physicalInteraction">
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#PARTICIPANTS"/>
        </owl:onProperty>
        <owl:someValuesFrom>
          <owl:Class rdf:about="#physicalEntityParticipant"/>
        </owl:someValuesFrom>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: An interaction in which at least one participant is a physical entity, e.g. a binding event.
Comment: This class should be used by default for representing molecular interactions, such as those defined by PSI-MI level 2. The participants in a molecular interaction should be listed in the PARTICIPANTS slot. Note that this is one of the few cases in which the PARTICPANT slot should be directly populated with instances (see comments on the PARTICPANTS property in the interaction class description). If sufficient information on the nature of a molecular interaction is available, a more specific BioPAX interaction class should be used.
Example: Two proteins observed to interact in a yeast-two-hybrid experiment where there is not enough experimental evidence to suggest that the proteins are forming a complex by themselves without any indirect involvement of other proteins. This is the case for most large-scale yeast two-hybrid screens.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#interaction"/>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="smallMolecule">
    <owl:disjointWith>
      <owl:Class rdf:about="#protein"/>
    </owl:disjointWith>
    <rdfs:subClassOf rdf:resource="#physicalEntity"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: Any bioactive molecule that is not a peptide, DNA, or RNA. Generally these are non-polymeric, but complex carbohydrates are not explicitly modeled as classes in this version of the ontology, thus are forced into this class.
Comment: Recently, a number of small molecule databases have become available to cross-reference from this class.
Examples: glucose, penicillin, phosphatidylinositol</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#CHEMICAL-FORMULA"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#MOLECULAR-WEIGHT"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith>
      <owl:Class rdf:about="#rna"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#dna"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#complex"/>
    </owl:disjointWith>
  </owl:Class>
  <owl:Class rdf:ID="sequenceLocation">
    <owl:disjointWith>
      <owl:Class rdf:about="#confidence"/>
    </owl:disjointWith>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A location on a nucleotide or amino acid sequence.
Comment: For organizational purposes only; direct instances of this class should not be created.</rdfs:comment>
    <owl:disjointWith>
      <owl:Class rdf:about="#evidence"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#utilityClass"/>
    </rdfs:subClassOf>
    <owl:disjointWith>
      <owl:Class rdf:about="#chemicalStructure"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#pathwayStep"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#externalReferenceUtilityClass"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#physicalEntityParticipant"/>
    </owl:disjointWith>
  </owl:Class>
  <owl:Class rdf:ID="sequenceInterval">
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#SEQUENCE-INTERVAL-BEGIN"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#SEQUENCE-INTERVAL-END"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf rdf:resource="#sequenceLocation"/>
    <owl:disjointWith>
      <owl:Class rdf:about="#sequenceSite"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#sequenceFeature"/>
    </owl:disjointWith>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: Describes an interval on a sequence. All of the sequence from the begin site to the end site (inclusive) is described, not any subset.</rdfs:comment>
  </owl:Class>
  <owl:Class rdf:ID="transport">
    <owl:disjointWith rdf:resource="#complexAssembly"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A conversion interaction in which an entity (or set of entities) changes location within or with respect to the cell. A transport interaction does not include the transporter entity, even if one is required in order for the transport to occur. Instead, transporters are linked to transport interactions via the catalysis class.
Comment: Transport interactions do not involve chemical changes of the participant(s). These cases are handled by the transportWithBiochemicalReaction class.
Synonyms: translocation.
Examples: The movement of Na+ into the cell through an open voltage-gated channel.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#conversion"/>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="sequenceSite">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: Describes a site on a sequence, i.e. the position of a single nucleotide or amino acid.</rdfs:comment>
    <owl:disjointWith>
      <owl:Class rdf:about="#sequenceFeature"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#POSITION-STATUS"/>
        </owl:onProperty>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf rdf:resource="#sequenceLocation"/>
    <owl:disjointWith rdf:resource="#sequenceInterval"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#SEQUENCE-POSITION"/>
        </owl:onProperty>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="biochemicalReaction">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A conversion interaction in which one or more entities (substrates) undergo covalent changes to become one or more other entities (products). The substrates of biochemical reactions are defined in terms of sums of species. This is convention in biochemistry, and, in principle, all of the EC reactions should be biochemical reactions.
Examples: ATP + H2O = ADP + Pi
Comment: In the example reaction above, ATP is considered to be an equilibrium mixture of several species, namely ATP4-, HATP3-, H2ATP2-, MgATP2-, MgHATP-, and Mg2ATP. Additional species may also need to be considered if other ions (e.g. Ca2+) that bind ATP are present. Similar considerations apply to ADP and to inorganic phosphate (Pi). When writing biochemical reactions, it is important not to attach charges to the biochemical reactants and not to include ions such as H+ and Mg2+ in the equation. The reaction is written in the direction specified by the EC nomenclature system, if applicable, regardless of the physiological direction(s) in which the reaction proceeds. Polymerization reactions involving large polymers whose structure is not explicitly captured should generally be represented as unbalanced reactions in which the monomer is consumed but the polymer remains unchanged, e.g. glycogen + glucose = glycogen.</rdfs:comment>
    <owl:disjointWith rdf:resource="#complexAssembly"/>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#conversion"/>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="complex">
    <owl:disjointWith>
      <owl:Class rdf:about="#rna"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#protein"/>
    </owl:disjointWith>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A physical entity whose structure is comprised of other physical entities bound to each other non-covalently, at least one of which is a macromolecule (protein, DNA, or RNA). Complexes must be stable enough to function as a biological unit; in general, the temporary association of an enzyme with its substrate(s) should not be considered or represented as a complex. A complex is the physical product of an interaction (complexAssembly) and is not itself considered an interaction.
Comment: In general, complexes should not be defined recursively so that smaller complexes exist within larger complexes, i.e. a complex should not be a COMPONENT of another complex (see comments on the COMPONENT property). The boundaries on the size of complexes described by this class are not defined here, although elements of the cell as large and dynamic as, e.g., a mitochondrion would typically not be described using this class (later versions of this ontology may include a cellularComponent class to represent these). The strength of binding and the topology of the components cannot be described currently, but may be included in future versions of the ontology, depending on community need.
Examples: Ribosome, RNA polymerase II. Other examples of this class include complexes of multiple protein monomers and complexes of proteins and small molecules.</rdfs:comment>
    <rdfs:subClassOf rdf:resource="#physicalEntity"/>
    <owl:disjointWith rdf:resource="#smallMolecule"/>
    <owl:disjointWith>
      <owl:Class rdf:about="#dna"/>
    </owl:disjointWith>
  </owl:Class>
  <owl:Class rdf:ID="publicationXref">
    <rdfs:subClassOf>
      <owl:Class rdf:about="#xref"/>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#relationshipXref"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#TITLE"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#YEAR"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#unificationXref"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: An xref that defines a reference to a publication such as a book, journal article, web page, or software manual. The reference may or may not be in a database, although references to PubMed are preferred when possible. The publication should make a direct reference to the instance it is attached to.
Comment: Publication xrefs should make use of PubMed IDs wherever possible. The DB property of an xref to an entry in PubMed should use the string â€œPubMedâ€ and not â€œMEDLINEâ€.
Examples: PubMed:10234245</rdfs:comment>
  </owl:Class>
  <owl:Class rdf:ID="sequenceFeature">
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#SHORT-NAME"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#sequenceSite"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#NAME"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#FEATURE-TYPE"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A feature on a sequence relevant to an interaction, such as a binding site or post-translational modification.
Examples: A phosphorylation on a protein.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#utilityClass"/>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#sequenceInterval"/>
  </owl:Class>
  <owl:Class rdf:ID="entity">
    <rdfs:subClassOf rdf:resource="http://www.w3.org/2002/07/owl#Thing"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A discrete biological unit used when describing pathways.
Comment: This is the root class for all biological concepts in the ontology, which include pathways, interactions and physical entities. As the most abstract class in the ontology, instances of the entity class should never be created. Instead, more specific classes should be used.
Synonyms: thing, object, bioentity.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#NAME"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith>
      <owl:Class rdf:about="#utilityClass"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#SHORT-NAME"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="confidence">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: Confidence that the containing instance actually occurs or exists in vivo, usually a statistical measure. The xref must contain at least on publication that describes the method used to determine the confidence. There is currently no standard way of describing confidence values, so any string is valid for the confidence value. In the future, a controlled vocabulary of accepted confidence values could become available, in which case it will likely be adopted for use here to describe the value.
Examples: The statistical significance of a result, e.g. â€œp&lt;0.05â€.</rdfs:comment>
    <owl:disjointWith>
      <owl:Class rdf:about="#externalReferenceUtilityClass"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#utilityClass"/>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:minCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:minCardinality>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#XREF"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith>
      <owl:Class rdf:about="#physicalEntityParticipant"/>
    </owl:disjointWith>
    <owl:disjointWith rdf:resource="#sequenceLocation"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#CONFIDENCE-VALUE"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith>
      <owl:Class rdf:about="#chemicalStructure"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#pathwayStep"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:allValuesFrom rdf:resource="#publicationXref"/>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#XREF"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith>
      <owl:Class rdf:about="#evidence"/>
    </owl:disjointWith>
  </owl:Class>
  <owl:Class rdf:ID="pathwayStep">
    <owl:disjointWith>
      <owl:Class rdf:about="#chemicalStructure"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#evidence"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#externalReferenceUtilityClass"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#physicalEntityParticipant"/>
    </owl:disjointWith>
    <owl:disjointWith rdf:resource="#sequenceLocation"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A step in a pathway.
Comment: Multiple interactions may occur in a pathway step, each should be listed in the STEP-INTERACTIONS property. Order relationships between pathway steps may be established with the NEXT-STEP slot. This order may not be temporally meaningful for specific steps, such as for a pathway loop or a reversible reaction, but represents a directed graph of step relationships that can be useful for describing the overall flow of a pathway, as may be useful in a pathway diagram.
Example: A metabolic pathway may contain a pathway step composed of one biochemical reaction (BR1) and one catalysis (CAT1) instance, where CAT1 describes the catalysis of BR1.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:minCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:minCardinality>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#STEP-INTERACTIONS"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#utilityClass"/>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#confidence"/>
  </owl:Class>
  <owl:Class rdf:ID="utilityClass">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: Utility classes are created when simple slots are insufficient to describe an aspect of an entity or to increase compatibility of this ontology with other standards.  The utilityClass class is actually a metaclass and is only present to organize the other helper classes under one class hierarchy; instances of utilityClass should never be created.</rdfs:comment>
    <owl:disjointWith rdf:resource="#entity"/>
  </owl:Class>
  <owl:Class rdf:ID="pathway">
    <owl:disjointWith>
      <owl:Class rdf:about="#interaction"/>
    </owl:disjointWith>
    <rdfs:subClassOf rdf:resource="#entity"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A set or series of interactions, often forming a network, which biologists have found useful to group together for organizational, historic, biophysical or other reasons.
Comment: It is possible to define a pathway without specifying the interactions within the pathway. In this case, the pathway instance could consist simply of a name and could be treated as a â€˜black boxâ€™.
Synonyms: network
Examples: glycolysis, valine biosynthesis</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#ORGANISM"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#physicalEntity"/>
  </owl:Class>
  <owl:Class rdf:ID="externalReferenceUtilityClass">
    <rdfs:subClassOf rdf:resource="#utilityClass"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A pointer to an external object, such as an entry in a database or a term in a controlled vocabulary.
Comment: This class is for organizational purposes only; direct instances of this class should not be created.</rdfs:comment>
    <owl:disjointWith rdf:resource="#pathwayStep"/>
    <owl:disjointWith>
      <owl:Class rdf:about="#evidence"/>
    </owl:disjointWith>
    <owl:disjointWith>
      <owl:Class rdf:about="#chemicalStructure"/>
    </owl:disjointWith>
    <owl:disjointWith rdf:resource="#sequenceLocation"/>
    <owl:disjointWith>
      <owl:Class rdf:about="#physicalEntityParticipant"/>
    </owl:disjointWith>
    <owl:disjointWith rdf:resource="#confidence"/>
  </owl:Class>
  <owl:Class rdf:ID="dna">
    <owl:disjointWith rdf:resource="#complex"/>
    <owl:disjointWith>
      <owl:Class rdf:about="#rna"/>
    </owl:disjointWith>
    <owl:disjointWith rdf:resource="#smallMolecule"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A physical entity consisting of a sequence of deoxyribonucleotide monophosphates; a deoxyribonucleic acid.
Comment: This is not a â€˜geneâ€™, since gene is a genetic concept, not a physical entity. The concept of a gene may be added later in BioPAX.
Examples: a chromosome, a plasmid. A specific example is chromosome 7 of Homo sapiens.</rdfs:comment>
    <rdfs:subClassOf rdf:resource="#physicalEntity"/>
    <owl:disjointWith>
      <owl:Class rdf:about="#protein"/>
    </owl:disjointWith>
  </owl:Class>
  <owl:Class rdf:ID="modulation">
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#CONTROLLER"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith>
      <owl:Class rdf:about="#catalysis"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#CONTROLLED"/>
        </owl:onProperty>
        <owl:allValuesFrom>
          <owl:Class rdf:about="#catalysis"/>
        </owl:allValuesFrom>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Class rdf:about="#control"/>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#CONTROLLED"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A control interaction in which a physical entity modulates a catalysis interaction. Biologically, most modulation interactions describe an interaction in which a small molecule alters the ability of an enzyme to catalyze a specific reaction. Instances of this class describe a pairing between a modulating entity and a catalysis interaction.
Comment: A separate modulation instance should be created for each different catalysis instance that a physical entity may modulate and for each different physical entity that may modulate a catalysis instance. A typical modulation instance has a small molecule as the controller entity and a catalysis instance as the controlled entity.
Examples: Allosteric activation and competitive inhibition of an enzymeâ€™s ability to catalyze a specific reaction.</rdfs:comment>
  </owl:Class>
  <owl:Class rdf:ID="xref">
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#DB-VERSION"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#dataSource"/>
    <rdfs:subClassOf rdf:resource="#externalReferenceUtilityClass"/>
    <owl:disjointWith>
      <owl:Class rdf:about="#bioSource"/>
    </owl:disjointWith>
    <owl:disjointWith rdf:resource="#openControlledVocabulary"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#ID"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#ID-VERSION"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A reference from an instance of a class in this ontology to an object in an external resource.
Comment: Instances of the xref class should never be created and more specific classes should be used instead.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#DB"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="protein">
    <rdfs:subClassOf rdf:resource="#physicalEntity"/>
    <owl:disjointWith rdf:resource="#complex"/>
    <owl:disjointWith rdf:resource="#dna"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A physical entity consisting of a sequence of amino acids; a protein monomer; a single polypeptide chain.
Examples: The epidermal growth factor receptor (EGFR) protein.</rdfs:comment>
    <owl:disjointWith>
      <owl:Class rdf:about="#rna"/>
    </owl:disjointWith>
    <owl:disjointWith rdf:resource="#smallMolecule"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#ORGANISM"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#SEQUENCE"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="experimentalForm">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: The form of a physical entity in a particular experiment, as it may be modified for purposes of experimental design.
Examples: A His-tagged protein in a binding assay. A protein can be tagged by multiple tags, so can have more than 1 experimental form type terms</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#PARTICIPANT"/>
        </owl:onProperty>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#EXPERIMENTAL-FORM-TYPE"/>
        </owl:onProperty>
        <owl:minCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:minCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf rdf:resource="#utilityClass"/>
  </owl:Class>
  <owl:Class rdf:ID="rna">
    <rdfs:subClassOf rdf:resource="#physicalEntity"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#SEQUENCE"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#dna"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#ORGANISM"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#smallMolecule"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A physical entity consisting of a sequence of ribonucleotide monophosphates; a ribonucleic acid.
Examples: messengerRNA, microRNA, ribosomalRNA. A specific example is the let-7 microRNA.</rdfs:comment>
    <owl:disjointWith rdf:resource="#complex"/>
    <owl:disjointWith rdf:resource="#protein"/>
  </owl:Class>
  <owl:Class rdf:ID="control">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: An interaction in which one entity regulates, modifies, or otherwise influences another. Two types of control interactions are defined: activation and inhibition.
Comment: In general, the targets of control processes (i.e. occupants of the CONTROLLED property) should be interactions. Conceptually, entities are involved in interactions (or events) and the events should be controlled or modified, not the entities themselves. For example, a kinase activating a protein is a frequent event in signaling pathways and is usually represented as an â€˜activationâ€™ arrow from the kinase to the substrate in signaling diagrams. This is an abstraction that can be ambiguous out of context. In BioPAX, this information should be captured as the kinase catalyzing (via an instance of the catalysis class) a reaction in which the substrate is phosphorylated, instead of as a control interaction in which the kinase activates the substrate. Since this class is a superclass for specific types of control, instances of the control class should only be created when none of its subclasses are applicable.
Synonyms: regulation, mediation
Examples: A small molecule that inhibits a pathway by an unknown mechanism controls the pathway.</rdfs:comment>
    <owl:disjointWith>
      <owl:Class rdf:about="#conversion"/>
    </owl:disjointWith>
    <rdfs:subClassOf rdf:resource="#physicalInteraction"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#CONTROL-TYPE"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="physicalEntityParticipant">
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#CELLULAR-LOCATION"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith>
      <owl:Class rdf:about="#chemicalStructure"/>
    </owl:disjointWith>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#PHYSICAL-ENTITY"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: Any additional special characteristics of a physical entity in the context of an interaction. These currently include stoichiometric coefficient and cellular location, but this list may be expanded in later levels.
Comment: PhysicalEntityParticipants should not be used in multiple interaction or complex instances. Instead, each interaction and complex should reference its own unique set of physicalEntityParticipants. The reason for this is that a user may add new information about a physicalEntityParticipant for one interaction or complex, such as the presence of a previously unknown post-translational modification, and unwittingly invalidate the physicalEntityParticipant for the other interactions or complexes that make use of it.
Example: In the interaction describing the transport of L-arginine into the cytoplasm in E. coli, the LEFT property in the interaction would be filled with an instance of physicalEntityParticipant that specified the location of L-arginine as periplasm and the stoichiometric coefficient as one.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#STOICHIOMETRIC-COEFFICIENT"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#pathwayStep"/>
    <owl:disjointWith rdf:resource="#confidence"/>
    <owl:disjointWith>
      <owl:Class rdf:about="#evidence"/>
    </owl:disjointWith>
    <owl:disjointWith rdf:resource="#sequenceLocation"/>
    <rdfs:subClassOf rdf:resource="#utilityClass"/>
    <owl:disjointWith rdf:resource="#externalReferenceUtilityClass"/>
  </owl:Class>
  <owl:Class rdf:ID="interaction">
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:someValuesFrom>
          <owl:Class>
            <owl:unionOf rdf:parseType="Collection">
              <owl:Class rdf:about="#entity"/>
              <owl:Class rdf:about="#physicalEntityParticipant"/>
            </owl:unionOf>
          </owl:Class>
        </owl:someValuesFrom>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#PARTICIPANTS"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf rdf:resource="#entity"/>
    <owl:disjointWith rdf:resource="#physicalEntity"/>
    <owl:disjointWith rdf:resource="#pathway"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A single biological relationship between two or more entities. An interaction cannot be defined without the entities it relates.
Comment: Since it is a highly abstract class in the ontology, instances of the interaction class should never be created. Instead, more specific classes should be used. Currently this class only has subclasses that define physical interactions; later levels of BioPAX may define other types of interactions, such as genetic (e.g. synthetic lethal).
Naming rationale: A number of names were considered for this concept, including â€œprocessâ€, â€œsynthesisâ€ and â€œrelationshipâ€; Interaction was chosen as it is understood by biologists in a biological context and is compatible with PSI-MI.
Examples: protein-protein interaction, biochemical reaction, enzyme catalysis</rdfs:comment>
  </owl:Class>
  <owl:Class rdf:ID="catalysis">
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#CONTROLLED"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: A control interaction in which a physical entity (a catalyst) increases the rate of a conversion interaction by lowering its activation energy. Instances of this class describe a pairing between a catalyzing entity and a catalyzed conversion.
Comment: A separate catalysis instance should be created for each different conversion that a physicalEntity may catalyze and for each different physicalEntity that may catalyze a conversion. For example, a bifunctional enzyme that catalyzes two different biochemical reactions would be linked to each of those biochemical reactions by two separate instances of the catalysis class. Also, catalysis reactions from multiple different organisms could be linked to the same generic biochemical reaction (a biochemical reaction is generic if it only includes small molecules). Generally, the enzyme catalyzing a conversion is known and the use of this class is obvious. In the cases where a catalyzed reaction is known to occur but the enzyme is not known, a catalysis instance should be created without a controller specified (i.e. the CONTROLLER property should remain empty).
Synonyms: facilitation, acceleration.
Examples: The catalysis of a biochemical reaction by an enzyme, the enabling of a transport interaction by a membrane pore complex, and the facilitation of a complex assembly by a scaffold protein. Hexokinase -> (The â€œGlucose + ATP -> Glucose-6-phosphate +ADPâ€ reaction). A plasma membrane Na+/K+ ATPase is an active transporter (antiport pump) using the energy of ATP to pump Na+ out of the cell and K+ in. Na+ from cytoplasm to extracellular space would be described in a transport instance. K+ from extracellular space to cytoplasm would be described in a transport instance. The ATPase pump would be stored in a catalysis instance controlling each of the above transport instances. A biochemical reaction that does not occur by itself under physiological conditions, but has been observed to occur in the presence of cell extract, likely via one or more unknown enzymes present in the extract, would be stored in the CONTROLLED property, with the CONTROLLER property empty.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#CONTROL-TYPE"/>
        </owl:onProperty>
        <owl:hasValue rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >ACTIVATION</owl:hasValue>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf rdf:resource="#control"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#DIRECTION"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#modulation"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#CONTROLLER"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#CONTROLLED"/>
        </owl:onProperty>
        <owl:allValuesFrom>
          <owl:Class rdf:about="#conversion"/>
        </owl:allValuesFrom>
      </owl:Restriction>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="conversion">
    <rdfs:subClassOf rdf:resource="#physicalInteraction"/>
    <owl:disjointWith rdf:resource="#control"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: An interaction in which one or more entities is physically transformed into one or more other entities.
Comment: This class is designed to represent a simple, single-step transformation. Multi-step transformations, such as the conversion of glucose to pyruvate in the glycolysis pathway, should be represented as pathways, if known. Since it is a highly abstract class in the ontology, instances of the conversion class should never be created.
Examples: A biochemical reaction converts substrates to products, the process of complex assembly converts single molecules to a complex, transport converts entities in one compartment to the same entities in another compartment.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#SPONTANEOUS"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#PARTICIPANTS"/>
        </owl:onProperty>
        <owl:allValuesFrom rdf:resource="#physicalEntityParticipant"/>
      </owl:Restriction>
    </rdfs:subClassOf>
  </owl:Class>
  <owl:Class rdf:ID="evidence">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: The support for a particular assertion, such as the existence of an interaction or pathway. At least one of CONFIDENCE, EVIDENCE-CODE, or EXPERIMENTAL-FORM must be instantiated when creating an evidence instance. XREF may reference a publication describing the experimental evidence using a publicationXref or may store a description of the experiment in an experimental description database using a unificationXref (if the referenced experiment is the same) or relationshipXref (if it is not identical, but similar in some way e.g. similar in protocol). Evidence is meant to provide more information than just an xref to the source paper.
Examples: A description of a molecular binding assay that was used to detect a protein-protein interaction.</rdfs:comment>
    <owl:disjointWith>
      <owl:Class rdf:about="#chemicalStructure"/>
    </owl:disjointWith>
    <owl:disjointWith rdf:resource="#sequenceLocation"/>
    <owl:disjointWith rdf:resource="#externalReferenceUtilityClass"/>
    <owl:disjointWith rdf:resource="#confidence"/>
    <owl:disjointWith rdf:resource="#pathwayStep"/>
    <rdfs:subClassOf>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Restriction>
            <owl:minCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
            >1</owl:minCardinality>
            <owl:onProperty>
              <owl:ObjectProperty rdf:about="#CONFIDENCE"/>
            </owl:onProperty>
          </owl:Restriction>
          <owl:Restriction>
            <owl:onProperty>
              <owl:ObjectProperty rdf:about="#EVIDENCE-CODE"/>
            </owl:onProperty>
            <owl:minCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
            >1</owl:minCardinality>
          </owl:Restriction>
          <owl:Restriction>
            <owl:minCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
            >1</owl:minCardinality>
            <owl:onProperty>
              <owl:ObjectProperty rdf:about="#EXPERIMENTAL-FORM"/>
            </owl:onProperty>
          </owl:Restriction>
        </owl:unionOf>
      </owl:Class>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#physicalEntityParticipant"/>
    <rdfs:subClassOf rdf:resource="#utilityClass"/>
  </owl:Class>
  <owl:Class rdf:ID="bioSource">
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#TISSUE"/>
        </owl:onProperty>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#xref"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#CELLTYPE"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: The biological source of an entity (e.g. protein, RNA or DNA). Some entities are considered source-neutral (e.g. small molecules), and the biological source of others can be deduced from their constituentss (e.g. complex, pathway).
Examples: HeLa cells, human, and mouse liver tissue.</rdfs:comment>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
        <owl:onProperty>
          <owl:ObjectProperty rdf:about="#TAXON-XREF"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:maxCardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:maxCardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#NAME"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf rdf:resource="#externalReferenceUtilityClass"/>
    <owl:disjointWith rdf:resource="#openControlledVocabulary"/>
    <owl:disjointWith rdf:resource="#dataSource"/>
  </owl:Class>
  <owl:Class rdf:ID="chemicalStructure">
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#STRUCTURE-FORMAT"/>
        </owl:onProperty>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
      </owl:Restriction>
    </rdfs:subClassOf>
    <rdfs:subClassOf rdf:resource="#utilityClass"/>
    <owl:disjointWith rdf:resource="#confidence"/>
    <owl:disjointWith rdf:resource="#pathwayStep"/>
    <rdfs:subClassOf>
      <owl:Restriction>
        <owl:cardinality rdf:datatype="http://www.w3.org/2001/XMLSchema#int"
        >1</owl:cardinality>
        <owl:onProperty>
          <owl:DatatypeProperty rdf:about="#STRUCTURE-DATA"/>
        </owl:onProperty>
      </owl:Restriction>
    </rdfs:subClassOf>
    <owl:disjointWith rdf:resource="#evidence"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Definition: Describes a small molecule structure. Structure information is stored in the property STRUCTURE-DATA, in one of three formats: the CML format (see URL www.xml-cml.org), the SMILES format (see URL www.daylight.com/dayhtml/smiles/) or the InChI format (http://www.iupac.org/inchi/). The STRUCTURE-FORMAT property specifies which format is used.
Comment: By virtue of the expressivity of CML, an instance of this class can also provide additional information about a small molecule, such as its chemical formula, names, and synonyms, if CML is used as the structure format.
Examples: The following SMILES string, which describes the structure of glucose-6-phosphate:
â€˜C(OP(=O)(O)O)[CH]1([CH](O)[CH](O)[CH](O)[CH](O)O1)â€™.</rdfs:comment>
    <owl:disjointWith rdf:resource="#sequenceLocation"/>
    <owl:disjointWith rdf:resource="#physicalEntityParticipant"/>
    <owl:disjointWith rdf:resource="#externalReferenceUtilityClass"/>
  </owl:Class>
  <owl:ObjectProperty rdf:ID="CONTROLLER">
    <rdfs:range rdf:resource="#physicalEntityParticipant"/>
    <rdfs:subPropertyOf>
      <owl:ObjectProperty rdf:about="#PARTICIPANTS"/>
    </rdfs:subPropertyOf>
    <rdfs:domain rdf:resource="#control"/>
    <rdfs:comment xml:lang="en">The controlling entity, e.g., in a biochemical reaction, an enzyme is the controlling entity of the reaction. CONTROLLER is a sub-property of PARTICIPANTS.</rdfs:comment>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="PARTICIPANTS">
    <rdfs:range>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Class rdf:about="#entity"/>
          <owl:Class rdf:about="#physicalEntityParticipant"/>
        </owl:unionOf>
      </owl:Class>
    </rdfs:range>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >This property lists the entities that participate in this interaction. For example, in a biochemical reaction, the participants are the union of the reactants and the products of the reaction. This property has a number of sub-properties, such as LEFT and RIGHT in the biochemicalInteraction class. Any participant listed in a sub-property will automatically be assumed to also be in PARTICIPANTS by a number of software systems, including ProtÃ©gÃ©, so this property should not contain any instances if there are instances contained in a sub-property.</rdfs:comment>
    <rdfs:domain rdf:resource="#interaction"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="XREF">
    <rdfs:range rdf:resource="#xref"/>
    <rdfs:comment xml:lang="en">Values of this property define external cross-references from this entity to entities in external databases.</rdfs:comment>
    <rdfs:domain>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Class rdf:about="#openControlledVocabulary"/>
          <owl:Class rdf:about="#entity"/>
          <owl:Class rdf:about="#sequenceFeature"/>
          <owl:Class rdf:about="#dataSource"/>
          <owl:Class rdf:about="#evidence"/>
          <owl:Class rdf:about="#confidence"/>
        </owl:unionOf>
      </owl:Class>
    </rdfs:domain>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="FEATURE-TYPE">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Description and classification of the feature.</rdfs:comment>
    <rdfs:range rdf:resource="#openControlledVocabulary"/>
    <rdfs:domain rdf:resource="#sequenceFeature"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="PATHWAY-COMPONENTS">
    <rdfs:domain rdf:resource="#pathway"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The set of interactions and/or pathwaySteps in this pathway/network. Each instance of the pathwayStep class defines: 1) a set of interactions that together define a particular step in the pathway, for example a catalysis instance and the conversion that it catalyzes; 2) an order relationship to one or more other pathway steps (via the NEXT-STEP property). Note: This ordering is not necessarily temporal - the order described may simply represent connectivity between adjacent steps. Temporal ordering information should only be inferred from the direction of each interaction.</rdfs:comment>
    <rdfs:range>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Class rdf:about="#interaction"/>
          <owl:Class rdf:about="#pathwayStep"/>
          <owl:Class rdf:about="#pathway"/>
        </owl:unionOf>
      </owl:Class>
    </rdfs:range>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="PARTICIPANT">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The participant that has the experimental form being described.</rdfs:comment>
    <rdfs:domain rdf:resource="#experimentalForm"/>
    <rdfs:range rdf:resource="#physicalEntityParticipant"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="PHYSICAL-ENTITY">
    <rdfs:range rdf:resource="#physicalEntity"/>
    <rdfs:domain rdf:resource="#physicalEntityParticipant"/>
    <rdfs:comment xml:lang="en">The physical entity annotated with stoichiometry and cellular location attributes from the physicalEntityParticipant instance.</rdfs:comment>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="EVIDENCE">
    <rdfs:domain>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Class rdf:about="#interaction"/>
          <owl:Class rdf:about="#pathway"/>
        </owl:unionOf>
      </owl:Class>
    </rdfs:domain>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Scientific evidence supporting the existence of the entity as described.</rdfs:comment>
    <rdfs:range rdf:resource="#evidence"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="RIGHT">
    <rdfs:subPropertyOf rdf:resource="#PARTICIPANTS"/>
    <rdfs:range rdf:resource="#physicalEntityParticipant"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The participants on the right side of the conversion interaction. Since conversion interactions may proceed in either the left-to-right or right-to-left direction, occupants of the RIGHT property may be either reactants or products. RIGHT is a sub-property of PARTICIPANTS.</rdfs:comment>
    <rdfs:domain rdf:resource="#conversion"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="CONFIDENCE">
    <rdfs:range rdf:resource="#confidence"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Confidence in the containing instance.  Usually a statistical measure.</rdfs:comment>
    <rdfs:domain rdf:resource="#evidence"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="STEP-INTERACTIONS">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The interactions that take place at this step of the pathway.</rdfs:comment>
    <rdfs:range>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Class rdf:about="#interaction"/>
          <owl:Class rdf:about="#pathway"/>
        </owl:unionOf>
      </owl:Class>
    </rdfs:range>
    <rdfs:domain rdf:resource="#pathwayStep"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="SEQUENCE-INTERVAL-BEGIN">
    <rdfs:range rdf:resource="#sequenceSite"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The begin position of a sequence interval.</rdfs:comment>
    <rdfs:domain rdf:resource="#sequenceInterval"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="INTERACTION-TYPE">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >External controlled vocabulary characterizing the interaction type, for example "phosphorylation".</rdfs:comment>
    <rdfs:range rdf:resource="#openControlledVocabulary"/>
    <rdfs:domain rdf:resource="#physicalInteraction"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="EVIDENCE-CODE">
    <rdfs:domain rdf:resource="#evidence"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >A pointer to a term in an external controlled vocabulary, such as the GO, PSI-MI or BioCyc evidence codes, that describes the nature of the support, such as 'traceable author statement' or 'yeast two-hybrid'.</rdfs:comment>
    <rdfs:range rdf:resource="#openControlledVocabulary"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="ORGANISM">
    <rdfs:comment xml:lang="en">An organism, e.g. 'Homo sapiens'. This is the organism that the entity is found in. Pathways may not have an organism associated with them, for instance, reference pathways from KEGG. Sequence-based entities (DNA, protein, RNA) may contain an xref to a sequence database that contains organism information, in which case the information should be consistent with the value for ORGANISM.</rdfs:comment>
    <rdfs:domain>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Class rdf:about="#rna"/>
          <owl:Class rdf:about="#protein"/>
          <owl:Class rdf:about="#pathway"/>
          <owl:Class rdf:about="#complex"/>
          <owl:Class rdf:about="#dna"/>
        </owl:unionOf>
      </owl:Class>
    </rdfs:domain>
    <rdfs:range rdf:resource="#bioSource"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="STRUCTURE">
    <rdfs:range rdf:resource="#chemicalStructure"/>
    <rdfs:domain rdf:resource="#smallMolecule"/>
    <rdfs:comment xml:lang="en">Defines the chemical structure and other information about this molecule, using an instance of class chemicalStructure.</rdfs:comment>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="SEQUENCE-FEATURE-LIST">
    <rdfs:domain rdf:resource="#sequenceParticipant"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Sequence features relevant for the interaction, for example binding domains or modification sites. Warning: this property may be moved into a state class in Level 3.</rdfs:comment>
    <rdfs:range rdf:resource="#sequenceFeature"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="TAXON-XREF">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >An xref to an organism taxonomy database, preferably NCBI taxon. This should be an instance of unificationXref, unless the organism is not in an existing database.</rdfs:comment>
    <rdfs:domain rdf:resource="#bioSource"/>
    <rdfs:range rdf:resource="#unificationXref"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="LEFT">
    <rdfs:domain rdf:resource="#conversion"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The participants on the left side of the conversion interaction. Since conversion interactions may proceed in either the left-to-right or right-to-left direction, occupants of the LEFT property may be either reactants or products. LEFT is a sub-property of PARTICIPANTS.</rdfs:comment>
    <rdfs:range rdf:resource="#physicalEntityParticipant"/>
    <rdfs:subPropertyOf rdf:resource="#PARTICIPANTS"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="CONTROLLED">
    <rdfs:range>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Class rdf:about="#entity"/>
          <owl:Class rdf:about="#physicalEntityParticipant"/>
        </owl:unionOf>
      </owl:Class>
    </rdfs:range>
    <rdfs:comment xml:lang="en">The entity that is controlled, e.g., in a biochemical reaction, the reaction is controlled by an enzyme. CONTROLLED is a sub-property of PARTICIPANTS.</rdfs:comment>
    <rdfs:subPropertyOf rdf:resource="#PARTICIPANTS"/>
    <rdfs:domain rdf:resource="#control"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="TISSUE">
    <rdfs:domain rdf:resource="#bioSource"/>
    <rdfs:comment xml:lang="en">An external controlled vocabulary of tissue types.</rdfs:comment>
    <rdfs:range rdf:resource="#openControlledVocabulary"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="COMPONENTS">
    <rdf:type rdf:resource="http://www.w3.org/2002/07/owl#TransitiveProperty"/>
    <rdfs:domain rdf:resource="#complex"/>
    <rdfs:range rdf:resource="#physicalEntityParticipant"/>
    <rdfs:comment xml:lang="en">Defines the physicalEntity subunits of this complex. This property should not contain other complexes, i.e. it should always be a flat representation of the complex. For example, if two protein complexes join to form a single larger complex via a complex assembly interaction, the COMPONENTS of the new complex should be the individual proteins of the smaller complexes, not the two smaller complexes themselves. Exceptions are black-box complexes (i.e. complexes in which the COMPONENTS property is empty), which may be used as COMPONENTS of other complexes because their constituent parts are unknown / unspecified. The reason for keeping complexes flat is to signify that there is no information stored in the way complexes are nested, such as assembly order.</rdfs:comment>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="COFACTOR">
    <rdfs:comment xml:lang="en">Any cofactor(s) or coenzyme(s) required for catalysis of the conversion by the enzyme. COFACTOR is a sub-property of PARTICIPANTS.</rdfs:comment>
    <rdfs:subPropertyOf rdf:resource="#PARTICIPANTS"/>
    <rdfs:domain rdf:resource="#catalysis"/>
    <rdfs:range rdf:resource="#physicalEntityParticipant"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="CELLULAR-LOCATION">
    <rdfs:range rdf:resource="#openControlledVocabulary"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >A cellular location, e.g. 'cytoplasm'. This should reference a term in the Gene Ontology Cellular Component ontology. The location referred to by this property should be as specific as is known. If an interaction is known to occur in multiple locations, separate interactions (and physicalEntityParticipants) must be created for each different location. Note: If a location is unknown then the GO term for 'cellular component unknown' (GO:0008372) should be used in the LOCATION property. If the location of a participant in a complex is unspecified, it may be assumed to be the same location as that of the complex. In case of conflicting information, the location of the most outer layer of any nesting should be considered correct. Note: Cellular location describes a specific location of a physical entity as it would be used in e.g. a transport reaction. It does not describe all of the possible locations that the physical entity could be in the cell.</rdfs:comment>
    <rdfs:domain rdf:resource="#physicalEntityParticipant"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="NEXT-STEP">
    <rdfs:domain rdf:resource="#pathwayStep"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The next step(s) of the pathway.  Contains zero or more pathwayStep instances.  If there is no next step, this property is empty.</rdfs:comment>
    <rdfs:range rdf:resource="#pathwayStep"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="FEATURE-LOCATION">
    <rdfs:domain rdf:resource="#sequenceFeature"/>
    <rdfs:range rdf:resource="#sequenceLocation"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Location of the feature on the sequence of the interactor. One feature may have more than one location, used e.g. for features which involve sequence positions close in the folded, three-dimensional state of a protein, but non-continuous along the sequence.</rdfs:comment>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="EXPERIMENTAL-FORM">
    <rdfs:range rdf:resource="#experimentalForm"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The experimental forms associated with an evidence instance.</rdfs:comment>
    <rdfs:domain rdf:resource="#evidence"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="SEQUENCE-INTERVAL-END">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The end position of a sequence interval.</rdfs:comment>
    <rdfs:domain rdf:resource="#sequenceInterval"/>
    <rdfs:range rdf:resource="#sequenceSite"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="EXPERIMENTAL-FORM-TYPE">
    <rdfs:range rdf:resource="#openControlledVocabulary"/>
    <rdfs:domain rdf:resource="#experimentalForm"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Descriptor of this experimental form from a controlled vocabulary.</rdfs:comment>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="DATA-SOURCE">
    <rdfs:range rdf:resource="#dataSource"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >A free text description of the source of this data, e.g. a database or person name. This property should be used to describe the source of the data. This is meant to be used by databases that export their data to the BioPAX format or by systems that are integrating data from multiple sources. The granularity of use (specifying the data source in many or few instances) is up to the user. It is intended that this property report the last data source, not all data sources that the data has passed through from creation.</rdfs:comment>
    <rdfs:domain rdf:resource="#entity"/>
  </owl:ObjectProperty>
  <owl:ObjectProperty rdf:ID="CELLTYPE">
    <rdfs:comment xml:lang="en">A cell type, e.g. 'HeLa'. This should reference a term in a controlled vocabulary of cell types.</rdfs:comment>
    <rdfs:range rdf:resource="#openControlledVocabulary"/>
    <rdfs:domain rdf:resource="#bioSource"/>
  </owl:ObjectProperty>
  <owl:DatatypeProperty rdf:ID="MOLECULAR-WEIGHT">
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#double"/>
    <rdfs:domain rdf:resource="#smallMolecule"/>
    <rdfs:comment xml:lang="en">Defines the molecular weight of the molecule, in daltons.</rdfs:comment>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="CHEMICAL-FORMULA">
    <rdfs:domain rdf:resource="#smallMolecule"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The chemical formula of the small molecule. Note: chemical formula can also be stored in the STRUCTURE property (in CML). In case of disagreement between the value of this property and that in the CML file, the CML value takes precedence.</rdfs:comment>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="AUTHORS">
    <rdfs:domain rdf:resource="#publicationXref"/>
    <rdfs:comment xml:lang="en">The authors of this publication, one per property value.</rdfs:comment>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="NAME">
    <rdfs:comment xml:lang="en">The preferred full name for this entity.</rdfs:comment>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    <rdfs:domain>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Class rdf:about="#bioSource"/>
          <owl:Class rdf:about="#entity"/>
          <owl:Class rdf:about="#dataSource"/>
          <owl:Class rdf:about="#sequenceFeature"/>
        </owl:unionOf>
      </owl:Class>
    </rdfs:domain>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="STRUCTURE-FORMAT">
    <rdfs:range>
      <owl:DataRange>
        <owl:oneOf rdf:parseType="Resource">
          <rdf:rest rdf:parseType="Resource">
            <rdf:rest rdf:parseType="Resource">
              <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
              >InChI</rdf:first>
              <rdf:rest rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#nil"/>
            </rdf:rest>
            <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
            >SMILES</rdf:first>
          </rdf:rest>
          <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
          >CML</rdf:first>
        </owl:oneOf>
      </owl:DataRange>
    </rdfs:range>
    <rdfs:comment xml:lang="en">This property specifies which format is used to define chemical structure data.</rdfs:comment>
    <rdfs:domain rdf:resource="#chemicalStructure"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="DB">
    <rdfs:comment xml:lang="en">The name of the external database to which this xref refers.</rdfs:comment>
    <rdfs:domain rdf:resource="#xref"/>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="SPONTANEOUS">
    <rdfs:range>
      <owl:DataRange>
        <owl:oneOf rdf:parseType="Resource">
          <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
          >L-R</rdf:first>
          <rdf:rest rdf:parseType="Resource">
            <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
            >R-L</rdf:first>
            <rdf:rest rdf:parseType="Resource">
              <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
              >NOT-SPONTANEOUS</rdf:first>
              <rdf:rest rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#nil"/>
            </rdf:rest>
          </rdf:rest>
        </owl:oneOf>
      </owl:DataRange>
    </rdfs:range>
    <rdfs:domain rdf:resource="#conversion"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Specifies whether a conversion occurs spontaneously (i.e. uncatalyzed, under biological conditions) left-to-right, right-to-left, or not at all. If the spontaneity is not known, the SPONTANEOUS property should be left empty.</rdfs:comment>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="SHORT-NAME">
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >An abbreviated name for this entity, preferably a name that is short enough to be used in a visualization application to label a graphical element that represents this entity. If no short name is available, an xref may be used for this purpose by the visualization application.</rdfs:comment>
    <rdfs:domain>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Class rdf:about="#sequenceFeature"/>
          <owl:Class rdf:about="#entity"/>
        </owl:unionOf>
      </owl:Class>
    </rdfs:domain>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="SEQUENCE-POSITION">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The integer listed gives the position. The first base or amino acid is position 1. In combination with the numeric value, the property 'POSITION-STATUS' allows to express fuzzy positions, e.g. 'less than 4'.</rdfs:comment>
    <rdfs:domain rdf:resource="#sequenceSite"/>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#unsignedLong"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="AVAILABILITY">
    <rdfs:comment xml:lang="en">Describes the availability of this data (e.g. a copyright statement).</rdfs:comment>
    <rdfs:domain rdf:resource="#entity"/>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="STRUCTURE-DATA">
    <rdfs:domain rdf:resource="#chemicalStructure"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >This property holds a string of data defining chemical structure or other information, in either the CML or SMILES format, as specified in property Structure-Format. If, for example, the CML format is used, then the value of this property is a string containing the XML encoding of the CML data.</rdfs:comment>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="SYNONYMS">
    <rdfs:domain>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Class rdf:about="#sequenceFeature"/>
          <owl:Class rdf:about="#entity"/>
        </owl:unionOf>
      </owl:Class>
    </rdfs:domain>
    <rdfs:comment xml:lang="en">One or more synonyms for the name of this entity. This should include the values of the NAME and SHORT-NAME property so that it is easy to find all known names in one place.</rdfs:comment>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="SEQUENCE">
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    <rdfs:domain>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Class rdf:about="#rna"/>
          <owl:Class rdf:about="#protein"/>
          <owl:Class rdf:about="#dna"/>
        </owl:unionOf>
      </owl:Class>
    </rdfs:domain>
    <rdfs:comment xml:lang="en">Polymer sequence in uppercase letters. For DNA, usually A,C,G,T letters representing the nucleosides of adenine, cytosine, guanine and thymine, respectively; for RNA, usually A, C, U, G; for protein, usually the letters corresponding to the 20 letter IUPAC amino acid code.</rdfs:comment>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="DELTA-S">
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#double"/>
    <rdfs:domain rdf:resource="#biochemicalReaction"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >For biochemical reactions, this property refers to the standard transformed entropy change for a reaction written in terms of biochemical reactants (sums of species), delta-S'&lt;sup>o&lt;/sup>.

  delta-G'&lt;sup>o&lt;/sup> = delta-H'&lt;sup>o&lt;/sup> - T delta-S'&lt;sup>o&lt;/sup>

(This definition from EcoCyc)</rdfs:comment>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="SOURCE">
    <rdfs:domain rdf:resource="#publicationXref"/>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The source  in which the reference was published, such as: a book title, or a journal title and volume and pages.</rdfs:comment>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="DELTA-H">
    <rdfs:domain rdf:resource="#biochemicalReaction"/>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#double"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >For biochemical reactions, this property refers to the standard transformed enthalpy change for a reaction written in terms of biochemical reactants (sums of species), delta-H'&lt;sup>o&lt;/sup>.

  delta-G'&lt;sup>o&lt;/sup> = delta-H'&lt;sup>o&lt;/sup> - T delta-S'&lt;sup>o&lt;/sup>

(This definition from EcoCyc)</rdfs:comment>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="COMMENT">
    <rdfs:domain>
      <owl:Class>
        <owl:unionOf rdf:parseType="Collection">
          <owl:Class rdf:about="#utilityClass"/>
          <owl:Class rdf:about="#entity"/>
        </owl:unionOf>
      </owl:Class>
    </rdfs:domain>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Comment on the data in the container class. This property should be used instead of the OWL documentation elements (rdfs:comment) for instances because information in COMMENT is data to be exchanged, whereas the rdfs:comment field is used for metadata about the structure of the BioPAX ontology.</rdfs:comment>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="DB-VERSION">
    <rdfs:comment xml:lang="en">The version of the external database in which this xref was last known to be valid. Resources may have recommendations for referencing dataset versions. For instance, the Gene Ontology recommends listing the date the GO terms were downloaded.</rdfs:comment>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    <rdfs:domain rdf:resource="#xref"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="CONFIDENCE-VALUE">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The value of the confidence measure.</rdfs:comment>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    <rdfs:domain rdf:resource="#confidence"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="URL">
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    <rdfs:comment xml:lang="en">The URL at which the publication can be found, if it is available through the Web.</rdfs:comment>
    <rdfs:domain rdf:resource="#publicationXref"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="DELTA-G">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >For biochemical reactions, this property refers to the standard transformed Gibbs energy change for a reaction written in terms of biochemical reactants (sums of species), delta-G'&lt;sup>o&lt;/sup>.

  delta-G'&lt;sup>o&lt;/sup> = -RT lnK'
and
  delta-G'&lt;sup>o&lt;/sup> = delta-H'&lt;sup>o&lt;/sup> - T delta-S'&lt;sup>o&lt;/sup>

delta-G'&lt;sup>o&lt;/sup> has units of kJ/mol.  Like K', it is a function of temperature (T), ionic strength (I), pH, and pMg (pMg = -log&lt;sub>10&lt;/sub>[Mg&lt;sup>2+&lt;/sup>]). Therefore, these quantities must be specified, and values for DELTA-G for biochemical reactions are represented as 5-tuples of the form (delta-G'&lt;sup>o&lt;/sup> T I pH pMg).  This property may have multiple values, representing different measurements for delta-G'&lt;sup>o&lt;/sup> obtained under the different experimental conditions listed in the 5-tuple.

(This definition from EcoCyc)</rdfs:comment>
    <rdfs:domain rdf:resource="#biochemicalReaction"/>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#double"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="TERM">
    <rdfs:domain rdf:resource="#openControlledVocabulary"/>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The external controlled vocabulary term.</rdfs:comment>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="TITLE">
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    <rdfs:comment xml:lang="en">The title of the publication.</rdfs:comment>
    <rdfs:domain rdf:resource="#publicationXref"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="RELATIONSHIP-TYPE">
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >This property names the type of relationship between the BioPAX object linked from, and the external object linked to, such as 'gene of this protein', or 'protein with similar sequence'.</rdfs:comment>
    <rdfs:domain rdf:resource="#relationshipXref"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="POSITION-STATUS">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The confidence status of the sequence position. This could be:
EQUAL: The SEQUENCE-POSITION is known to be at the SEQUENCE-POSITION.
GREATER-THAN: The site is greater than the SEQUENCE-POSITION.
LESS-THAN: The site is less than the SEQUENCE-POSITION.</rdfs:comment>
    <rdfs:domain rdf:resource="#sequenceSite"/>
    <rdfs:range>
      <owl:DataRange>
        <owl:oneOf rdf:parseType="Resource">
          <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
          >EQUAL</rdf:first>
          <rdf:rest rdf:parseType="Resource">
            <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
            >LESS-THAN</rdf:first>
            <rdf:rest rdf:parseType="Resource">
              <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
              >GREATER-THAN</rdf:first>
              <rdf:rest rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#nil"/>
            </rdf:rest>
          </rdf:rest>
        </owl:oneOf>
      </owl:DataRange>
    </rdfs:range>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="ID">
    <rdfs:domain rdf:resource="#xref"/>
    <rdfs:comment xml:lang="en">The primary identifier in the external database of the object to which this xref refers.</rdfs:comment>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="ID-VERSION">
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
    <rdfs:domain rdf:resource="#xref"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The version number of the identifier (ID). E.g. The RefSeq accession number NM_005228.3 should be split into NM_005228 as the ID and 3 as the ID-VERSION.</rdfs:comment>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="EC-NUMBER">
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The unique number assigned to a reaction by the Enzyme Commission of the International Union of Biochemistry and Molecular Biology.

Note that not all biochemical reactions currently have EC numbers assigned to them.</rdfs:comment>
    <rdfs:domain rdf:resource="#biochemicalReaction"/>
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#string"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="YEAR">
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#int"/>
    <rdfs:domain rdf:resource="#publicationXref"/>
    <rdfs:comment xml:lang="en">The year in which this publication was published.</rdfs:comment>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="DIRECTION">
    <rdfs:domain rdf:resource="#catalysis"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Specifies the reaction direction of the interaction catalyzed by this instance of the catalysis class.

Possible values of this slot are:

REVERSIBLE: Interaction occurs in both directions in physiological settings.

PHYSIOL-LEFT-TO-RIGHT
PHYSIOL-RIGHT-TO-LEFT
The interaction occurs in the specified direction in physiological settings,  because of several possible factors including the energetics of the reaction, local concentrations
of reactants and products, and the regulation of the enzyme or its expression.

IRREVERSIBLE-LEFT-TO-RIGHT
IRREVERSIBLE-RIGHT-TO-LEFT
For all practical purposes, the interactions occurs only in the specified direction in physiological settings, because of chemical properties of the reaction.

(This definition from EcoCyc)</rdfs:comment>
    <rdfs:range>
      <owl:DataRange>
        <owl:oneOf rdf:parseType="Resource">
          <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
          >REVERSIBLE</rdf:first>
          <rdf:rest rdf:parseType="Resource">
            <rdf:rest rdf:parseType="Resource">
              <rdf:rest rdf:parseType="Resource">
                <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
                >IRREVERSIBLE-LEFT-TO-RIGHT</rdf:first>
                <rdf:rest rdf:parseType="Resource">
                  <rdf:rest rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#nil"/>
                  <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
                  >IRREVERSIBLE-RIGHT-TO-LEFT</rdf:first>
                </rdf:rest>
              </rdf:rest>
              <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
              >PHYSIOL-RIGHT-TO-LEFT</rdf:first>
            </rdf:rest>
            <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
            >PHYSIOL-LEFT-TO-RIGHT</rdf:first>
          </rdf:rest>
        </owl:oneOf>
      </owl:DataRange>
    </rdfs:range>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="KEQ">
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#double"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >This quantity is dimensionless and is usually a single number. The measured equilibrium constant for a biochemical reaction, encoded by the slot KEQ, is actually the apparent equilibrium constant, K'.  Concentrations in the equilibrium constant equation refer to the total concentrations of  all forms of particular biochemical reactants. For example, in the equilibrium constant equation for the biochemical reaction in which ATP is hydrolyzed to ADP and inorganic phosphate:

K' = [ADP][P&lt;sub>i&lt;/sub>]/[ATP],

The concentration of ATP refers to the total concentration of all of the following species:

[ATP] = [ATP&lt;sup>4-&lt;/sup>] + [HATP&lt;sup>3-&lt;/sup>] + [H&lt;sub>2&lt;/sub>ATP&lt;sup>2-&lt;/sup>] + [MgATP&lt;sup>2-&lt;/sup>] + [MgHATP&lt;sup>-&lt;/sup>] + [Mg&lt;sub>2&lt;/sub>ATP].

The apparent equilibrium constant is formally dimensionless, and can be kept so by inclusion of as many of the terms (1 mol/dm&lt;sup>3&lt;/sup>) in the numerator or denominator as necessary.  It is a function of temperature (T), ionic strength (I), pH, and pMg (pMg = -log&lt;sub>10&lt;/sub>[Mg&lt;sup>2+&lt;/sup>]). Therefore, these quantities must be specified to be precise, and values for KEQ for biochemical reactions may be represented as 5-tuples of the form (K' T I pH pMg).  This property may have multiple values, representing different measurements for K' obtained under the different experimental conditions listed in the 5-tuple. (This definition adapted from EcoCyc)</rdfs:comment>
    <rdfs:domain rdf:resource="#biochemicalReaction"/>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="CONTROL-TYPE">
    <rdfs:domain rdf:resource="#control"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Defines the nature of the control relationship between the CONTROLLER and the CONTROLLED entities.

The following terms are possible values:

ACTIVATION: General activation. Compounds that activate the specified enzyme activity by an unknown mechanism. The mechanism is defined as unknown, because either the mechanism has yet to be elucidated in the experimental literature, or the paper(s) curated thus far do not define the mechanism, and a full literature search has yet to be performed.

The following term can not be used in the catalysis class:
INHIBITION: General inhibition. Compounds that inhibit the specified enzyme activity by an unknown mechanism. The mechanism is defined as unknown, because either the mechanism has yet to be elucidated in the experimental literature, or the paper(s) curated thus far do not define the mechanism, and a full literature search has yet to be performed.

The following terms can only be used in the modulation class (these definitions from EcoCyc):
INHIBITION-ALLOSTERIC
Allosteric inhibitors decrease the specified enzyme activity by binding reversibly to the enzyme and inducing a conformational change that decreases the affinity of the enzyme to its substrates without affecting its VMAX. Allosteric inhibitors can be competitive or noncompetitive inhibitors, therefore, those inhibition categories can be used in conjunction with this category.

INHIBITION-COMPETITIVE
Competitive inhibitors are compounds that competitively inhibit the specified enzyme activity by binding reversibly to the enzyme and preventing the substrate from binding. Binding of the inhibitor and substrate are mutually exclusive because it is assumed that the inhibitor and substrate can both bind only to the free enzyme. A competitive inhibitor can either bind to the active site of the enzyme, directly excluding the substrate from binding there, or it can bind to another site on the enzyme, altering the conformation of the enzyme such that the substrate can not bind to the active site.

INHIBITION-IRREVERSIBLE
Irreversible inhibitors are compounds that irreversibly inhibit the specified enzyme activity by binding to the enzyme and dissociating so slowly that it is considered irreversible. For example, alkylating agents, such as iodoacetamide, irreversibly inhibit the catalytic activity of some enzymes by modifying cysteine side chains.

INHIBITION-NONCOMPETITIVE
Noncompetitive inhibitors are compounds that noncompetitively inhibit the specified enzyme by binding reversibly to both the free enzyme and to the enzyme-substrate complex. The inhibitor and substrate may be bound to the enzyme simultaneously and do not exclude each other. However, only the enzyme-substrate complex (not the enzyme-substrate-inhibitor complex) is catalytically active.

INHIBITION-OTHER
Compounds that inhibit the specified enzyme activity by a mechanism that has been characterized, but that cannot be clearly classified as irreversible, competitive, noncompetitive, uncompetitive, or allosteric.

INHIBITION-UNCOMPETITIVE
Uncompetitive inhibitors are compounds that uncompetitively inhibit the specified enzyme activity by binding reversibly to the enzyme-substrate complex but not to the enzyme alone.

ACTIVATION-NONALLOSTERIC
Nonallosteric activators increase the specified enzyme activity by means other than allosteric.

ACTIVATION-ALLOSTERIC
Allosteric activators increase the specified enzyme activity by binding reversibly to the enzyme and inducing a conformational change that increases the affinity of the enzyme to its substrates without affecting its VMAX.</rdfs:comment>
    <rdfs:range>
      <owl:DataRange>
        <owl:oneOf rdf:parseType="Resource">
          <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
          >INHIBITION</rdf:first>
          <rdf:rest rdf:parseType="Resource">
            <rdf:rest rdf:parseType="Resource">
              <rdf:rest rdf:parseType="Resource">
                <rdf:rest rdf:parseType="Resource">
                  <rdf:rest rdf:parseType="Resource">
                    <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
                    >INHIBITION-NONCOMPETITIVE</rdf:first>
                    <rdf:rest rdf:parseType="Resource">
                      <rdf:rest rdf:parseType="Resource">
                        <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
                        >INHIBITION-UNCOMPETITIVE</rdf:first>
                        <rdf:rest rdf:parseType="Resource">
                          <rdf:rest rdf:parseType="Resource">
                            <rdf:rest rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#nil"/>
                            <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
                            >ACTIVATION-ALLOSTERIC</rdf:first>
                          </rdf:rest>
                          <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
                          >ACTIVATION-NONALLOSTERIC</rdf:first>
                        </rdf:rest>
                      </rdf:rest>
                      <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
                      >INHIBITION-OTHER</rdf:first>
                    </rdf:rest>
                  </rdf:rest>
                  <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
                  >INHIBITION-IRREVERSIBLE</rdf:first>
                </rdf:rest>
                <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
                >INHIBITION-COMPETITIVE</rdf:first>
              </rdf:rest>
              <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
              >INHIBITION-ALLOSTERIC</rdf:first>
            </rdf:rest>
            <rdf:first rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
            >ACTIVATION</rdf:first>
          </rdf:rest>
        </owl:oneOf>
      </owl:DataRange>
    </rdfs:range>
  </owl:DatatypeProperty>
  <owl:DatatypeProperty rdf:ID="STOICHIOMETRIC-COEFFICIENT">
    <rdfs:range rdf:resource="http://www.w3.org/2001/XMLSchema#double"/>
    <rdfs:comment rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Each value of this property represents the stoichiometric coefficient for one of the physical entities in an interaction or complex. For a given interaction, the stoichiometry should always be used where possible instead of representing the number of participants with separate instances of each participant. If there are three ATP molecules, one ATP molecule should be represented as a participant and the stoichiometry should be set to 3.</rdfs:comment>
    <rdfs:domain rdf:resource="#physicalEntityParticipant"/>
  </owl:DatatypeProperty>
  <relationshipXref rdf:ID="relationshipXref504">
    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
    <DB>OMIM</DB>
    <ID>313700</ID>
  </relationshipXref>
  <evidence rdf:ID="evidence321">
    <XREF>
      <publicationXref rdf:ID="publicationXref393">
        <ID>14579272</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
    <EVIDENCE-CODE>
      <openControlledVocabulary rdf:ID="openControlledVocabulary651">
        <TERM>in vitro</TERM>
        <XREF>
          <unificationXref rdf:ID="unificationXref524">
            <ID>MI:0492</ID>
            <DB>PSIMI</DB>
          </unificationXref>
        </XREF>
      </openControlledVocabulary>
    </EVIDENCE-CODE>
  </evidence>
  <evidence rdf:ID="evidence325">
    <XREF>
      <publicationXref rdf:ID="publicationXref436">
        <DB>Pubmed</DB>
        <ID>9247637</ID>
      </publicationXref>
    </XREF>
  </evidence>
  <sequenceParticipant rdf:ID="sequenceParticipant101">
    <CELLULAR-LOCATION>
      <openControlledVocabulary rdf:ID="openControlledVocabulary652">
        <XREF>
          <unificationXref rdf:ID="unificationXref528">
            <DB>GO</DB>
            <ID>0005737</ID>
          </unificationXref>
        </XREF>
        <TERM>cytoplasm</TERM>
      </openControlledVocabulary>
    </CELLULAR-LOCATION>
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein220">
        <XREF>
          <publicationXref rdf:ID="publicationXref375">
            <ID>11684709</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref377">
            <DB>Pubmed</DB>
            <ID>8655574</ID>
          </publicationXref>
        </XREF>
        <SHORT-NAME>FYN</SHORT-NAME>
        <SYNONYMS>LK</SYNONYMS>
        <ORGANISM>
          <bioSource rdf:ID="bioSource44">
            <NAME>Homo sapiens</NAME>
            <TAXON-XREF>
              <unificationXref rdf:ID="unificationXref527">
                <ID>9606</ID>
                <DB>taxon</DB>
              </unificationXref>
            </TAXON-XREF>
          </bioSource>
        </ORGANISM>
        <SYNONYMS>OKT3-induced calcium influx regulator</SYNONYMS>
        <SYNONYMS>tyrosine kinase p59fyn(T)</SYNONYMS>
        <NAME>FYN</NAME>
        <SYNONYMS>c-syn protooncogene</SYNONYMS>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref474">
            <DB>OMIM</DB>
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
            <ID>137025</ID>
          </relationshipXref>
        </XREF>
        <XREF>
          <unificationXref rdf:ID="unificationXref536">
            <DB>HPRD</DB>
            <ID>00655</ID>
          </unificationXref>
        </XREF>
        <SEQUENCE>MGCVQCKDKEATKLTEERDGSLNQSSGYRYGTDPTPQHYPSFGVTSIPNYNNFHAAGGQGLTVFGGVNSSSHTGTLRTRGGTGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSIQAEEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLVQHYSERAAGLCCRLVVPCHKGMPRLTDLSVKTKDVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPGENL</SEQUENCE>
        <SYNONYMS>MGC45350</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref376">
            <ID>9060467</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <XREF>
          <unificationXref rdf:ID="unificationXref535">
            <DB>refseq</DB>
            <ID>NP_002028</ID>
          </unificationXref>
        </XREF>
        <SYNONYMS>FYN</SYNONYMS>
        <SYNONYMS>proto-oncogene tyrosine-protein kinase fyn</SYNONYMS>
        <SYNONYMS>SYN</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
  </sequenceParticipant>
  <evidence rdf:ID="evidence316">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <XREF>
      <publicationXref rdf:ID="publicationXref429">
        <DB>Pubmed</DB>
        <ID>11375975</ID>
      </publicationXref>
    </XREF>
    <EVIDENCE-CODE>
      <openControlledVocabulary rdf:ID="openControlledVocabulary900">
        <XREF>
          <unificationXref rdf:ID="unificationXref598">
            <ID>MI:0018</ID>
            <DB>PSIMI</DB>
          </unificationXref>
        </XREF>
        <TERM>two hybrid</TERM>
      </openControlledVocabulary>
    </EVIDENCE-CODE>
  </evidence>
  <evidence rdf:ID="evidence320">
    <XREF>
      <publicationXref rdf:ID="publicationXref431">
        <ID>10637308</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
  </evidence>
  <sequenceParticipant rdf:ID="sequenceParticipant137">
    <CELLULAR-LOCATION>
      <openControlledVocabulary rdf:ID="openControlledVocabulary657">
        <TERM>plasma membrane</TERM>
        <XREF>
          <unificationXref rdf:ID="unificationXref540">
            <DB>GO</DB>
            <ID>0005886</ID>
          </unificationXref>
        </XREF>
      </openControlledVocabulary>
    </CELLULAR-LOCATION>
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein233">
        <SYNONYMS>CD49f</SYNONYMS>
        <SEQUENCE>MAAAGQLCLLYLSAGLLSRLGAAFNLDTREDNVIRKYGDPGSLFGFSLAMHWQLQPEDKRLLLVGAPRGEALPLQRANRTGGLYSCDITARGPCTRIEFDNDADPTSESKEDQWMGVTVQSQGPGGKVVTCAHRYEKRQHVNTKQESRDIFGRCYVLSQNLRIEDDMDGGDWSFCDGRLRGHEKFGSCQQGVAATFTKDFHYIVFGAPGTYNWKGIVRVEQKNNTFFDMNIFEDGPYEVGGETEHDESLVPVPANSYLGFSLDSGKGIVSKDEITFVSGAPRANHSGAVVLLKRDMKSAHLLPEHIFDGEGLASSFGYDVAVVDLNKDGWQDIVIGAPQYFDRDGEVGGAVYVYMNQQGRWNNVKPIRLNGTKDSMFGIAVKNIGDINQDGYPDIAVGAPYDDLGKVFIYHGSANGINTKPTQVLKGISPYFGYSIAGNMDLDRNSYPDVAVGSLSDSVTIFRSRPVINIQKTITVTPNRIDLRQKTACGAPSGICLQVKSCFEYTANPAGYNPSISIVGTLEAEKERRKSGLSSRVQFRNQGSEPKYTQELTLKRQKQKVCMEETLWLQDNIRDKLRPIPITASVEIQEPSSRRRVNSLPEVLPILNSDEPKTAHIDVHFLKEGCGDDNVCNSNLKLEYKFCTREGNQDKFSYLPIQKGVPELVLKDQKDIALEITVTNSPSNPRNPTKDGDDAHEAKLIATFPDTLTYSAYRELRAFPEKQLSCVANQNGSQADCELGNPFKRNSNVTFYLVLSTTEVTFDTPYLDINLKLETTSNQDNLAPITAKAKVVIELLLSVSGVAKPSQVYFGGTVVGEQAMKSEDEVGSLIEYEFRVINLGKPLTNLGTATLNIQWPKEISNGKWLLYLVKVESKGLEKVTCEPQKEINSLNLTESHNSRKKREITEKQIDDNRKFSLFAERKYQTLNCSVNVNCVNIRCPLRGLDSKASLILRSRLWNSTFLEEYSKLNYLDILMRAFIDVTAAAENIRLPNAGTQVRVTVFPSKTVAQYSGVPWWIILVAILAGILMLALLVFILWKCGFFKRNKKDHYDATYHKAEIHAQPSDKERLTSDA</SEQUENCE>
        <SYNONYMS>VLA-6</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref566">
            <DB>HPRD</DB>
            <ID>00945</ID>
          </unificationXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref399">
            <ID>7721947</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref486">
            <DB>OMIM</DB>
            <ID>147556</ID>
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
          </relationshipXref>
        </XREF>
        <SHORT-NAME>ITGA6</SHORT-NAME>
        <ORGANISM rdf:resource="#bioSource44"/>
        <NAME>ITGA6</NAME>
        <XREF>
          <unificationXref rdf:ID="unificationXref565">
            <DB>refseq</DB>
            <ID>NP_000201</ID>
          </unificationXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref398">
            <DB>Pubmed</DB>
            <ID>2070796</ID>
          </publicationXref>
        </XREF>
        <SYNONYMS>ITGA6</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
  </sequenceParticipant>
  <unificationXref rdf:ID="unificationXref617">
    <ID>01809</ID>
    <DB>HPRD</DB>
  </unificationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant120">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein237">
        <SYNONYMS>Focal adhesion kinase 1</SYNONYMS>
        <SYNONYMS>PTK2</SYNONYMS>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref490">
            <DB>OMIM</DB>
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
            <ID>600758</ID>
          </relationshipXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref405">
            <ID>10801330</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <ORGANISM rdf:resource="#bioSource44"/>
        <SEQUENCE>MAAAYLDPNLNHTPNSSTKTHLGTGMERSPGAMERVLKVFHYFESNSEPTTWASIIRHGDATDVRGIIQKIVDSHKVKHVACYGFRLSHLRSEEVHWLHVDMGVSSVREKYELAHPPEEWKYELRIRYLPKGFLNQFTEDKPTLNFFYQQVKSDYMLEIADQVDQEIALKLGCLEIRRSYWEMRGNALEKKSNYEVLEKDVGLKRFFPKSLLDSVKAKTLRKLIQQTFRQFANLNREESILKFFEILSPVYRFDKECFKCALGSSWIISVELAIGPEEGISYLTDKGCNPTHLADFTQVQTIQYSNSEDKDRKGMLQLKIAGAPEPLTVTAPSLTIAENMADLIDGYCRLVNGTSQSFIIRPQKEGERALPSIPKLANSEKQGMRTHAVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQQEERMRMESRRQATVSWDSGGSDEAPPKPSRPGYPSPRSSEGFYPSPQHMVQTNHYQVSGYPGSHGITAMAGSIYPGQASLLDQTDSWNHRPQEIAMWQPNVEDSTVLDLRGIGQVLPTHLMEERLIRQQQEMEEDQRWLEKEERFLKPDVRLSRGSIDREDGSLQGPIGNQHIYQPVGKPDPAAPPKKPPRPGAPGHLGSLASLSSPADSYNEGVKLQPQEISPPPTANLDRSNDKVYENVTGLVKAVIEMSSKIQPAPPEEYVPMVKEVGLALRTLLATVDETIPLLPASTHREIEMAQKLLNSDLGELINKMKLAQQYVMTSLQQEYKKQMLTAAHALAVDAKNLLDVIDQARLKMLGQTRPH</SEQUENCE>
        <SHORT-NAME>PTK2</SHORT-NAME>
        <SYNONYMS>Focal adhesion kinase</SYNONYMS>
        <SYNONYMS>Protein tyrosine kinase 2</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref574">
            <ID>02859</ID>
            <DB>HPRD</DB>
          </unificationXref>
        </XREF>
        <SYNONYMS>FAK1</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref403">
            <DB>Pubmed</DB>
            <ID>12110680</ID>
          </publicationXref>
        </XREF>
        <SYNONYMS>FADK 1</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref573">
            <ID>NP_722560</ID>
            <DB>refseq</DB>
          </unificationXref>
        </XREF>
        <NAME>FAK</NAME>
        <SYNONYMS>FAK</SYNONYMS>
        <SYNONYMS>pp125FAK</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
  </sequenceParticipant>
  <publicationXref rdf:ID="publicationXref435">
    <ID>9531560</ID>
    <DB>Pubmed</DB>
  </publicationXref>
  <physicalEntityParticipant rdf:ID="physicalEntityParticipant36">
    <PHYSICAL-ENTITY>
      <complex rdf:ID="complex40">
        <COMPONENTS>
          <sequenceParticipant rdf:ID="sequenceParticipant187">
            <PHYSICAL-ENTITY>
              <protein rdf:ID="protein223">
                <XREF>
                  <publicationXref rdf:ID="publicationXref384">
                    <ID>11331299</ID>
                    <DB>Pubmed</DB>
                  </publicationXref>
                </XREF>
                <XREF>
                  <unificationXref rdf:ID="unificationXref544">
                    <DB>genbank</DB>
                    <ID>P27986</ID>
                  </unificationXref>
                </XREF>
                <XREF>
                  <unificationXref rdf:ID="unificationXref545">
                    <ID>01381</ID>
                    <DB>HPRD</DB>
                  </unificationXref>
                </XREF>
                <SYNONYMS>Phosphatidyl inositol 3 kinase associated p85 alpha</SYNONYMS>
                <SYNONYMS>Phosphatidyl inositol 3 kinase regulatory 85 KD, alpha</SYNONYMS>
                <SYNONYMS>p85 alpha</SYNONYMS>
                <SYNONYMS>Phosphatidylinositol 3 kinase regulatory subunit, alpha</SYNONYMS>
                <SHORT-NAME>PIK3R1</SHORT-NAME>
                <NAME>PIK3R1</NAME>
                <XREF>
                  <relationshipXref rdf:ID="relationshipXref477">
                    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                    <DB>OMIM</DB>
                    <ID>171833</ID>
                  </relationshipXref>
                </XREF>
                <SEQUENCE>MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQNAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR</SEQUENCE>
                <XREF>
                  <publicationXref rdf:ID="publicationXref383">
                    <ID>11752634</ID>
                    <DB>Pubmed</DB>
                  </publicationXref>
                </XREF>
                <SYNONYMS>GRB1</SYNONYMS>
                <ORGANISM rdf:resource="#bioSource44"/>
                <SYNONYMS>PIK3R1</SYNONYMS>
              </protein>
            </PHYSICAL-ENTITY>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
          </sequenceParticipant>
        </COMPONENTS>
        <COMPONENTS>
          <sequenceParticipant rdf:ID="sequenceParticipant193">
            <PHYSICAL-ENTITY>
              <protein rdf:ID="protein272">
                <XREF>
                  <publicationXref rdf:ID="publicationXref461">
                    <DB>Pubmed</DB>
                    <ID>10973965</ID>
                  </publicationXref>
                </XREF>
                <XREF>
                  <relationshipXref rdf:ID="relationshipXref520">
                    <DB>OMIM</DB>
                    <ID>601232</ID>
                    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                  </relationshipXref>
                </XREF>
                <XREF>
                  <unificationXref rdf:ID="unificationXref644">
                    <DB>refseq</DB>
                    <ID>NP_002640</ID>
                  </unificationXref>
                </XREF>
                <SYNONYMS>PIK3CG</SYNONYMS>
                <SHORT-NAME>PIK3CG</SHORT-NAME>
                <SYNONYMS>PI3K gamma</SYNONYMS>
                <SEQUENCE>MELENYKQPVVLREDNCRRRRRMKPRSAAASLSSMELIPIEFVLPTSQRKCKSPETALLHVAGHGNVEQMKAQVWLRALETSVAADFYHRLGPHHFLLLYQKKGQWYEIYDKYQVVQTLDCLRYWKATHRSPGQIHLVQRHPPSEESQAFQRQLTALIGYDVTDVSNVHDDELEFTRRGLVTPRMAEVASRDPKLYAMHPWVTSKPLPEYLWKKIANNCIFIVIHRSTTSQTIKVSPDDTPGAILQSFFTKMAKKKSLMDIPESQSEQDFVLRVCGRDEYLVGETPIKNFQWVRHCLKNGEEIHVVLDTPPDPALDEVRKEEWPLVDDCTGVTGYHEQLTIHGKDHESVFTVSLWDCDRKFRVKIRGIDIPVLPRNTDLTVFVEANIQHGQQVLCQRRTSPKPFTEEVLWNVWLEFSIKIKDLPKGALLNLQIYCGKAPALSSKASAESPSSESKGKVQLLYYVNLLLIDHRFLLRRGEYVLHMWQISGKGEDQGSFNADKLTSATNPDKENSMSISILLDNYCHPIALPKHQPTPDPEGDRVRAEMPNQLRKQLEAIIATDPLNPLTAEDKELLWHFRYESLKHPKAYPKLFSSVKWGQQEIVAKTYQLLARREVWDQSALDVGLTMQLLDCNFSDENVRAIAVQKLESLEDDDVLHYLLQLVQAVKFEPYHDSALARFLLKRGLRNKRIGHFLFWFLRSEIAQSRHYQQRFAVILEAYLRGCGTAMLHDFTQQVQVIEMLQKVTLDIKSLSAEKYDVSSQVISQLKQKLENLQNSQLPESFRVPYDPGLKAGALAIEKCKVMASKKKPLWLEFKCADPTALSNETIGIIFKHGDDLRQDMLILQILRIMESIWETESLDLCLLPYGCISTGDKIGMIEIVKDATTIAKIQQSTVGNTGAFKDEVLNHWLKEKSPTEEKFQAAVERFVYSCAGYCVATFVLGIGDRHNDNIMITETGNLFHIDFGHILGNYKSFLGINKERVPFVLTPDFLFVMGTSGKKTSPHFQKFQDICVKAYLALRHHTNLLIILFSMMLMTGMPQLTSKEDIEYIRDALTVGKNEEDAKKYFLDQIEVCRDKGWTVQFNWFLHLVLGIKQGEKHSA</SEQUENCE>
                <NAME>PIK3CG</NAME>
                <ORGANISM rdf:resource="#bioSource44"/>
                <SYNONYMS>p110-gamma</SYNONYMS>
                <SYNONYMS>PI3-kinase p110 subunit gamma</SYNONYMS>
                <XREF>
                  <unificationXref rdf:ID="unificationXref645">
                    <ID>03135</ID>
                    <DB>HPRD</DB>
                  </unificationXref>
                </XREF>
                <XREF>
                  <publicationXref rdf:ID="publicationXref464">
                    <ID>11416136</ID>
                    <DB>Pubmed</DB>
                  </publicationXref>
                </XREF>
              </protein>
            </PHYSICAL-ENTITY>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
          </sequenceParticipant>
        </COMPONENTS>
        <ORGANISM rdf:resource="#bioSource44"/>
        <NAME>PIK3R1-Human_PIK3R2-Human_PIK3R3-Human_PIK3CA-Human_PIK3CB-Human_PIK3CD-Human_PIK3CG-Human</NAME>
        <COMPONENTS>
          <sequenceParticipant rdf:ID="sequenceParticipant189">
            <CELLULAR-LOCATION>
              <openControlledVocabulary rdf:ID="openControlledVocabulary659">
                <XREF>
                  <unificationXref rdf:ID="unificationXref549">
                    <ID>0008372</ID>
                    <DB>GO</DB>
                  </unificationXref>
                </XREF>
                <TERM>cellular component unknown</TERM>
              </openControlledVocabulary>
            </CELLULAR-LOCATION>
            <PHYSICAL-ENTITY>
              <protein rdf:ID="protein268">
                <SYNONYMS>Phosphatidylinositol 3-kinase, regulatory gamma subunit</SYNONYMS>
                <SYNONYMS>p55PIK</SYNONYMS>
                <XREF>
                  <unificationXref rdf:ID="unificationXref637">
                    <DB>HPRD</DB>
                    <ID>05831</ID>
                  </unificationXref>
                </XREF>
                <SEQUENCE>MYNTVWSMDRDDADWREVMMPYSTELIFYIEMDPPALPPKPPKPMTSAVPNGMKDSSVSLQDAEWYWGDISREEVNDKLRDMPDGTFLVRDASTKMQGDYTLTLRKGGNNKLIKIYHRDGKYGFSDPLTFNSVVELINHYHHESLAQYNPKLDVKLMYPVSRYQQDQLVKEDNIDAVGKKLQEYHSQYQEKSKEYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCHTQEQHSKEYIERFRREGNEKEIERIMMNYDKLKSRLGEIHDSKMRLEQDLKNQALDNREIDKKMNSIKPDLIQLRKIRDQHLVWLNHKGVRQKRLNVWLGIKNEDAAENYFINEEDENLPHYDEKTWFVEDINRVQAEDLLYGKPDGAFLIRESSKKGCYACSVVADGEVKHCVIYSTARGYGFAEPYNLYSSLKELVLHYQQTSLVQHNDSLNVRLAYPVHAQMPSLCR</SEQUENCE>
                <NAME>PIK3R3</NAME>
                <SYNONYMS>PIK3R3</SYNONYMS>
                <XREF>
                  <relationshipXref rdf:ID="relationshipXref516">
                    <ID>606076</ID>
                    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                    <DB>OMIM</DB>
                  </relationshipXref>
                </XREF>
                <SHORT-NAME>PIK3R3</SHORT-NAME>
                <XREF rdf:resource="#publicationXref461"/>
                <ORGANISM rdf:resource="#bioSource44"/>
                <XREF>
                  <unificationXref rdf:ID="unificationXref636">
                    <DB>refseq</DB>
                    <ID>NP_003620</ID>
                  </unificationXref>
                </XREF>
                <SYNONYMS>p55 gamma</SYNONYMS>
              </protein>
            </PHYSICAL-ENTITY>
          </sequenceParticipant>
        </COMPONENTS>
        <COMPONENTS>
          <sequenceParticipant rdf:ID="sequenceParticipant192">
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
            <PHYSICAL-ENTITY>
              <protein rdf:ID="protein271">
                <XREF>
                  <unificationXref rdf:ID="unificationXref643">
                    <DB>HPRD</DB>
                    <ID>04161</ID>
                  </unificationXref>
                </XREF>
                <SYNONYMS>PIK3CD</SYNONYMS>
                <SYNONYMS>p110-delta</SYNONYMS>
                <XREF>
                  <relationshipXref rdf:ID="relationshipXref519">
                    <DB>OMIM</DB>
                    <ID>602839</ID>
                    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                  </relationshipXref>
                </XREF>
                <ORGANISM rdf:resource="#bioSource44"/>
                <XREF>
                  <unificationXref rdf:ID="unificationXref642">
                    <DB>uniprot</DB>
                    <ID>AAB53966</ID>
                  </unificationXref>
                </XREF>
                <SEQUENCE>MPPGVDCPMEFWTKEENQRVVVDFLLPTGVYLNFPVSRNANLSTIKQLLWHRAQYEPLFHMLSAPKAYVFTCINQTAEQQELEDEQRRLCDVQPFLPVLRLVAREGDRVKKLINSQISLLIGKGLHEFDSLCDPEVNDFRAKMCQFCEEAAARRQQLGWEAWLQYSFPLQLEPSAQTWGPGTLRLPNRALLVNVKFEGSEESFTFQVSTKDVPLALMACALRKKATVFRQPLVEQPEDYTLQVNGRHEYLYGSYPLCQFQVQKPRAKPPPIPAKKPSSVSLWSLEQPFRIELIQGSKVNADERMKLVVQAGLFHGNEMLCKTVSSSEVSVCSEPVWKQRLEFDINICDLPRMARLCFALYAVIEKAKKARSTKKKSKKADCPIAWANLMLFDYKDQLKTGERCLYMWPSVPDEKGELLNPTGTVRSNPNTDSAAALLICLPEVAPHPVYYPALEKLPGGMLLASREWRPELLWMRLHAEDSAPSRMIGVAMPGLGVLPGLVQAPGDAECSRLLQILELGRHSECVHVTEEEQLQLREILERRGSGELYEHEKDLVWKLRHEVQEHFPEALARLLLVTKWNKHEDVAPDALPAVSWPELPVLSALELLDFSFPDCHVGSFAIKSLRKLTDDELFQYLLQLVQVLKYESYLDCELTKFLLERALANRKIGHFLFWHLRSEMHVPSVALRFGLILEAYCRGSTHHMKVLMKQGEALSKLKALNDFVKLSSQKTPKPQTKELMHLCMRQEAYLEALSHLQSPLDPSTLLAEVCVEQCTFMDSKMKPLWIMYSNEEAGSGGTVGIIFKNGDDLRQDMLTLQMIQLMDVLWKQEGLDLRMTPYGCLPTGDRTGLIEVVLRSDTIANIQLNKSNMAATAAFNKDALLNWLKSKNPGEALDRAIEEFTLSCAGYCVATYVLGIGDRHSDNIMIRESGQLFHIDFGHFLGNFKTKFGINRERVPFILTYDLVHVIQQGKTNNSEKFERFRGYCERAYTILRRHGLLFLHLFALMRAAGLPELSCSKDIQYLKDSLALGKTEEEALKHFREKFNEALREGWKTKVNWLAHNVSKDNRQ</SEQUENCE>
                <XREF>
                  <publicationXref rdf:ID="publicationXref463">
                    <ID>12147247</ID>
                    <DB>Pubmed</DB>
                  </publicationXref>
                </XREF>
                <NAME>PIK3CD</NAME>
                <SYNONYMS>Phosphatidylinositol 3 kinase, catalytic subunit, delta</SYNONYMS>
                <SHORT-NAME>PIK3CD</SHORT-NAME>
                <XREF rdf:resource="#publicationXref461"/>
              </protein>
            </PHYSICAL-ENTITY>
          </sequenceParticipant>
        </COMPONENTS>
        <COMPONENTS>
          <sequenceParticipant rdf:ID="sequenceParticipant191">
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary659"/>
            <PHYSICAL-ENTITY>
              <protein rdf:ID="protein270">
                <XREF>
                  <relationshipXref rdf:ID="relationshipXref518">
                    <ID>602925</ID>
                    <DB>OMIM</DB>
                    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                  </relationshipXref>
                </XREF>
                <XREF>
                  <unificationXref rdf:ID="unificationXref640">
                    <DB>refseq</DB>
                    <ID>NP_006210</ID>
                  </unificationXref>
                </XREF>
                <SYNONYMS>PIK3CB</SYNONYMS>
                <ORGANISM rdf:resource="#bioSource44"/>
                <SYNONYMS>p110-beta</SYNONYMS>
                <SYNONYMS>PI3Kbeta</SYNONYMS>
                <XREF>
                  <unificationXref rdf:ID="unificationXref641">
                    <ID>04234</ID>
                    <DB>HPRD</DB>
                  </unificationXref>
                </XREF>
                <SEQUENCE>MCFSFIMPPAMADILDIWAVDSQIASDGSIPVDFLLPTGIYIQLEVPREATISYIKQMLWKQVHNYPMFNLLMDIDSYMFACVNQTAVYEELEDETRRLCDVRPFLPVLKLVTRSCDPGEKLDSKIGVLIGKGLHEFDSLKDPEVNEFRRKMRKFSEEKILSLVGLSWMDWLKQTYPPEHEPSIPENLEDKLYGGKLIVAVHFENCQDVFSFQVSPNMNPIKVNELAIQKRLTIHGKEDEVSPYDYVLQVSGRVEYVFGDHPLIQFQYIRNCVMNRALPHFILVECCKIKKMYEQEMIAIEAAINRNSSNLPLPLPPKKTRIISHVWENNNPFQIVLVKGNKLNTEETVKVHVRAGLFHGTELLCKTIVSSEVSGKNDHIWNEPLEFDINICDLPRMARLCFAVYAVLDKVKTKKSTKTINPSKYQTIRKAGKVHYPVAWVNTMVFDFKGQLRTGDIILHSWSSFPDELEEMLNPMGTVQTNPYTENATALHVKFPENKKQPYYYPPFDKIIEKAAEIASSDSANVSSRGGKKFLPVLKEILDRDPLSQLCENEMDLIWTLRQDCREIFPQSLPKLLLSIKWNKLEDVAQLQALLQIWPKLPPREALELLDFNYPDQYVREYAVGCLRQMSDEELSQYLLQLVQVLKYEPFLDCALSRFLLERALGNRRIGQFLFWHLRSEVHIPAVSVQFGVILEAYCRGSVGHMKVLSKQVEALNKLKTLNSLIKLNAVKLNRAKGKEAMHTCLKQSAYREALSDLQSPLNPCVILSELYVEKCKYMDSKMKPLWLVYNNKVFGEDSVGVIFKNGDDLRQDMLTLQMLRLMDLLWKEAGLDLRMLPYGCLATGDRSGLIEVVSTSETIADIQLNSSNVAAAAAFNKDALLNWLKEYNSGDDLDRAIEEFTLSCAGYCVASYVLGIGDRHSDNIMVKKTGQLFHIDFGHILGNFKSKFGIKRERVPFILTYDFIHVIQQGKTGNTEKFGRFRQCCEDAYLILRRHGNLFITLFALMLTAGLPELTSVKDIQYLKDSLALGKSEEEALKQFKQKFDEALRESWTTKVNWMAHTVRKDYRS</SEQUENCE>
                <NAME>PIK3CB</NAME>
                <SHORT-NAME>PIK3CB</SHORT-NAME>
                <SYNONYMS>PI3K</SYNONYMS>
                <XREF rdf:resource="#publicationXref461"/>
              </protein>
            </PHYSICAL-ENTITY>
          </sequenceParticipant>
        </COMPONENTS>
        <COMPONENTS>
          <sequenceParticipant rdf:ID="sequenceParticipant190">
            <PHYSICAL-ENTITY>
              <protein rdf:ID="protein269">
                <SYNONYMS>PIK3CA</SYNONYMS>
                <XREF>
                  <unificationXref rdf:ID="unificationXref638">
                    <DB>refseq</DB>
                    <ID>NP_006209</ID>
                  </unificationXref>
                </XREF>
                <XREF>
                  <publicationXref rdf:ID="publicationXref462">
                    <DB>Pubmed</DB>
                    <ID>10213474</ID>
                  </publicationXref>
                </XREF>
                <SYNONYMS>p110-alpha</SYNONYMS>
                <SEQUENCE>MPPRPSSGELWGIHLMPPRILVECLLPNGMIVTLECLREATLVTIKHELFKEARKYPLHQLLQDESSYIFVSVTQEAEREEFFDETRRLCDLRLFQPFLKVIEPVGNREEKILNREIGFAIGMPVCEFDMVKDPEVQDFRRNILNVCKEAVDLRDLNSPHSRAMYVYPPHVESSPELPKHIYNKLDRGQIIVVIWVIVSPNNDKQKYTLKINHDCVPEQVIAEAIRKKTRSMLLSSEQLKLCVLEYQGKYILKVCGCDEYFLEKYPLSQYKYIRSCIMLGRMPNLKMMAKESLYSQLPMDCFTMPSYSRRISTATPYMNGETSTKSLWVINRALRIKILCATYVNLNIRDIDKIYVRTGIYHGGEPLCDNVNTQRVPCSNPRWNEWLNYDIYIPDLPRAARLCLSICSVKGRKGAKEEHCPLAWGNINLFDYTDTLVSGKMALNLWPVPHGLEDLLNPIGVTGSNPNKETPCLELEFDWFSSVVKFPDMSVIEEHANWSVSREAGFSYSHAGLSNRLARDNELRENDKEQLKAISTRDPLSEITEQEKDFLWSHRHYCVTIPEILPKLLLSVKWNSRDEVAQMYCLVKDWPPIKPEQAMELLDCNYPDPMVRGFAVRCLEKYLTDDKLSQYLIQLVQVLKYEQYLDNLLVRFLLKKALTNQRIGHFFFWHLKSEMHNKTVSQRFGLLLESYCRACGMYLKHLNRQVEAMEKLINLTDILKQERKDETQKVQMKFLVEQMRRPDFMDALQGLLSPLNPAHQLGNLRLKECRIMSSAKRPLWLNWENPDIMSELLFQNNEIIFKNGDDLRQDMLTLQIIRIMENIWQNQGLDLRMLPYGCLSIGDCVGLIEVVRNSHTIMQIQCKGGLKGALQFNSHTLHQWLKDKNKGEIYDAAIDLFTRSCAGYCVATFILGIGDRHNSNIMVKDDGQLFHIDFGHFLDHKKKKFGYKRERVPFVLTQDFLIVISKGAQECTKTREFERFQEMCYKAYLAIRQHANLFINLFSMMLGSGMPELQSFDDIAYIRKTLALDKTEQEALEYFMKQMNDAHHGGWTTKMDWIFHTIKQHALN</SEQUENCE>
                <XREF>
                  <relationshipXref rdf:ID="relationshipXref517">
                    <ID>171834</ID>
                    <DB>OMIM</DB>
                    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                  </relationshipXref>
                </XREF>
                <ORGANISM rdf:resource="#bioSource44"/>
                <XREF>
                  <unificationXref rdf:ID="unificationXref639">
                    <DB>HPRD</DB>
                    <ID>01382</ID>
                  </unificationXref>
                </XREF>
                <SHORT-NAME>PIK3CA</SHORT-NAME>
                <XREF rdf:resource="#publicationXref461"/>
                <SYNONYMS>PI3-kinase, p110, subunit alpha</SYNONYMS>
                <NAME>PIK3CA</NAME>
              </protein>
            </PHYSICAL-ENTITY>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
          </sequenceParticipant>
        </COMPONENTS>
        <COMPONENTS>
          <sequenceParticipant rdf:ID="sequenceParticipant188">
            <PHYSICAL-ENTITY>
              <protein rdf:ID="protein267">
                <SHORT-NAME>PIK3R2</SHORT-NAME>
                <SEQUENCE>MAGPEGFQYRALYPFRRERPEDLELLPGDVLVVSRAALQALGVAEGGERCPQSVGWMPGLNERTRQRGDFPGTYVEFLGPVALARPGPRPRGPRPLPARPRDGAPEPGLTLPDLPEQFSPPDVAPPLLVKLVEAIERTGLDSESHYRPELPAPRTDWSLSDVDQWDTAALADGIKSFLLALPAPLVTPEASAEARRALREAAGPVGPALEPPTLPLHRALTLRFLLQHLGRVARRAPALGPAVRALGATFGPLLLRAPPPPSSPPPGGAPDGSEPSPDFPALLVEKLLQEHLEEQEVAPPALPPKPPKAKPAPTVLANGGSPPSLQDAEWYWGDISREEVNEKLRDTPDGTFLVRDASSKIQGEYTLTLRKGGNNKLIKVFHRDGHYGFSEPLTFCSVVDLINHYRHESLAQYNAKLDTRLLYPVSKYQQDQIVKEDSVEAVGAQLKVYHQQYQDKSREYDQLYEEYTRTSQELQMKRTAIEAFNETIKIFEEQGQTQEKCSKEYLERFRREGNEKEMQRILLNSERLKSRIAEIHESRTKLEQQLRAQASDNREIDKRMNSLKPDLMQLRKIRDQYLVWLTQKGARQKKINEWLGIKNETEDQYALMEDEDDLPHHEERTWYVGKINRTQAEEMLSGKRDGTFLIRESSQRGCYACSVVVDGDTKHCVIYRTATGFGFAEPYNLYGSLKELVLHYQHASLVQHNDALTVTLAHPVRAPGPGPPPAAR</SEQUENCE>
                <SYNONYMS>PIK3R2</SYNONYMS>
                <SYNONYMS>Phosphatidylinositol 3-kinase p85, beta subunit</SYNONYMS>
                <NAME>PIK3R2</NAME>
                <XREF>
                  <unificationXref rdf:ID="unificationXref635">
                    <DB>HPRD</DB>
                    <ID>04404</ID>
                  </unificationXref>
                </XREF>
                <SYNONYMS>p85 beta</SYNONYMS>
                <XREF rdf:resource="#publicationXref461"/>
                <XREF>
                  <unificationXref rdf:ID="unificationXref634">
                    <DB>refseq</DB>
                    <ID>NP_005018</ID>
                  </unificationXref>
                </XREF>
                <SYNONYMS>Phosphoinositide-3-kinase, regulatory subunit, polypeptide 2</SYNONYMS>
                <ORGANISM rdf:resource="#bioSource44"/>
                <XREF>
                  <relationshipXref rdf:ID="relationshipXref515">
                    <ID>603157</ID>
                    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                    <DB>OMIM</DB>
                  </relationshipXref>
                </XREF>
              </protein>
            </PHYSICAL-ENTITY>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
          </sequenceParticipant>
        </COMPONENTS>
      </complex>
    </PHYSICAL-ENTITY>
  </physicalEntityParticipant>
  <protein rdf:ID="protein252">
    <XREF>
      <unificationXref rdf:ID="unificationXref605">
        <DB>refseq</DB>
        <ID>NP_958782</ID>
      </unificationXref>
    </XREF>
    <SYNONYMS>Intermediate filament binding protein, 500kD</SYNONYMS>
    <SYNONYMS>Plectin 1</SYNONYMS>
    <SHORT-NAME>PLEC1</SHORT-NAME>
    <XREF>
      <publicationXref rdf:ID="publicationXref434">
        <DB>Pubmed</DB>
        <ID>10525545</ID>
      </publicationXref>
    </XREF>
    <SYNONYMS>PCN</SYNONYMS>
    <ORGANISM rdf:resource="#bioSource44"/>
    <SYNONYMS>EBSO</SYNONYMS>
    <SYNONYMS>PLEC1</SYNONYMS>
    <SYNONYMS>EBS1</SYNONYMS>
    <XREF>
      <publicationXref rdf:ID="publicationXref433">
        <ID>8633055</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
    <XREF>
      <unificationXref rdf:ID="unificationXref606">
        <ID>03180</ID>
        <DB>HPRD</DB>
      </unificationXref>
    </XREF>
    <XREF>
      <relationshipXref rdf:ID="relationshipXref501">
        <DB>OMIM</DB>
        <ID>601282</ID>
        <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
      </relationshipXref>
    </XREF>
    <SYNONYMS>HD1</SYNONYMS>
    <SEQUENCE>MVAGMLMPRDQLRAIYEVLFREGVMVAKKDRRPRSLHPHVPGVTNLQVMRAMASLRARGLVRETFAWCHFYWYLTNEGIAHLRQYLHLPPEIVPASLQRVRRPVAMVMPARRTPHVQAVQGPLGSPPKRGPLPTEEQRVYRRKELEEVSPETPVVPATTQRTLARPGPEPAPATDERDRVQKKTFTKWVNKHLIKAQRHISDLYEDLRDGHNLISLLEVLSGDSLPREKGRMRFHKLQNVQIALDYLRHRQVKLVNIRNDDIADGNPKLTLGLIWTIILHFQISDIQVSGQSEDMTAKEKLLLWSQRMVEGYQGLRCDNFTSSWRDGRLFNAIIHRHKPLLIDMNKVYRQTNLENLDQAFSVAERDLGVTRLLDPEDVDVPQPDEKSIITYVSSLYDAMPRVPDVQDGVRANELQLRWQEYRELVLLLLQWMRHHTAAFEERRFPSSFEEIEILWSQFLKFKEMELPAKEADKNRSKGIYQSLEGAVQAGQLKVPPGYHPLDVEKEWGKLHVAILEREKQLRSEFERLECLQRIVTKLQMEAGLCEEQLNQADALLQSDVRLLAAGKVPQRAGEVERDLDKADSMIRLLFNDVQTLKDGRHPQGEQMYRRVYRLHERLVAIRTEYNLRLKAGVAAPATQVAQVTLQSVQRRPELEDSTLRYLQDLLAWVEENQHRVDGAEWGVDLPSVEAQLGSHRGLHQSIEEFRAKIERARSDEGQLSPATRGAYRDCLGRLDLQYAKLLNSSKARLRSLESLHSFVAAATKELMWLNEKEEEEVGFDWSDRNTNMTAKKESYSALMRELELKEKKIKELQNAGDRLLREDHPARPTVESFQAALQTQWSWMLQLCCCIEAHLKENAAYFQFFSDVREAEGQLQKLQEALRRKYSCDRSATVTRLEDLLQDAQDEKEQLNEYKGHLSGLAKRAKAVVQLKPRHPAHPMRGRLPLLAVCDYKQVEVTVHKGDECQLVGPAQPSHWKVLSSSGSEAAVPSVCFLVPPPNQEAQEAVTRLEAQHQALVTLWHQLHVDMKSLLAWQSLRRDVQLIRSWSLATFRTLKPEEQRQALHSLELHYQAFLRDSQDAGGFGPEDRLMAEREYGSCSHHYQQLLQSLEQGAQEESRCQRCISELKDIRLQLEACETRTVHRLRLPLDKEPARECAQRIAEQQKAQAEVEGLGKGVARLSAEAEKVLALPEPSPAAPTLRSELELTLGKLEQVRSLSAIYLEKLKTISLVIRGTQGAEEVLRAHEEQLKEAQAVPATLPELEATKASLKKLRAQAEAQQPTFDALRDELRGAQEVGERLQQRHGERDVEVERWRERVAQLLERWQAVLAQTDVRQRELEQLGRQLRYYRESADPLGAWLQDARRRQEQIQAMPLADSQAVREQLRQEQALLEEIERHGEKVEECQRFAKQYINAIKDYELQLVTYKAQLEPVASPAKKPKVQSGSESVIQEYVDLRTHYSELTTLTSQYIKFISETLRRMEEEERLAEQQRAEERERLAEVEAALEKQRQLAEAHAQAKAQAEREAKELQQRMQEEVVRREEAAVDAQQQKRSIQEELQQLRQSSEAEIQAKARQAEAAERSRLRIEEEIRVVRLQLEATERQRGGAEGELQALRARAEEAEAQKRQAQEEAERLRRQVQDESQRKRQAEVELASRVKAEAEAAREKQRALQALEELRLQAEEAERRLRQAEVERARQVQVALETAQRSAEAELQSKRASFAEKTAQLERSLQEEHVAVAQLREEAERRAQQQAEAERAREEAERELERWQLKANEALRLRLQAEEVAQQKSLAQAEAEKQKEEAEREARRRGKAEEQAVRQRELAEQELEKQRQLAEGTAQQRLAAEQELIRLRAETEQGEQQRQLLEEELARLQREAAAATQKRQELEAELAKVRAEMEVLLASKARAEEESRSTSEKSKQRLEAEAGRFRELAEEAARLRALAEEAKRQRQLAEEDAARQRAEAERVLAEKLAAIGEATRLKTEAEIALKEKEAENERLRRLAEDEAFQRRRLEEQAAQHKADIEERLAQLRKASDSELERQKGLVEDTLRQRRQVEEEILALKASFEKAAAGKAELELELGRIRSNAEDTLRSKEQAELEAARQRQLAAEEERRRREAEERVQKSLAAEEEAARQRKAALEEVERLKAKVEEARRLRERAEQESARQLQLAQEAAQKRLQAEEKAHAFAVQQKEQELQQTLQQEQSVLDQLRGEAEAARRAAEEAEEARVQAEREAAQSRRQVEEAERLKQSAEEQAQARAQAQAAAEKLRKEAEQEAARRAQAEQAALRQKQAADAEMEKHKKFAEQTLRQKAQVEQELTTLRLQLEETDHQKNLLDEELQRLKAEATEAARQRSQVEEELFSVRVQMEELSKLKARIEAENRALILRDKDNTQRFLQEEAEKMKQVAEEAARLSVAAQEAARLRQLAEEDLAQQRALAEKMLKEKMQAVQEATRLKAEAELLQQQKELAQEQARRLQEDKEQMAQQLAEETQGFQRTLEAERQRQLEMSAEAERLKLRVAEMSRAQARAEEDAQRFRKQAEEIGEKLHRTELATQEKVTLVQTLEIQRQQSDHDAERLREAIAELEREKEKLQQEAKLLQLKSEEMQTVQQEQLLQETQALQQSFLSEKDSLLQRERFIEQEKAKLEQLFQDEVAKAQQLREEQQRQQQQMEQERQRLVASMEEARRRQHEAEEGVRRKQEELQQLEQQRRQQEELLAEENQRLREQLQLLEEQHRAALAHSEEVTASQVAATKTLPNGRDALDGPAAEAEPEHSFDGLRRKVSAQRLQEAGILSAEELQRLAQGHTTVDELARREDVRHYLQGRSSIAGLLLKATNEKLSVYAALQRQLLSPGTALILLEAQAASGFLLDPVRNRRLTVNEAVKEGVVGPELHHKLLSAERAVTGYKDPYTGQQISLFQAMQKGLIVREHGIRLLEAQIATGGVIDPVHSHRVPVDVAYRRGYFDEEMNRVLADPSDDTKGFFDPNTHENLTYLQLLERCVEDPETGLCLLPLTDKAAKGGELVYTDSEARDVFEKATVSAPFGKFQGKTVTIWEIINSEYFTAEQRRDLLRQFRTGRITVEKIIKIIITVVEEQEQKGRLCFEGLRSLVPAAELLESRVIDRELYQQLQRGERSVRDVAEVDTVRRALRGANVIAGVWLEEAGQKLSIYNALKKDLLPSDMAVALLEAQAGTGHIIDPATSARLTVDEAVRAGLVGPEFHEKLLSAEKAVTGYRDPYTGQSVSLFQALKKGLIPREQGLRLLDAQLSTGGIVDPSKSHRVPLDVACARGCLDEETSRALSAPRADAKAYSDPSTGEPATYGELQQRCRPDQLTGLSLLPLSEKAARARQEELYSELQARETFEKTPVEVPVGGFKGRTVTVWELISSEYFTAEQRQELLRQFRTGKVTVEKVIKILITIVEEVETLRQERLSFSGLRAPVPASELLASGVLSRAQFEQLKDGKTTVKDLSELGSVRTLLQGSGCLAGIYLEDTKEKVSIYEAMRRGLLRATTAALLLEAQAATGFLVDPVRNQRLYVHEAVKAGVVGPELHEQLLSAEKAVTGYRDPYSGSTISLFQAMQKGLVLRQHGIRLLEAQIATGGIIDPVHSHRVPVDVAYQRGYFSEEMNRVLADPSDDTKGFFDPNTHENLTYRQLLERCVEDPETGLRLLPLKGAEKAEVVETTQVYTEEETRRAFEETQIDIPGGGSHGGSTMSLWEVMQSDLIPEEQRAQLMADFQAGRVTKERMIIIIIEIIEKTEIIRQQGLASYDYVRRRLTAEDLFEARIISLETYNLLREGTRSLREALEAESAWCYLYGTGSVAGVYLPGSRQTLSIYQALKKGLLSAEVARLLLEAQAATGFLLDPVKGERLTVDEAVRKGLVGPELHDRLLSAERAVTGYRDPYTEQTISLFQAMKKELIPTEEALRLLDAQLATGGIVDPRLGFHLPLEVAYQRGYLNKDTHDQLSEPSEVRSYVDPSTDERLSYTQLLRRCRRDDGTGQLLLPLSDARKLTFRGLRKQITMEELVRSQVMDEATALQLREGLTSIEEVTKNLQKFLEGTSCIAGVFVDATKERLSVYQAMKKGIIRPGTAFELLEAQAATGYVIDPIKGLKLTVEEAVRMGIVGPEFKDKLLSAERAVTGYKDPYSGKLISLFQAMKKGLILKDHGIRLLEAQIATGGIIDPEESHRLPVEVAYKRGLFDEEMNEILTDPSDDTKGFFDPNTEENLTYLQLMERCITDPQTGLCLLPLKEKKRERKTSSKSSVRKRRVVIVDPETGKEMSVYEAYRKGLIDHQTYLELSEQECEWEEITISSSDGVVKSMIIDRRSGRQYDIDDAIAKNLIDRSALDQYRAGTLSITEFADMLSGNAGGFRSRSSSVGSSSSYPISPAVSRTQLASWSDPTEETGPVAGILDTETLEKVSITEAMHRNLVDNITGQRLLEAQACTGGIIDPSTGERFPVTDAVNKGLVDKIMVDRINLAQKAFCGFEDPRTKTKMSAAQALKKGWLYYEAGQRFLEVQYLTGGLIEPDTPGRVPLDEALQRGTVDARTAQKLRDVGAYSKYLTCPKTKLKISYKDALDRSMVEEGTGLRLLEAAAQSTKGYYSPYSVSGSGSTAGSRTGSRTGSRAGSRRGSFDATGSGFSMTFSSSSYSSSGYGRRYASGSSASLGGPESAVA</SEQUENCE>
    <NAME>PLEC1</NAME>
    <SYNONYMS>PLTN</SYNONYMS>
  </protein>
  <physicalInteraction rdf:ID="physicalInteraction712">
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ERBB2-ITGB4</NAME>
    <EVIDENCE>
      <evidence rdf:ID="evidence338">
        <XREF>
          <publicationXref rdf:ID="publicationXref450">
            <ID>10744756</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <EVIDENCE-CODE>
          <openControlledVocabulary rdf:ID="openControlledVocabulary655">
            <TERM>in vivo</TERM>
            <XREF>
              <unificationXref rdf:ID="unificationXref534">
                <DB>PSIMI</DB>
                <ID>MI:0493</ID>
              </unificationXref>
            </XREF>
          </openControlledVocabulary>
        </EVIDENCE-CODE>
      </evidence>
    </EVIDENCE>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ERBB2-ITGB4</SHORT-NAME>
    <INTERACTION-TYPE>
      <openControlledVocabulary rdf:ID="openControlledVocabulary901_reaction">
        <TERM>direct interaction</TERM>
        <XREF>
          <unificationXref rdf:ID="unificationXref585">
            <ID>MI:0407</ID>
            <DB>PSIMI</DB>
          </unificationXref>
        </XREF>
      </openControlledVocabulary>
    </INTERACTION-TYPE>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant154">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein234">
            <SYNONYMS>NGL</SYNONYMS>
            <ORGANISM rdf:resource="#bioSource44"/>
            <SYNONYMS>ERBB2</SYNONYMS>
            <XREF>
              <relationshipXref rdf:ID="relationshipXref487">
                <DB>OMIM</DB>
                <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                <ID>164870</ID>
              </relationshipXref>
            </XREF>
            <NAME>ERBB2</NAME>
            <SYNONYMS>ErbB2</SYNONYMS>
            <SHORT-NAME>ERBB2</SHORT-NAME>
            <XREF>
              <unificationXref rdf:ID="unificationXref567">
                <DB>refseq</DB>
                <ID>NP_004439</ID>
              </unificationXref>
            </XREF>
            <SYNONYMS>TKR1</SYNONYMS>
            <XREF>
              <unificationXref rdf:ID="unificationXref568">
                <DB>HPRD</DB>
                <ID>01281</ID>
              </unificationXref>
            </XREF>
            <SEQUENCE>MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNGDPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACPYNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLPDLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTVPWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARCPSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQRASPLTSIVSAVVGILLVVVLGVVFGILIKRRQQKIRKYTMRRLLQETELVEPLTPSGAMPNQAQMRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDAEEYLVPQQGFFCPDPAPGAGGMVHHRHRSSSTRSGGGDLTLGLEPSEEEAPRSPLAPSEGAGSDVFDGDLGMGAAKGLQSLPTHDPSPLQRYSEDPTVPLPSETDGYVAPLTCSPQPEYVNQPDVRPQPPSPREGPLPAARPAGATLERAKTLSPGKNGVVKDVFAFGGAVENPEYLTPQGGAAPQPHPPPAFSPAFDNLYYWDQDPPERGAPPSTFKGTPTAENPEYLGLDVPV</SEQUENCE>
            <XREF>
              <publicationXref rdf:ID="publicationXref400">
                <DB>Pubmed</DB>
                <ID>14730713</ID>
              </publicationXref>
            </XREF>
            <XREF>
              <publicationXref rdf:ID="publicationXref401">
                <ID>9344587</ID>
                <DB>Pubmed</DB>
              </publicationXref>
            </XREF>
            <SYNONYMS>NEU</SYNONYMS>
            <SYNONYMS>HER2</SYNONYMS>
            <XREF rdf:resource="#publicationXref384"/>
          </protein>
        </PHYSICAL-ENTITY>
      </sequenceParticipant>
    </PARTICIPANTS>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant155">
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein221">
            <SYNONYMS>ITGB4</SYNONYMS>
            <ORGANISM rdf:resource="#bioSource44"/>
            <SYNONYMS>GP150</SYNONYMS>
            <XREF>
              <publicationXref rdf:ID="publicationXref379">
                <DB>Pubmed</DB>
                <ID>12441134</ID>
              </publicationXref>
            </XREF>
            <XREF>
              <unificationXref rdf:ID="unificationXref538">
                <ID>NP_000204</ID>
                <DB>refseq</DB>
              </unificationXref>
            </XREF>
            <XREF>
              <publicationXref rdf:ID="publicationXref378">
                <DB>Pubmed</DB>
                <ID>2311577</ID>
              </publicationXref>
            </XREF>
            <SYNONYMS>CD104 antigen</SYNONYMS>
            <XREF>
              <relationshipXref rdf:ID="relationshipXref475">
                <DB>OMIM</DB>
                <ID>147557</ID>
                <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
              </relationshipXref>
            </XREF>
            <SHORT-NAME>ITGB4</SHORT-NAME>
            <NAME>ITGB4</NAME>
            <SYNONYMS>Integrin beta 4</SYNONYMS>
            <XREF rdf:resource="#publicationXref375"/>
            <XREF>
              <unificationXref rdf:ID="unificationXref539">
                <DB>HPRD</DB>
                <ID>00946</ID>
              </unificationXref>
            </XREF>
            <SEQUENCE>MAGPRPSPWARLLLAALISVSLSGTLANRCKKAPVKSCTECVRVDKDCAYCTDEMFRDRRCNTQAELLAAGCQRESIVVMESSFQITEETQIDTTLRRSQMSPQGLRVRLRPGEERHFELEVFEPLESPVDLYILMDFSNSMSDDLDNLKKMGQNLARVLSQLTSDYTIGFGKFVDKVSVPQTDMRPEKLKEPWPNSDPPFSFKNVISLTEDVDEFRNKLQGERISGNLDAPEGGFDAILQTAVCTRDIGWRPDSTHLLVFSTESAFHYEADGANVLAGIMSRNDERCHLDTTGTYTQYRTQDYPSVPTLVRLLAKHNIIPIFAVTNYSYSYYEKLHTYFPVSSLGVLQEDSSNIVELLEEAFNRIRSNLDIRALDSPRGLRTEVTSKMFQKTRTGSFHIRRGEVGIYQVQLRALEHVDGTHVCQLPEDQKGNIHLKPSFSDGLKMDAGIICDVCTCELQKEVRSARCSFNGDFVCGQCVCSEGWSGQTCNCSTGSLSDIQPCLREGEDKPCSGRGECQCGHCVCYGEGRYEGQFCEYDNFQCPRTSGFLCNDRGRCSMGQCVCEPGWTGPSCDCPLSNATCIDSNGGICNGRGHCECGRCHCHQQSLYTDTICEINYSAIHPGLCEDLRSCVQCQAWGTGEKKGRTCEECNFKVKMVDELKRAEEVVVRCSFRDEDDDCTYSYTMEGDGAPGPNSTVLVHKKKDCPPGSFWWLIPLLLLLLPLLALLLLLCWKYCACCKACLALLPCCNRGHMVGFKEDHYMLRENLMASDHLDTPMLRSGNLKGRDVVRWKVTNNMQRPGFATHAASINPTELVPYGLSLRLARLCTENLLKPDTRECAQLRQEVEENLNEVYRQISGVHKLQQTKFRQQPNAGKKQDHTIVDTVLMAPRSAKPALLKLTEKQVEQRAFHDLKVAPGYYTLTADQDARGMVEFQEGVELVDVRVPLFIRPEDDDEKQLLVEAIDVPAGTATLGRRLVNITIIKEQARDVVSFEQPEFSVSRGDQVARIPVIRRVLDGGKSQVSYRTQDGTAQGNRDYIPVEGELLFQPGEAWKELQVKLLELQEVDSLLRGRQVRRFHVQLSNPKFGAHLGQPHSTTIIIRDPDELDRSFTSQMLSSQPPPHGDLGAPQNPNAKAAGSRKIHFNWLPPSGKPMGYRVKYWIQGDSESEAHLLDSKVPSVELTNLYPYCDYEMKVCAYGAQGEGPYSSLVSCRTHQEVPSEPGRLAFNVVSSTVTQLSWAEPAETNGEITAYEVCYGLVNDDNRPIGPMKKVLVDNPKNRMLLIENLRESQPYRYTVKARNGAGWGPEREAIINLATQPKRPMSIPIIPDIPIVDAQSGEDYDSFLMYSDDVLRSPSGSQRPSVSDDTGCGWKFEPLLGEELDLRRVTWRLPPELIPRLSASSGRSSDAEAPTAPRTTAARAGRAAAVPRSATPGPPGEHLVNGRMDFAFPGSTNSLHRMTTTSAAAYGTHLSPHVPHRVLSTSSTLTRDYNSLTRSEHSHSTTLPRDYSTLTSVSSHDSRLTAGVPDTPTRLVFSALGPTSLRVSWQEPRCERPLQGYSVEYQLLNGGELHRLNIPNPAQTSVVVEDLLPNHSYVFRVRAQSQEGWGREREGVITIESQVHPQSPLCPLPGSAFTLSTPSAPGPLVFTALSPDSLQLSWERPRRPNGDIVGYLVTCEMAQGGGPATAFRVDGDSPESRLTVPGLSENVPYKFKVQARTTEGFGPEREGIITIESQDGGPFPQLGSRAGLFQHPLQSEYSSITTTHTSATEPFLVDGLTLGAQHLEAGGSLTRHVTQEFVSRTLTTSGTLSTHMDQQFFQT</SEQUENCE>
          </protein>
        </PHYSICAL-ENTITY>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ERBB2 and ITGB4</COMMENT>
    <XREF rdf:resource="#publicationXref450"/>
  </physicalInteraction>
  <unificationXref rdf:ID="unificationXref623">
    <ID>00215</ID>
    <DB>HPRD</DB>
  </unificationXref>
  <publicationXref rdf:ID="publicationXref412">
    <ID>9374518</ID>
    <DB>Pubmed</DB>
  </publicationXref>
  <publicationXref rdf:ID="publicationXref439">
    <ID>9111230</ID>
    <DB>Pubmed</DB>
  </publicationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant124">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein248">
        <SYNONYMS>BP240</SYNONYMS>
        <NAME>BPAG1</NAME>
        <XREF>
          <publicationXref rdf:ID="publicationXref425">
            <ID>11323216</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref423">
            <DB>Pubmed</DB>
            <ID>2579167</ID>
          </publicationXref>
        </XREF>
        <ORGANISM rdf:resource="#bioSource44"/>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref497">
            <DB>OMIM</DB>
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
            <ID>113810</ID>
          </relationshipXref>
        </XREF>
        <SYNONYMS>BPAG1</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref597">
            <ID>00222</ID>
            <DB>HPRD</DB>
          </unificationXref>
        </XREF>
        <SEQUENCE>MAGYLSPAAYLYVEEQEYLQAYEDVLERYKDERDKVQKKTFTKWINQHLMKVRKHVNDLYEDLRDGHNLISLLEVLSGDTLPREKGRMRFHRLQNVQIALDYLKRRQVKLVNIRNDDITDGNPKLTLGLIWTIILHFQISDIHVTGESEDMSAKERLLLWTQQATEGYAGIRCENFTTCWRDGKLFNAIIHKYRPDLIDMNTVAVQSNLANLEHAFYVAEKIGVIRLLDPEDVDVSSPDEKSVITYVSSLYDAFPKVPEGGEGIGANDVEVKWIEYQNMVNYLIQWIRHHVTTMSERTFPNNPVELKALYNQYLQFKETEIPPKETEKSKIKRLYKLLEIWIEFGRIKLLQGYHPNDIEKEWGKLIIAMLEREKALRPEVERLEMLQQIANRVQRDSVICEDKLILAGNALQSDSKRLESGVQFQNEAEIAGYILECENLLRQHVIDVQILIDGKYYQADQLVQRVAKLRDEIMALRNECSSVYSKGRILTTEQTKLMISGITQSLNSGFAQTLHPSLTSGLTQSLTPSLTSSSMTSGLSSGMTSRLTPSVTPAYTPGFPSGLVPNFSSGVEPNSLQTLKLMQIRKPLLKSSLLDQNLTEEEINMKFVQDLLNWVDEMQVQLDRTEWGSDLPSVESHLENHKNVHRAIEEFESSLKEAKISEIQMTAPLKLTYAEKLHRLESQYAKLLNTSRNQERHLDTLHNFVSRATNELIWLNEKEEEEVAYDWSERNTNIARKKDYHAELMRELDQKEENIKSVQEIAEQLLLENHPARLTIEAYRAAMQTQWSWILQLCQCVEQHIKENTAYFEFFNDAKEATDYLRNLKDAIQRKYSCDRSSSIHKLEDLVQESMEEKEELLQYKSTIANLMGKAKTIIQLKPRNSDCPLKTSIPIKAICDYRQIEITIYKDDECVLANNSHRAKWKVISPTGNEAMVPSVCFTVPPPNKEAVDLANRIEQQYQNVLTLWHESHINMKSVVSWHYLINEIDRIRASNVASIKTMLPGEHQQVLSNLQSRFEDFLEDSQESQVFSGSDITQLEKEVNVCKQYYQELLKSAEREEQEESVYNLYISEVRNIRLRLENCEDRLIRQIRTPLERDDLHESVFRITEQEKLKKELERLKDDLGTITNKCEEFFSQAAASSSVPTLRSELNVVLQNMNQVYSMSSTYIDKLKTVNLVLKNTQAAEALVKLYETKLCEEEAVIADKNNIENLISTLKQWRSEVDEKRQVFHALEDELQKAKAISDEMFKTYKERDLDFDWHKEKADQLVERWQNVHVQIDNRLRDLEGIGKSLKYYRDTYHPLDDWIQQVETTQRKIQENQPENSKTLATQLNQQKMLVSEIEMKQSKMDECQKYAEQYSATVKDYELQTMTYRAMVDSQQKSPVKRRRMQSSADLIIQEFMDLRTRYTALVTLMTQYIKFAGDSLKRLEEEEKSLEEEKKEHVEKAKELQKWVSNISKTLKDAEKAGKPPFSKQKISSEEISTKKEQLSEALQTIQLFLAKHGDKMTDEERNELEKQVKTLQESYNLLFSESLKQLQESQTSGDVKVEEKIVAERQQEYKEKLQGICDLLTQTENRLIGHQEAFMIGDGTVELKKYQSKQEELQKDMQGSAQALAEVVKNTENFLKENGEKLSQEDKALIEQKLNEAKIKCEQLNLKAEQSKKELDKVVTTAIKEETEKVAAVKQLEESKTKIENLLDWLSNVDKDSERAGTKHKQVIEQNGTHFQEGDGKSAIGEEDEVNGNLLETDVDGQVGTTQENLNQQYQKVKAQHEKIISQHQAVIIATQSAQVLLEKQGQYLSPEEKEKLQKNMKELKVHYETALAESEKKMKLTHSLQEELEKFDADYTEFEHWLQQSEQELENLEAGADDINGLMTKLKRQKSFSEDVISHKGDLRYITISGNRVLEAAKSCSKRDGGKVDTSATHREVQRKLDHATDRFRSLYSKCNVLGNNLKDLVDKYQHYEDASCGLLAGLQACEATASKHLSEPIAVDPKNLQRQLEETKALQGQISSQQVAVEKLKKTAEVLLDARGSLLPAKNDIQKTLDDIVGRYEDLSKSVNERNEKLQITLTRSLSVQDGLDEMLDWMGNVESSLKEQGQVPLNSTALQDIISKNIMLEQDIAGRQSSINAMNEKVKKFMETTDPSTASSLQAKMKDLSARFSEASHKHKETLAKMEELKTKVELFENLSEKLQTFLETKTQALTEVDVPGKDVTELSQYMQESTSEFLEHKKHLEVLHSLLKEISSHGLPSDKALVLEKTNNLSKKFKEMEDTIKEKKEAVTSCQEQLDAFQVLVKSLKSWIKETTKKVPIVQPSFGAEDLGKSLEDTKKLQEKWSLKTPEIQKVNNSGISLCNLISAVTTPAKAIAAVKSGGAVLNGEGTATNTEEFWANKGLTSIKKDMTDISHGYEDLGLLLKDKIAELNTKLSKLQKAQEESSAMMQWLQKMNKTATKWQQTPAPTDTEAVKTQVEQNKSFEAELKQNVNKVQELKDKLTELLEENPDTPEAPRWKQMLTEIDSKWQELNQLTIDRQQKLEESSNNLTQFQTVEAQLKQWLVEKELMVSVLGPLSIDPNMLNTQRQQVQILLQEFATRKPQYEQLTAAGQGILSRPGEDPSLRGIVKEQLAAVTQKWDSLTGQLSDRCDWIDQAIVKSTQYQSLLRSLSDKLSDLDNKLSSSLAVSTHPDAMNQQLETAQKMKQEIQQEKKQIKVAQALCEDLSALVKEEYLKAELSRQLEGILKSFKDVEQKAENHVQHLQSACASSHQFQQMSRDFQAWLDTKKEEQNKSHPISAKLDVLESLIKDHKDFSKTLTAQSHMYEKTIAEGENLLLKTQGSEKAALQLQLNTIKTNWDTFNKQVKERENKLKESLEKALKYKEQVETLWPWIDKCQNNLEEIKFCLDPAEGENSIAKLKSLQKEMDQHFGMVELLNNTANSLLSVCEIDKEVVTDENKSLIQKVDMVTEQLHSKKFCLENMTQKFKEFQEVSKESKRQLQCAKEQLDIHDSLGSQAYSNKYLTMLQTQQKSLQALKHQVDLAKRLAQDLVVEASDSKGTSDVLLQVETIAQEHSTLSQQVDEKCSFLETKLQGIGHFQNTIREMFSQFAEFDDELDSMAPVGRDAETLQKQKETIKAFLKKLEALMASNDNANKTCKMMLATEETSPDLVGIKRDLEALSKQCNKLLDRAQAREEQVEGTIKRLEEFYSKLKEFSILLQKAEEHEESQGPVGMETETINQQLNMFKVFQKEEIEPLQGKQQDVNWLGQGLIQSAAKSTSTQGLEHDLDDVNARWKTLNKKVAQRAAQLQEALLHCGRFQDALESLLSWMVDTEELVANQKPPSAEFKVVKAQIQEQKLLQRLLDDRKSTVEVIKREGEKIATTAEPADKVKILKQLSLLDSRWEALLNKAETRNRQLEGISVVAQQFHETLEPLNEWLTTIEKRLVNCEPIGTQASKLEEQIAQHKALEDDIINHNKHLHQAVSIGQSLKVLSSREDKDMVQSKLDFSQVWYIEIQEKSHSRSELLQQALCNAKIFGEDEVELMNWLNEVHDKLSKLSVQDYSTEGLWKQQSELRVLQEDILLRKQNVDQALLNGLELLKQTTGDEVLIIQDKLEAIKARYKDITKLSTDVAKTLEQALQLARRLHSTHEELCTWLDKVEVELLSYETQVLKGEEASQAQMRPKELKKEAKNNKALLDSLNEVSSALLELVPWRAREGLEKMVAEDNERYRLVSDTITQKVEEIDAAILRSQQFDQAADAELSWITETEKKLMSLGDIRLEQDQTSAQLQVQKTFTMEILRHKDIIDDLVKSGHKIMTACSEEEKQSMKKKLDKVLKNYDTICQINSERYLQLERAQSLVNQFWETYEELWPWLTETQSIISQLPAPALEYETLRQQQEEHRQLRELIAEHKPHIDKMNKTGPQLLELSPGEGFSIQEKYVAADTLYSQIKEDVKKRAVALDEAISQSTQFHDKIDQILESLERIVERLRQPPSISAEVEKIKEQISENKNVSVDMEKLQPLYETLKQRGEEMIARSGGTDKDISAKAVQDKLDQMVFIWENIHTLVEEREAKLLDVMELAEKFWCDHMSLIVTIKDTQDFIRDLEDPGIDPSVVKQQQEAAETIREEIDGLQEELDIVINLGSELIAACGEPDKPIVKKSIDELNSAWDSLNKAWKDRIDKLEEAMQAAVQYQDGLQAVFDWVDIAGGKLASMSPIGTDLETVKQQIEELKQFKSEAYQQQIEMERLNHQAELLLKKVTEESDKHTVQDPLMELKLIWDSLEERIINRQHKLEGALLALGQFQHALDELLAWLTHTEGLLSEQKPVGGDPKAIEIELAKHHVLQNDVLAHQSTVEAVNKAGNDLIESSAGEEASNLQNKLEVLNQRWQNVLEKTEQRKQQLDGALRQAKGFHGEIEDLQQWLTDTERHLLASKPLGGLPETAKEQLNVHMEVCAAFEAKEETYKSLMQKGQQMLARCPKSAETNIDQDINNLKEKWESVETKLNERKTKLEEALNLAMEFHNSLQDFINWLTQAEQTLNVASRPSLILDTVLFQIDEHKVFANEVNSHREQIIELDKTGTHLKYFSQKQDVVLIKNLLISVQSRWEKVVQRLVERGRSLDDARKRAKQFHEAWSKLMEWLEESEKSLDSELEIANDPDKIKTQLAQHKEFQKSLGAKHSVYDTTNRTGRSLKEKTSLADDNLKLDDMLSELRDKWDTICGKSVERQNKLEEALLFSGQFTDALQALIDWLYRVEPQLAEDQPVHGDIDLVMNLIDNHKAFQKELGKRTSSVQALKRSARELIEGSRDDSSWVKVQMQELSTRWETVCALSISKQTRLEAALRQAEEFHSVVHALLEWLAEAEQTLRFHGVLPDDEDALRTLIDQHKEFMKKLEEKRAELNKATTMGDTVLAICHPDSITTIKHWITIIRARFEEVLAWAKQHQQRLASALAGLIAKQELLEALLAWLQWAETTLTDKDKEVIPQEIEEVKALIAEHQTFMEEMTRKQPDVDKVTKTYKRRAADPSSLQSHIPVLDKGRAGRKRFPASSLYPSGSQTQIETKNPRVNLLVSKWQQVWLLALERRRKLNDALDRLEELREFANFDFDIWRKKYMRWMNHKKSRVMDFFRRIDKDQDGKITRQEFIDGILSSKFPTSRLEMSAVADIFDRDGDGYIDYYEFVAALHPNKDAYKPITDADKIEDEVTRQVAKCKCAKRFQVEQIGDNKYRFFLGNQFGDSQQLRLVRILRSTVMVRVGGGWMALDEFLVKNDPCRAKGRTNMELREKFILADGASQGMAAFRPRGRRSRPSSRGASPNRSTSVSSQAAQAASPQVPATTTPKILHPLTRNYGKPWLTNSK</SEQUENCE>
        <SYNONYMS>DMH</SYNONYMS>
        <SYNONYMS>Dystonia musculorum protein</SYNONYMS>
        <SYNONYMS>CATX15</SYNONYMS>
        <SHORT-NAME>BPAG1</SHORT-NAME>
        <XREF>
          <publicationXref rdf:ID="publicationXref422">
            <ID>2645368</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref426">
            <DB>Pubmed</DB>
            <ID>12482924</ID>
          </publicationXref>
        </XREF>
        <SYNONYMS>Dystonin</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref427">
            <DB>Pubmed</DB>
            <ID>14517317</ID>
          </publicationXref>
        </XREF>
        <SYNONYMS>BPA</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref424">
            <ID>3880796</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <SYNONYMS>MACF2</SYNONYMS>
        <SYNONYMS>Trabeculin-beta</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref596">
            <DB>refseq</DB>
            <ID>NP_899236</ID>
          </unificationXref>
        </XREF>
      </protein>
    </PHYSICAL-ENTITY>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant195">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein267"/>
  </sequenceParticipant>
  <evidence rdf:ID="evidence370">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <XREF>
      <publicationXref rdf:ID="publicationXref386">
        <DB>Pubmed</DB>
        <ID>12919677</ID>
      </publicationXref>
    </XREF>
  </evidence>
  <relationshipXref rdf:ID="relationshipXref521">
    <DB>OMIM</DB>
    <ID>600560</ID>
    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
  </relationshipXref>
  <sequenceParticipant rdf:ID="sequenceParticipant72">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein231">
        <XREF>
          <relationshipXref rdf:ID="relationshipXref484">
            <DB>OMIM</DB>
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
            <ID>159430</ID>
          </relationshipXref>
        </XREF>
        <SEQUENCE>MASQKRPSQRHGSKYLATASTMDHARHGFLPRHRDTGILDSIGRFFGGDRGAPKRGSGKVPWLKPGRSPLPSHARSQPGLCNMYKDSHHPARTAHYGSLPQKSHGRTQDENPVVHFFKNIVTPRTPPPSQGKGAEGQRPGFGYGGRASDYKSAHKGFKGVDAQGTLSKIFKLGGRDSRSGSPMARR</SEQUENCE>
        <NAME>MBP</NAME>
        <XREF>
          <unificationXref rdf:ID="unificationXref561">
            <DB>refseq</DB>
            <ID>NP_002376</ID>
          </unificationXref>
        </XREF>
        <SYNONYMS>MBP</SYNONYMS>
        <SYNONYMS>Myelin A1 protein</SYNONYMS>
        <ORGANISM rdf:resource="#bioSource44"/>
        <SYNONYMS>Myelin membrane encephalitogenic protein</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref395">
            <ID>9136767</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <XREF>
          <unificationXref rdf:ID="unificationXref562">
            <DB>HPRD</DB>
            <ID>01158</ID>
          </unificationXref>
        </XREF>
        <SHORT-NAME>MBP</SHORT-NAME>
        <SYNONYMS>Myelin basic protein</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant153">
    <CELLULAR-LOCATION>
      <openControlledVocabulary rdf:ID="openControlledVocabulary660">
        <XREF>
          <unificationXref rdf:ID="unificationXref554">
            <DB>GO</DB>
            <ID>0005634</ID>
          </unificationXref>
        </XREF>
        <TERM>nucleus</TERM>
      </openControlledVocabulary>
    </CELLULAR-LOCATION>
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein256">
        <SEQUENCE>MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPPGASLLLLQQQQQQQQQQQQQQQQQQQQQQQETSPRQQQQQQGEDGSPQAHRRGPTGYLVLDEEQQPSQPQSALECHPERGCVPEPGAAVAASKGLPQQLPAPPDEDDSAAPSTLSLLGPTFPGLSSCSADLKDILSEASTMQLLQQQQQEAVSEGSSSGRAREASGAPTSSKDNYLGGTSTISDNAKELCKAVSVSMGLGVEALEHLSPGEQLRGDCMYAPLLGVPPAVRPTPCAPLAECKGSLLDDSAGKSTEDTAEYSPFKGGYTKGLEGESLGCSGSAAAGSSGTLELPSTLSLYKSGALDEAAAYQSRDYYNFPLALAGPPPPPPPPHPHARIKLENPLDYGSAWAAAAAQCRYGDLASLHGAGAAGPGSGSPSAAASSSWHTLFTAEEGQLYGPCGGGGGGGGGGGGGGGGGGGGGGGEAGAVAPYGYTRPPQGLAGQESDFTAPDVWYPGGMVSRVPYPSPTCVKSEMGPWMDSYSGPYGDMRLETARDHVLPIDYYFPPQKTCLICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDCTIDKFRRKNCPSCRLRKCYEAGMTLGARKLKKLGNLKLQEEGEASSTTSPTEETTQKLTVSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ</SEQUENCE>
        <SYNONYMS>SBMA</SYNONYMS>
        <XREF rdf:resource="#relationshipXref504"/>
        <SYNONYMS>NR3C4</SYNONYMS>
        <ORGANISM rdf:resource="#bioSource44"/>
        <XREF>
          <unificationXref rdf:ID="unificationXref613">
            <ID>02437</ID>
            <DB>HPRD</DB>
          </unificationXref>
        </XREF>
        <SYNONYMS>SMAX1</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref448">
            <DB>Pubmed</DB>
            <ID>11795379</ID>
          </publicationXref>
        </XREF>
        <SYNONYMS>DHTR</SYNONYMS>
        <SHORT-NAME>AR</SHORT-NAME>
        <XREF>
          <publicationXref rdf:ID="publicationXref449">
            <ID>12534934</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <SYNONYMS>Dihydrotestosterone receptor</SYNONYMS>
        <SYNONYMS>KD</SYNONYMS>
        <SYNONYMS>HUMARA</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref447">
            <ID>11396657</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <XREF>
          <unificationXref rdf:ID="unificationXref612">
            <ID>NP_000035</ID>
            <DB>refseq</DB>
          </unificationXref>
        </XREF>
        <NAME>AR</NAME>
        <SYNONYMS>AIS</SYNONYMS>
        <SYNONYMS>AR</SYNONYMS>
        <SYNONYMS>TFM</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant53">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein222">
        <SYNONYMS>MET</SYNONYMS>
        <SEQUENCE>MKAPAVLAPGILVLLFTLVQRSNGECKEALAKSEMNVNMKYQLPNFTAETPIQNVILHEHHIFLGATNYIYVLNEEDLQKVAEYKTGPVLEHPDCFPCQDCSSKANLSGGVWKDNINMALVVDTYYDDQLISCGSVNRGTCQRHVFPHNHTADIQSEVHCIFSPQIEEPSQCPDCVVSALGAKVLSSVKDRFINFFVGNTINSSYFPDHPLHSISVRRLKETKDGFMFLTDQSYIDVLPEFRDSYPIKYVHAFESNNFIYFLTVQRETLDAQTFHTRIIRFCSINSGLHSYMEMPLECILTEKRKKRSTKKEVFNILQAAYVSKPGAQLARQIGASLNDDILFGVFAQSKPDSAEPMDRSAMCAFPIKYVNDFFNKIVNKNNVRCLQHFYGPNHEHCFNRTLLRNSSGCEARRDEYRTEFTTALQRVDLFMGQFSEVLLTSISTFIKGDLTIANLGTSEGRFMQVVVSRSGPSTPHVNFLLDSHPVSPEVIVEHTLNQNGYTLVITGKKITKIPLNGLGCRHFQSCSQCLSAPPFVQCGWCHDKCVRSEECLSGTWTQQICLPAIYKVFPNSAPLEGGTRLTICGWDFGFRRNNKFDLKKTRVLLGNESCTLTLSESTMNTLKCTVGPAMNKHFNMSIIISNGHGTTQYSTFSYVDPVITSISPKYGPMAGGTLLTLTGNYLNSGNSRHISIGGKTCTLKSVSNSILECYTPAQTISTEFAVKLKIDLANRETSIFSYREDPIVYEIHPTKSFISGGSTITGVGKNLNSVSVPRMVINVHEAGRNFTVACQHRSNSEIICCTTPSLQQLNLQLPLKTKAFFMLDGILSKYFDLIYVHNPVFKPFEKPVMISMGNENVLEIKGNDIDPEAVKGEVLKVGNKSCENIHLHSEAVLCTVPNDLLKLNSELNIEWKQAISSTVLGKVIVQPDQNFTGLIAGVVSISTALLLLLGFFLWLKKRKQIKDLGSELVRYDARVHTPHLDRLVSARSVSPTTEMVSNESVDYRATFPEDQFPNSSQNGSCRQVQYPLTDMSPILTSGDSDISSPLLQNTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVKCVAPYPSLLSSEDNADDEVDTRPASFWETS</SEQUENCE>
        <SHORT-NAME>MET</SHORT-NAME>
        <XREF>
          <unificationXref rdf:ID="unificationXref542">
            <ID>NP_000236</ID>
            <DB>refseq</DB>
          </unificationXref>
        </XREF>
        <ORGANISM rdf:resource="#bioSource44"/>
        <SYNONYMS>HGFR</SYNONYMS>
        <SYNONYMS>Hepatocyte growth factor receptor</SYNONYMS>
        <SYNONYMS>RCCP2</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref380">
            <DB>Pubmed</DB>
            <ID>11733063</ID>
          </publicationXref>
        </XREF>
        <XREF>
          <unificationXref rdf:ID="unificationXref543">
            <ID>01280</ID>
            <DB>HPRD</DB>
          </unificationXref>
        </XREF>
        <SYNONYMS>Renal cell carcinoma, papillary, 2 gene</SYNONYMS>
        <NAME>MET</NAME>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref476">
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
            <DB>OMIM</DB>
            <ID>164860</ID>
          </relationshipXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref381">
            <DB>Pubmed</DB>
            <ID>2819873</ID>
          </publicationXref>
        </XREF>
      </protein>
    </PHYSICAL-ENTITY>
  </sequenceParticipant>
  <protein rdf:ID="protein266">
    <ORGANISM rdf:resource="#bioSource44"/>
    <SYNONYMS>Eukaryotic translation initiation factor 4E</SYNONYMS>
    <SHORT-NAME>EIF4E</SHORT-NAME>
    <SYNONYMS>Messenger RNA cap binding protein EIF4E</SYNONYMS>
    <SEQUENCE>MATVEPETTPTPNPPTTEEEKTESNQEVANPEHYIKHPLQNRWALWFFKNDKSKTWQANLRLISKFDTVEDFWALYNHIQLSSNLMPGCDYSLFKDGIEPMWEDEKNKRGGRWLITLNKQQRRSDLDRFWLETLLCLIGESFDDYSDDVCGAVVNVRAKGDKIAIWTTECENREAVTHIGRVYKERLGLPPKIVIGYQSHADTATKSGSTTKNRFVV</SEQUENCE>
    <XREF>
      <unificationXref rdf:ID="unificationXref633">
        <ID>00591</ID>
        <DB>HPRD</DB>
      </unificationXref>
    </XREF>
    <XREF>
      <publicationXref rdf:ID="publicationXref391">
        <ID>12105188</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
    <NAME>EIF4E</NAME>
    <SYNONYMS>EIF4EL1</SYNONYMS>
    <XREF>
      <relationshipXref rdf:ID="relationshipXref514">
        <ID>133440</ID>
        <DB>OMIM</DB>
        <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
      </relationshipXref>
    </XREF>
    <XREF>
      <unificationXref rdf:ID="unificationXref632">
        <DB>refseq</DB>
        <ID>NP_001959</ID>
      </unificationXref>
    </XREF>
    <SYNONYMS>EIF4E</SYNONYMS>
    <XREF>
      <publicationXref rdf:ID="publicationXref460">
        <ID>10648556</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
    <SYNONYMS>Eukaryotic translation initiation factor 4E like 1</SYNONYMS>
  </protein>
  <sequenceParticipant rdf:ID="sequenceParticipant118">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein221"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant208">
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein250">
        <SYNONYMS>BP180</SYNONYMS>
        <SHORT-NAME>BPAG2</SHORT-NAME>
        <SYNONYMS>Collagen, type XVII, alpha-1</SYNONYMS>
        <NAME>COL17A1</NAME>
        <SYNONYMS>Bullous pemphigoid antigen 2</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref602">
            <ID>00223</ID>
            <DB>HPRD</DB>
          </unificationXref>
        </XREF>
        <SEQUENCE>MDVTKKNKRDGTEVTERIVTETVTTRLTSLPPKGGTSNGYAKTASLGGGSRLEKQSLTHGSSGYINSTGSTRGHASTSSYRRAHSPASTLPNSPGSTFERKTHVTRHAYEGSSSGNSSPEYPRKEFASSSTRGRSQTRESEIRVRLQSASPSTRWTELDDVKRLLKGSRSASVSPTRNSSNTLPIPKKGTVETKIVTASSQSVSGTYDATILDANLPSHVWSSTLPAGSSMGTYHNNMTTQSSSLLNTNAYSAGSVFGVPNNMASCSPTLHPGLSTSSSVFGMQNNLAPSLTTLSHGTTTTSTAYGVKKNMPQSPAAVNTGVSTSAACTTSVQSDDLLHKDCKFLILEKDNTPAKKEMELLIMTKDSGKVFTASPASIAATSFSEDTLKKEKQAAYNADSGLKAEANGDLKTVSTKGKTTTADIHSYSSSGGGGSGGGGGVGGAGGGPWGPAPAWCPCGSCCSWWKWLLGLLLTWLLLLGLLFGLIALAEEVRKLKARVDELERIRRSILPYGDSMDRIEKDRLQGMAPAAGADLDKIGLHSDSQEELWMFVRKKLMMEQENGNLRGSPGPKGDMGSPGPKGDRGFPGTPGIPGPLGHPGPQGPKGQKGSVGDPGMEGPMGQRGREGPMGPRGEAGPPGSGEKGERGAAGEPGPHGPPGVPGSVGPKGSSGSPGPQGPPGPVGLQGLRGEVGLPGVKGDKGPMGPPGPKGDQGEKGPRGLTGEPGMRGLPGAVGEPGAKGAMGPAGPDGHQGPRGEQGLTGMPGIRGPPGPSGDPGKPGLTGPQGPQGLPGTPGRPGIKGEPGAPGKIVTSEGSSMLTVPGPPGPPGAMGPPGPPGAPGPAGPAGLPGHQEVLNLQGPPGPPGPRGPPGPSIPGPPGPRGPPGEGLPGPPGPPGSFLSNSETFLFGPPGPPGPPGPKGDQGPPGPRGHQGEQGLPGFSTSGSSSFGLNLQGPPGPPGPQGPKGDKGDPGVPGALGIPSGPSEGGSSSTMYVSGPPGPPGPPGPPGSISSSGQEIQQYISEYMQSDSIRSYLSGVQGPPGPPGPPGPVTTITGETFDYSELASHVVSYLRTSGYGVSLFSSSISSEDILAVLQRDDVRQYLRQYLMGPRGPPGPPGASGDGSLLSLDYAELSSRILSYMSSSGISIGLPGPPGPPGLPGTSYEELLSLLRGSEFRGIVGPPGPPGPPGIPGNVWSSISVEDLSSYLHTAGLSFIPGPPGPPGPPGPRGPPGVSGALATYAAENSDSFRSELISYLTSPDVRSFIVGPPGPPGPQGPPGDSRLLSTDASHSRGSSSSSHSSSVRRGSSYSSSMSTGGGGAGSLGAGGAFGEAAGDRGPYGTDIGPGGGYGAAAEGGMYAGNGGLLGADFAGDLDYNELAVRVSESMQRQGLLQGMAYTVQGPPGQPGPQGPPGISKVFSAYSNVTADLMDFFQTYGAIQGPPGQKGEMGTPGPKGDRGPAGPPGHPGPPGPRGHKGEKGDKGDQVYAGRRRRRSIAVKP</SEQUENCE>
        <SYNONYMS>COL17A1</SYNONYMS>
        <SYNONYMS>Alpha 1 type XVII collagen</SYNONYMS>
        <XREF rdf:resource="#publicationXref426"/>
        <XREF rdf:resource="#publicationXref431"/>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref499">
            <ID>113811</ID>
            <DB>OMIM</DB>
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
          </relationshipXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref430">
            <ID>11514543</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <XREF>
          <unificationXref rdf:ID="unificationXref601">
            <DB>refseq</DB>
            <ID>NP_000485</ID>
          </unificationXref>
        </XREF>
        <SYNONYMS>BPAG2</SYNONYMS>
        <ORGANISM rdf:resource="#bioSource44"/>
      </protein>
    </PHYSICAL-ENTITY>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant57">
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein224">
        <NAME>AKT1</NAME>
        <SYNONYMS>RAC-alpha serine/threonine protein kinase</SYNONYMS>
        <SYNONYMS>PRKBA</SYNONYMS>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref473">
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
            <DB>OMIM</DB>
            <ID>164730</ID>
          </relationshipXref>
        </XREF>
        <SYNONYMS>Protein kinase B</SYNONYMS>
        <SEQUENCE>MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASSTA</SEQUENCE>
        <SYNONYMS>AKT1</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref531">
            <ID>01261</ID>
            <DB>HPRD</DB>
          </unificationXref>
        </XREF>
        <SHORT-NAME>AKT1</SHORT-NAME>
        <SYNONYMS>PKB</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref546">
            <ID>NP_005154</ID>
            <DB>refseq</DB>
          </unificationXref>
        </XREF>
        <SYNONYMS>C-AKT</SYNONYMS>
        <SYNONYMS>RAC-PK-alpha</SYNONYMS>
        <ORGANISM rdf:resource="#bioSource44"/>
        <SYNONYMS>RAC</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref374">
            <DB>Pubmed</DB>
            <ID>9395488</ID>
          </publicationXref>
        </XREF>
      </protein>
    </PHYSICAL-ENTITY>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <publicationXref rdf:ID="publicationXref416">
    <ID>8985115</ID>
    <DB>Pubmed</DB>
  </publicationXref>
  <relationshipXref rdf:ID="relationshipXref510">
    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
    <DB>OMIM</DB>
    <ID>609009</ID>
  </relationshipXref>
  <sequenceParticipant rdf:ID="sequenceParticipant105">
    <PHYSICAL-ENTITY rdf:resource="#protein237"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <unificationXref rdf:ID="unificationXref553">
    <ID>01498</ID>
    <DB>HPRD</DB>
  </unificationXref>
  <physicalInteraction rdf:ID="physicalInteraction725">
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGB4 and MET.1)Following Met activation, alpha6beta4 is tyrosine phosphorylated and combines with Shc and PI3K, generating an additional signaling platform that potentiates HGF-triggered activation of Ras- and PI3K-dependent pathways.</COMMENT>
    <XREF rdf:resource="#publicationXref380"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant180">
        <PHYSICAL-ENTITY rdf:resource="#protein222"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >MET-ITGB4</SHORT-NAME>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant181">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <EVIDENCE>
      <evidence rdf:ID="evidence355">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <XREF rdf:resource="#publicationXref380"/>
      </evidence>
    </EVIDENCE>
    <XREF>
      <publicationXref rdf:ID="publicationXref442">
        <DB>Pubmed</DB>
        <ID>14602071</ID>
      </publicationXref>
    </XREF>
    <EVIDENCE>
      <evidence rdf:ID="evidence356">
        <XREF rdf:resource="#publicationXref442"/>
      </evidence>
    </EVIDENCE>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >MET-ITGB4</NAME>
  </physicalInteraction>
  <evidence rdf:ID="evidence329">
    <XREF>
      <publicationXref rdf:ID="publicationXref415">
        <DB>Pubmed</DB>
        <ID>14512419</ID>
      </publicationXref>
    </XREF>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
  </evidence>
  <evidence rdf:ID="evidence304">
    <XREF rdf:resource="#publicationXref403"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
  </evidence>
  <evidence rdf:ID="evidence341">
    <XREF rdf:resource="#publicationXref386"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
  </evidence>
  <evidence rdf:ID="evidence312">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
    <XREF rdf:resource="#publicationXref399"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
  </evidence>
  <sequenceParticipant rdf:ID="sequenceParticipant213">
    <PHYSICAL-ENTITY rdf:resource="#protein221"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
  </sequenceParticipant>
  <publicationXref rdf:ID="publicationXref458">
    <ID>9087447</ID>
    <DB>Pubmed</DB>
  </publicationXref>
  <sequenceFeature rdf:ID="sequenceFeature675">
    <FEATURE-TYPE>
      <openControlledVocabulary rdf:ID="openControlledVocabulary654">
        <TERM>proteolytic cleavage site</TERM>
        <XREF>
          <unificationXref rdf:ID="unificationXref533">
            <DB>IOB</DB>
            <ID>IOB:05</ID>
          </unificationXref>
        </XREF>
      </openControlledVocabulary>
    </FEATURE-TYPE>
  </sequenceFeature>
  <sequenceParticipant rdf:ID="sequenceParticipant87">
    <PHYSICAL-ENTITY rdf:resource="#protein237"/>
    <SEQUENCE-FEATURE-LIST>
      <sequenceFeature rdf:ID="sequenceFeature676">
        <FEATURE-LOCATION>
          <sequenceSite rdf:ID="sequenceSite681">
            <SEQUENCE-POSITION>925</SEQUENCE-POSITION>
            <POSITION-STATUS>EQUAL</POSITION-STATUS>
          </sequenceSite>
        </FEATURE-LOCATION>
        <FEATURE-TYPE>
          <openControlledVocabulary rdf:ID="openControlledVocabulary658">
            <XREF>
              <unificationXref rdf:ID="unificationXref541">
                <DB>PSIMI</DB>
                <ID>MI:0170</ID>
              </unificationXref>
            </XREF>
            <TERM>phosphorylation site</TERM>
          </openControlledVocabulary>
        </FEATURE-TYPE>
      </sequenceFeature>
    </SEQUENCE-FEATURE-LIST>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <publicationXref rdf:ID="publicationXref396">
    <DB>Pubmed</DB>
    <ID>11389095</ID>
  </publicationXref>
  <unificationXref rdf:ID="unificationXref526">
    <DB>HPRD</DB>
    <ID>02799</ID>
  </unificationXref>
  <protein rdf:ID="protein228">
    <SYNONYMS>FRAP2</SYNONYMS>
    <XREF>
      <relationshipXref rdf:ID="relationshipXref481">
        <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
        <DB>OMIM</DB>
        <ID>601231</ID>
      </relationshipXref>
    </XREF>
    <XREF>
      <unificationXref rdf:ID="unificationXref556">
        <ID>03134</ID>
        <DB>HPRD</DB>
      </unificationXref>
    </XREF>
    <NAME>FRAP1</NAME>
    <XREF rdf:resource="#publicationXref391"/>
    <ORGANISM rdf:resource="#bioSource44"/>
    <SYNONYMS>mTOR</SYNONYMS>
    <SYNONYMS>FRAP</SYNONYMS>
    <XREF>
      <publicationXref rdf:ID="publicationXref392">
        <ID>11114166</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
    <SYNONYMS>FK506-binding protein 12 rapamycin complex associated protein 1</SYNONYMS>
    <SEQUENCE>MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQHYVTMELREMSQEESTRFYDQLNHHIFELVSSSDANERKGGILAIASLIGVEGGNATRIGRFANYLRNLLPSNDPVVMEMASKAIGRLAMAGDTFTAEYVEFEVKRALEWLGADRNEGRRHAAVLVLRELAISVPTFFFQQVQPFFDNIFVAVWDPKQAIREGAVAALRACLILTTQREPKEMQKPQWYRHTFEEAEKGFDETLAKEKGMNRDDRIHGALLILNELVRISSMEGERLREEMEEITQQQLVHDKYCKDLMGFGTKPRHITPFTSFQAVQPQQSNALVGLLGYSSHQGLMGFGTSPSPAKSTLVESRCCRDLMEEKFDQVCQWVLKCRNSKNSLIQMTILNLLPRLAAFRPSAFTDTQYLQDTMNHVLSCVKKEKERTAAFQALGLLSVAVRSEFKVYLPRVLDIIRAALPPKDFAHKRQKAMQVDATVFTCISMLARAMGPGIQQDIKELLEPMLAVGLSPALTAVLYDLSRQIPQLKKDIQDGLLKMLSLVLMHKPLRHPGMPKGLAHQLASPGLTTLPEASDVGSITLALRTLGSFEFEGHSLTQFVRHCADHFLNSEHKEIRMEAARTCSRLLTPSIHLISGHAHVVSQTAVQVVADVLSKLLVVGITDPDPDIRYCVLASLDERFDAHLAQAENLQALFVALNDQVFEIRELAICTVGRLSSMNPAFVMPFLRKMLIQILTELEHSGIGRIKEQSARMLGHLVSNAPRLIRPYMEPILKALILKLKDPDPDPNPGVINNVLATIGELAQVSGLEMRKWVDELFIIIMDMLQDSSLLAKRQVALWTLGQLVASTGYVVEPYRKYPTLLEVLLNFLKTEQNQGTRREAIRVLGLLGALDPYKHKVNIGMIDQSRDASAVSLSESKSSQDSSDYSTSEMLVNMGNLPLDEFYPAVSMVALMRIFRDQSLSHHHTMVVQAITFIFKSLGLKCVQFLPQVMPTFLNVIRVCDGAIREFLFQQLGMLVSFVKSHIRPYMDEIVTLMREFWVMNTSIQSTIILLIEQIVVALGGEFKLYLPQLIPHMLRVFMHDNSPGRIVSIKLLAAIQLFGANLDDYLHLLLPPIVKLFDAPEAPLPSRKAALETVDRLTESLDFTDYASRIIHPIVRTLDQSPELRSTAMDTLSSLVFQLGKKYQIFIPMVNKVLVRHRINHQRYDVLICRIVKGYTLADEEEDPLIYQHRMLRSGQGDALASGPVETGPMKKLHVSTINLQKAWGAARRVSKDDWLEWLRRLSLELLKDSSSPSLRSCWALAQAYNPMARDLFNAAFVSCWSELNEDQQDELIRSIELALTSQDIAEVTQTLLNLAEFMEHSDKGPLPLRDDNGIVLLGERAAKCRAYAKALHYKELEFQKGPTPAILESLISINNKLQQPEAAAGVLEYAMKHFGELEIQATWYEKLHEWEDALVAYDKKMDTNKDDPELMLGRMRCLEALGEWGQLHQQCCEKWTLVNDETQAKMARMAAAAAWGLGQWDSMEEYTCMIPRDTHDGAFYRAVLALHQDLFSLAQQCIDKARDLLDAELTAMAGESYSRAYGAMVSCHMLSELEEVIQYKLVPERREIIRQIWWERLQGCQRIVEDWQKILMVRSLVVSPHEDMRTWLKYASLCGKSGRLALAHKTLVLLLGVDPSRQLDHPLPTVHPQVTYAYMKNMWKSARKIDAFQHMQHFVQTMQQQAQHAIATEDQQHKQELHKLMARCFLKLGEWQLNLQGINESTIPKVLQYYSAATEHDRSWYKAWHAWAVMNFEAVLHYKHQNQARDEKKKLRHASGANITNATTAATTAATATTTASTEGSNSESEAESTENSPTPSPLQKKVTEDLSKTLLMYTVPAVQGFFRSISLSRGNNLQDTLRVLTLWFDYGHWPDVNEALVEGVKAIQIDTWLQVIPQLIARIDTPRPLVGRLIHQLLTDIGRYHPQALIYPLTVASKSTTTARHNAANKILKNMCEHSNTLVQQAMMVSEELIRVAILWHEMWHEGLEEASRLYFGERNVKGMFEVLEPLHAMMERGPQTLKETSFNQAYGRDLMEAQEWCRKYMKSGNVKDLTQAWDLYYHVFRRISKQLPQLTSLELQYVSPKLLMCRDLELAVPGTYDPNQPIIRIQSIAPSLQVITSKQRPRKLTLMGSNGHEFVFLLKGHEDLRQDERVMQLFGLVNTLLANDPTSLRKNLSIQRYAVIPLSTNSGLIGWVPHCDTLHALIRDYREKKKILLNIEHRIMLRMAPDYDHLTLMQKVEVFEHAVNNTAGDDLAKLLWLKSPSSEVWFDRRTNYTRSLAVMSMVGYILGLGDRHPSNLMLDRLSGKILHIDFGDCFEVAMTREKFPEKIPFRLTRMLTNAMEVTGLDGNYRITCHTVMEVLREHKDSVMAVLEAFVYDPLLNWRLMDTNTKGNKRSRTRTDSYSAGQSVEILDGVELGEPAHKKTGTTVPESIHSFIGDGLVKPEALNKKAIQIINRVRDKLTGRDFSHDDTLDVPTQVELLIKQATSHENLCQCYIGWCPFW</SEQUENCE>
    <XREF>
      <unificationXref rdf:ID="unificationXref555">
        <DB>refseq</DB>
        <ID>NP_004949</ID>
      </unificationXref>
    </XREF>
    <SHORT-NAME>FRAP1</SHORT-NAME>
    <SYNONYMS>Mammalian target of rapamycin</SYNONYMS>
    <SYNONYMS>RAFT1</SYNONYMS>
    <SYNONYMS>FRAP1</SYNONYMS>
  </protein>
  <sequenceFeature rdf:ID="sequenceFeature667">
    <FEATURE-TYPE rdf:resource="#openControlledVocabulary658"/>
  </sequenceFeature>
  <physicalInteraction rdf:ID="physicalInteraction695">
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >PTK2-GRB2</NAME>
    <EVIDENCE>
      <evidence rdf:ID="evidence313">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <XREF rdf:resource="#publicationXref403"/>
      </evidence>
    </EVIDENCE>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <XREF rdf:resource="#publicationXref403"/>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >PTK2-GRB2</SHORT-NAME>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between PTK2 and GRB2</COMMENT>
    <PARTICIPANTS rdf:resource="#sequenceParticipant120"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant121">
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein247">
            <SEQUENCE>MEAIAKYDFKATADDELSFKRGDILKVLNEECDQNWYKAELNGKDGFIPKNYIEMKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTYVQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNRNV</SEQUENCE>
            <XREF>
              <publicationXref rdf:ID="publicationXref421">
                <ID>9171350</ID>
                <DB>Pubmed</DB>
              </publicationXref>
            </XREF>
            <SYNONYMS>Growth factor receptor bound protein 2</SYNONYMS>
            <XREF>
              <relationshipXref rdf:ID="relationshipXref496">
                <DB>OMIM</DB>
                <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                <ID>108355</ID>
              </relationshipXref>
            </XREF>
            <SYNONYMS>Abundant Src homology protein</SYNONYMS>
            <XREF>
              <unificationXref rdf:ID="unificationXref594">
                <ID>NP_002077</ID>
                <DB>refseq</DB>
              </unificationXref>
            </XREF>
            <ORGANISM rdf:resource="#bioSource44"/>
            <XREF>
              <publicationXref rdf:ID="publicationXref420">
                <DB>Pubmed</DB>
                <ID>10051406</ID>
              </publicationXref>
            </XREF>
            <SYNONYMS>GRB2</SYNONYMS>
            <NAME>GRB2</NAME>
            <SHORT-NAME>GRB2</SHORT-NAME>
            <XREF>
              <unificationXref rdf:ID="unificationXref595">
                <ID>00150</ID>
                <DB>HPRD</DB>
              </unificationXref>
            </XREF>
            <SYNONYMS>ASH</SYNONYMS>
          </protein>
        </PHYSICAL-ENTITY>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
      </sequenceParticipant>
    </PARTICIPANTS>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant61">
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein225">
        <XREF>
          <unificationXref rdf:ID="unificationXref548">
            <DB>HPRD</DB>
            <ID>04409</ID>
          </unificationXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref382">
            <ID>10527852</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <SHORT-NAME>BAD</SHORT-NAME>
        <ORGANISM rdf:resource="#bioSource44"/>
        <SYNONYMS>BCL2L8</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref385">
            <ID>10949026</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <SYNONYMS>Bcl-XL/Bcl-2 associated death promoter</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref547">
            <ID>NP_004313</ID>
            <DB>refseq</DB>
          </unificationXref>
        </XREF>
        <SYNONYMS>BCL2 binding protein</SYNONYMS>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref478">
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
            <DB>OMIM</DB>
            <ID>603167</ID>
          </relationshipXref>
        </XREF>
        <NAME>BAD</NAME>
        <SYNONYMS>BBC2</SYNONYMS>
        <SEQUENCE>MFQIPEFEPSEQEDSSSAERGLGPSPAGDGPSGSGKHHRQAPGLLWDASHQQEQPTSSSHHGGAGAVEIRSRHSSYPAGTEDDEGMGEEPSPFRGRSRSAPPNLWAAQRYGRELRRMSDEFVDSFKKGLPRPKSAGTATQMRQSSSWTRVFQSWWDRNLGRGSSAPSQ</SEQUENCE>
        <SYNONYMS>BBC6</SYNONYMS>
        <SYNONYMS>BCL2 antagonist of cell death protein</SYNONYMS>
        <SYNONYMS>BCL2 binding component 6</SYNONYMS>
        <SYNONYMS>BAD</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
    <SEQUENCE-FEATURE-LIST rdf:resource="#sequenceFeature667"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary659"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant186">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein221"/>
  </sequenceParticipant>
  <physicalInteraction rdf:ID="physicalInteraction734">
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-SHC1</SHORT-NAME>
    <XREF rdf:resource="#publicationXref380"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence368">
        <XREF rdf:resource="#publicationXref421"/>
      </evidence>
    </EVIDENCE>
    <XREF>
      <publicationXref rdf:ID="publicationXref469">
        <DB>Pubmed</DB>
        <ID>11044453</ID>
      </publicationXref>
    </XREF>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-SHC1</NAME>
    <EVIDENCE>
      <evidence rdf:ID="evidence367">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <XREF rdf:resource="#publicationXref380"/>
      </evidence>
    </EVIDENCE>
    <PARTICIPANTS rdf:resource="#sequenceParticipant213"/>
    <XREF rdf:resource="#publicationXref421"/>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGB4 and SHC.1)Uncoupling  alpha6beta4 from Shc Prevents HGF-Dependent Responses.</COMMENT>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant214">
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein273">
            <SYNONYMS>SHC1</SYNONYMS>
            <SYNONYMS>SHCA</SYNONYMS>
            <NAME>SHC1</NAME>
            <SYNONYMS>p66</SYNONYMS>
            <SEQUENCE>MNKLSGGGGRRTRVEGGQLGGEEWTRHGSFVNKPTRGWLHPNDKVMGPGVSYLVRYMGCVEVLQSMRALDFNTRTQVTREAISLVCEAVPGAKGATRRRKPCSRPLSSILGRSNLKFAGMPITLTVSTSSLNLMAADCKQIIANHHMQSISFASGGDPDTAEYVAYVAKDPVNQRACHILECPEGLAQDVISTIGQAFELRFKQYLRNPPKLVTPHDRMAGFDGSAWDEEEEEPPDHQYYNDFPGKEPPLGGVVDMRLREGAAPGAARPTAPNAQTPSHLGATLPVGQPVGGDPEVRKQMPPPPPCPAGRELFDDPSYVNVQNLDKARQAVGGAGPPNPAINGSAPRDLFDMKPFEDALRVPPPPQSVSMAEQLRGEPWFHGKLSRREAEALLQLNGDFLVRESTTTPGQYVLTGLQSGQPKHLLLVDPEGVVRTKDHRFESVSHLISYHMDNHLPIISAGSELCLQQPVERKL</SEQUENCE>
            <XREF>
              <unificationXref rdf:ID="unificationXref646">
                <ID>NP_892113</ID>
                <DB>refseq</DB>
              </unificationXref>
            </XREF>
            <SHORT-NAME>SHC1</SHORT-NAME>
            <XREF rdf:resource="#publicationXref421"/>
            <XREF>
              <publicationXref rdf:ID="publicationXref468">
                <ID>10971656</ID>
                <DB>Pubmed</DB>
              </publicationXref>
            </XREF>
            <SYNONYMS>SHC (Src homology 2 domain containing) transforming protein 1</SYNONYMS>
            <XREF rdf:resource="#relationshipXref521"/>
            <XREF>
              <unificationXref rdf:ID="unificationXref647">
                <DB>HPRD</DB>
                <ID>02780</ID>
              </unificationXref>
            </XREF>
            <ORGANISM rdf:resource="#bioSource44"/>
            <SYNONYMS>p52</SYNONYMS>
            <SYNONYMS>SHC</SYNONYMS>
            <SYNONYMS>p46</SYNONYMS>
          </protein>
        </PHYSICAL-ENTITY>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <EVIDENCE>
      <evidence rdf:ID="evidence369">
        <XREF rdf:resource="#publicationXref469"/>
      </evidence>
    </EVIDENCE>
  </physicalInteraction>
  <physicalInteraction rdf:ID="physicalInteraction706">
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <XREF rdf:resource="#publicationXref403"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Molecular association of ITGB4 and CLCA2.</COMMENT>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-CLCA2</NAME>
    <EVIDENCE>
      <evidence rdf:ID="evidence330">
        <XREF rdf:resource="#publicationXref403"/>
      </evidence>
    </EVIDENCE>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant142">
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-CLCA2</SHORT-NAME>
    <EVIDENCE rdf:resource="#evidence329"/>
    <XREF rdf:resource="#publicationXref415"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant143">
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein254">
            <XREF>
              <relationshipXref rdf:ID="relationshipXref495">
                <DB>OMIM</DB>
                <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                <ID>604003</ID>
              </relationshipXref>
            </XREF>
            <XREF>
              <unificationXref rdf:ID="unificationXref593">
                <DB>HPRD</DB>
                <ID>04923</ID>
              </unificationXref>
            </XREF>
            <SEQUENCE>MTQRSIAGPICNLKFVTLLVALSSELPFLGAGVQLQDNGYNGLLIAINPQVPENQNLISNIKEMITEASFYLFNATKRRVFFRNIKILIPATWKANNNSKIKQESYEKANVIVTDWYGAHGDDPYTLQYRGCGKEGKYIHFTPNFLLNDNLTAGYGSRGRVFVHEWAHLRWGVFDEYNNDKPFYINGQNQIKVTRCSSDITGIFVCEKGPCPQENCIISKLFKEGCTFIYNSTQNATASIMFMQSLSSVVEFCNASTHNQEAPNLQNQMCSLRSAWDVITDSADFHHSFPMNGTELPPPPTFSLVQAGDKVVCLVLDVSSKMAEADRLLQLQQAAEFYLMQIVEIHTFVGIASFDSKGEIRAQLHQINSNDDRKLLVSYLPTTVSAKTDISICSGLKKGFEVVEKLNGKAYGSVMILVTSGDDKLLGNCLPTVLSSGSTIHSIALGSSAAPNLEELSRLTGGLKFFVPDISNSNSMIDAFSRISSGTGDIFQQHIQLESTGENVKPHHQLKNTVTVDNTVGNDTMFLVTWQASGPPEIILFDPDGRKYYTNNFITNLTFRTASLWIPGTAKPGHWTYTLNNTHHSLQALKVTVTSRASNSAVPPATVEAFVERDSLHFPHPVMIYANVKQGFYPILNATVTATVEPETGDPVTLRLLDDGAGADVIKNDGIYSRYFFSFAANGRYSLKVHVNHSPSISTPAHSIPGSHAMYVPGYTANGNIQMNAPRKSVGRNEEERKWGFSRVSSGGSFSVLGVPAGPHPDVFPPCKIIDLEAVKVEEELTLSWTAPGEDFDQGQATSYEIRMSKSLQNIQDDFNNAILVNTSKRNPQQAGIREIFTFSPQISTNGPEHQPNGETHESHRIYVAIRAMDRNSLQSAVSNIAQAPLFIPPNSDPVPARDYLILKGVLTAMGLIGIICLIIVVTHHTLSRKKRADKKENGTKLL</SEQUENCE>
            <XREF>
              <publicationXref rdf:ID="publicationXref419">
                <DB>Pubmed</DB>
                <ID>10362588</ID>
              </publicationXref>
            </XREF>
            <ORGANISM rdf:resource="#bioSource44"/>
            <XREF rdf:resource="#publicationXref415"/>
            <SYNONYMS>Calcium activated chloride channel 2</SYNONYMS>
            <SYNONYMS>CLCA2</SYNONYMS>
            <SHORT-NAME>CLCA2</SHORT-NAME>
            <XREF>
              <unificationXref rdf:ID="unificationXref609">
                <DB>refseq</DB>
                <ID>NP_006527</ID>
              </unificationXref>
            </XREF>
            <NAME>CLCA2</NAME>
            <XREF rdf:resource="#publicationXref403"/>
          </protein>
        </PHYSICAL-ENTITY>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary659"/>
      </sequenceParticipant>
    </PARTICIPANTS>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant176">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein250"/>
  </sequenceParticipant>
  <relationshipXref rdf:ID="relationshipXref508">
    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
    <ID>605066</ID>
    <DB>OMIM</DB>
  </relationshipXref>
  <sequenceParticipant rdf:ID="sequenceParticipant133">
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein251">
        <XREF>
          <publicationXref rdf:ID="publicationXref432">
            <DB>Pubmed</DB>
            <ID>11590143</ID>
          </publicationXref>
        </XREF>
        <XREF>
          <unificationXref rdf:ID="unificationXref603">
            <ID>NP_061485</ID>
            <DB>refseq</DB>
          </unificationXref>
        </XREF>
        <SEQUENCE>MQAIKCVVVGDGAVGKTCLLISYTTNAFPGEYIPTVFDNYSANVMVDGKPVNLGLWDTAGQEDYDRLRPLSYPQTVGETYGKDITSRGKDKPIADVFLICFSLVSPASFENVRAKWYPEVRHHCPNTPIILVGTKLDLRDDKDTIEKLKEKKLTPITYPQGLAMAKEIGAVKYLECSALTQRGLKTVFDEAIRAVLCPPPVKKRKRKCLLL</SEQUENCE>
        <SYNONYMS>Ras related C3 botulinum toxin substrate 1</SYNONYMS>
        <SYNONYMS>RAC1</SYNONYMS>
        <SYNONYMS>Ras like protein TC25</SYNONYMS>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref500">
            <DB>OMIM</DB>
            <ID>602048</ID>
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
          </relationshipXref>
        </XREF>
        <SYNONYMS>Rho family, small GTP binding protein RAC1</SYNONYMS>
        <XREF rdf:resource="#publicationXref393"/>
        <NAME>RAC1</NAME>
        <SHORT-NAME>RAC1</SHORT-NAME>
        <XREF>
          <unificationXref rdf:ID="unificationXref604">
            <ID>03627</ID>
            <DB>HPRD</DB>
          </unificationXref>
        </XREF>
        <ORGANISM rdf:resource="#bioSource44"/>
      </protein>
    </PHYSICAL-ENTITY>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <sequenceFeature rdf:ID="sequenceFeature663">
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >unknown site</NAME>
    <FEATURE-TYPE rdf:resource="#openControlledVocabulary654"/>
  </sequenceFeature>
  <evidence rdf:ID="evidence353">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
    <XREF rdf:resource="#publicationXref426"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
  </evidence>
  <relationshipXref rdf:ID="relationshipXref485">
    <ID>176977</ID>
    <DB>OMIM</DB>
    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
  </relationshipXref>
  <sequenceParticipant rdf:ID="sequenceParticipant182">
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein229">
        <SYNONYMS>4EBP1</SYNONYMS>
        <XREF rdf:resource="#publicationXref392"/>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref482">
            <ID>602223</ID>
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
            <DB>OMIM</DB>
          </relationshipXref>
        </XREF>
        <SHORT-NAME>4EBP1</SHORT-NAME>
        <NAME>EIF4EBP1</NAME>
        <XREF>
          <unificationXref rdf:ID="unificationXref557">
            <DB>refseq</DB>
            <ID>NP_004086</ID>
          </unificationXref>
        </XREF>
        <SYNONYMS>PHAS1</SYNONYMS>
        <SYNONYMS>Eukaryotic translation initiation factor 4E binding protein 1</SYNONYMS>
        <XREF rdf:resource="#publicationXref391"/>
        <XREF>
          <unificationXref rdf:ID="unificationXref558">
            <ID>03746</ID>
            <DB>HPRD</DB>
          </unificationXref>
        </XREF>
        <SYNONYMS>EIF 4E binding protein 1</SYNONYMS>
        <SEQUENCE>MSGGSSCSQTPSRAIPATRRVVLGDGVQLPPGDYSTTPGGTLFSTTPGGTRIIYDRKFLMECRNSPVTKTPPRDLPTIPGVTSPSSDEPPMEASQSHLRNSPEDKRAGGEESQFEMDI</SEQUENCE>
        <ORGANISM rdf:resource="#bioSource44"/>
        <SYNONYMS>EIF4EBP1</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <unificationXref rdf:ID="unificationXref630">
    <DB>refseq</DB>
    <ID>NP_004406</ID>
  </unificationXref>
  <unificationXref rdf:ID="unificationXref532">
    <DB>taxon</DB>
    <ID>10090</ID>
  </unificationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant166">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein221"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant147">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein233"/>
  </sequenceParticipant>
  <evidence rdf:ID="evidence334">
    <XREF>
      <publicationXref rdf:ID="publicationXref445">
        <ID>11438664</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
  </evidence>
  <sequenceParticipant rdf:ID="sequenceParticipant79">
    <PHYSICAL-ENTITY rdf:resource="#protein233"/>
    <SEQUENCE-FEATURE-LIST>
      <sequenceFeature rdf:ID="sequenceFeature673">
        <FEATURE-TYPE rdf:resource="#openControlledVocabulary658"/>
      </sequenceFeature>
    </SEQUENCE-FEATURE-LIST>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
  </sequenceParticipant>
  <unificationXref rdf:ID="unificationXref599">
    <DB>genbank</DB>
    <ID>AAK69431</ID>
  </unificationXref>
  <biochemicalReaction rdf:ID="biochemicalReaction25">
    <RIGHT rdf:resource="#sequenceParticipant61"/>
    <INTERACTION-TYPE>
      <openControlledVocabulary rdf:ID="openControlledVocabulary656">
        <TERM>phosphorylation reaction</TERM>
        <XREF>
          <unificationXref rdf:ID="unificationXref537">
            <ID>MI:0217</ID>
            <DB>PSIMI</DB>
          </unificationXref>
        </XREF>
      </openControlledVocabulary>
    </INTERACTION-TYPE>
    <XREF rdf:resource="#publicationXref382"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence281">
        <XREF rdf:resource="#publicationXref382"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
      </evidence>
    </EVIDENCE>
    <LEFT>
      <sequenceParticipant rdf:ID="sequenceParticipant60">
        <PHYSICAL-ENTITY rdf:resource="#protein225"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary659"/>
      </sequenceParticipant>
    </LEFT>
    <NAME>Phosphorylation</NAME>
    <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
  </biochemicalReaction>
  <evidence rdf:ID="evidence308">
    <XREF rdf:resource="#publicationXref399"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
  </evidence>
  <evidence rdf:ID="evidence289">
    <XREF rdf:resource="#publicationXref396"/>
  </evidence>
  <publicationXref rdf:ID="publicationXref446">
    <ID>7640657</ID>
    <DB>Pubmed</DB>
  </publicationXref>
  <physicalInteraction rdf:ID="physicalInteraction716">
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant162">
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein226">
            <XREF rdf:resource="#publicationXref386"/>
            <SEQUENCE>MELLPPLPQSFLLLLLLPAKPAAGEDWQCPRTPYAASRDFDVKYVVPSFSAGGLVQAMVTYEGDRNESAVFVAIRNRLHVLGPDLKSVQSLATGPAGDPGCQTCAACGPGPHGPPGDTDTKVLVLDPALPALVSCGSSLQGRCFLHDLEPQGTAVHLAAPACLFSAHHNRPDDCPDCVASPLGTRVTVVEQGQASYFYVASSLDAAVAGSFSPRSVSIRRLKADASGFAPGFVALSVLPKHLVSYSIEYVHSFHTGAFVYFLTVQPASVTDDPSALHTRLARLSATEPELGDYRELVLDCRFAPKRRRRGAPEGGQPYPVLQVAHSAPVGAQLATELSIAEGQEVLFGVFVTGKDGGPGVGPNSVVCAFPIDLLDTLIDEGVERCCESPVHPGLRRGLDFFQSPSFCPNPPGLEALSPNTSCRHFPLLVSSSFSRVDLFNGLLGPVQVTALYVTRLDNVTVAHMGTMDGRILQVELVRSLNYLLYVSNFSLGDSGQPVQRDVSRLGDHLLFASGDQVFQVPIRGPGCRHFLTCGRCLRAWHFMGCGWCGNMCGQQKECPGSWQQDHCPPKLTEFHPHSGPLRGSTRLTLCGSNFYLHPSGLVPEGTHQVTVGQSPCRPLPKDSSKLRPVPRKDFVEEFECELEPLGTQAVGPTNVSLTVTNMPPGKHFRVDGTSVLRGFSFMEPVLIAVQPLFGPRAGGTCLTLEGQSLSVGTSRAVLVNGTECLLARVSEGQLLCATPPGATVASVPLSLQVGGAQVPGSWTFQYREDPVVLSISPNCGYINSHITICGQHLTSAWHLVLSFHDGLRAVESRCERQLPEQQLCRLPEYVVRDPQGWVAGNLSARGDGAAGFTLPGFRFLPPPHPPSANLVPLKPEEHAIKFEYIGLGAVADCVGINVTVGGESCQHEFRGDMVVCPLPPSLQLGQDGAPLQVCVDGECHILGRVVRPGPDGVPQSTLLGILLPLLLLVAALATALVFSYWWRRKQLVLPPNLNDLASLDQTAGATPLPILYSGSDYRSGLALPAIDGLDSTTCVHGASFSDSEDESCVPLLRKESIQLRDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWMALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGDHYVQLPATYMNLGPSTSHEMNVRPEQPQFSPMPGNVRRPRPLSEPPRPT</SEQUENCE>
            <ORGANISM rdf:resource="#bioSource44"/>
            <XREF>
              <relationshipXref rdf:ID="relationshipXref479">
                <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                <DB>OMIM</DB>
                <ID>600168</ID>
              </relationshipXref>
            </XREF>
            <XREF>
              <unificationXref rdf:ID="unificationXref550">
                <DB>refseq</DB>
                <ID>NP_002438</ID>
              </unificationXref>
            </XREF>
            <SYNONYMS>Macrophage stimulating protein receptor</SYNONYMS>
            <SYNONYMS>RON</SYNONYMS>
            <SHORT-NAME>MST1R</SHORT-NAME>
            <SYNONYMS>CDw136</SYNONYMS>
            <SYNONYMS>Ron protein tyrosine kinase</SYNONYMS>
            <XREF>
              <publicationXref rdf:ID="publicationXref387">
                <DB>Pubmed</DB>
                <ID>7939629</ID>
              </publicationXref>
            </XREF>
            <NAME>MST1R</NAME>
            <SYNONYMS>MST1R</SYNONYMS>
            <SYNONYMS>MSP receptor</SYNONYMS>
            <XREF>
              <unificationXref rdf:ID="unificationXref551">
                <DB>HPRD</DB>
                <ID>02545</ID>
              </unificationXref>
            </XREF>
            <SYNONYMS>Macrophage stimulating 1 receptor</SYNONYMS>
          </protein>
        </PHYSICAL-ENTITY>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant163">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein260">
            <SHORT-NAME>14-3-3-epsilon</SHORT-NAME>
            <SYNONYMS>KCIP-1</SYNONYMS>
            <ORGANISM rdf:resource="#bioSource44"/>
            <NAME>YWHAE</NAME>
            <SYNONYMS>Tyrpsine 3-monoogenase/typtophan 5-monoxygenase activation protein, epsilon isoform</SYNONYMS>
            <SEQUENCE>MDDREDLVYQAKLAEQAERYDEMVESMKKVAGMDVELTVEERNLLSVAYKNVIGARRASWRIISSIEQKEENKGGEDKLKMIREYRQMVETELKLICCDILDVLDKHLIPAANTGESKVFYYKMKGDYHRYLAEFATGNDRKEAAENSLVAYKAASDIAMTELPPTHPIRLGLALNFSVFYYEILNSPDRACRLAKAAFDDAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDMQGDGEEQNKEALQDVEDENQ</SEQUENCE>
            <SYNONYMS>14-3-3 epsilon</SYNONYMS>
            <SYNONYMS>14-3-3E</SYNONYMS>
            <SYNONYMS>Mitochondrial import stimulation factor L subunit</SYNONYMS>
            <XREF>
              <unificationXref rdf:ID="unificationXref620">
                <ID>NP_006752</ID>
                <DB>refseq</DB>
              </unificationXref>
            </XREF>
            <SYNONYMS>Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide</SYNONYMS>
            <SYNONYMS>YWHAE</SYNONYMS>
            <XREF>
              <publicationXref rdf:ID="publicationXref455">
                <DB>Pubmed</DB>
                <ID>11864996</ID>
              </publicationXref>
            </XREF>
            <XREF rdf:resource="#publicationXref386"/>
            <SYNONYMS>14-3-3-epsilon</SYNONYMS>
            <XREF rdf:resource="#relationshipXref508"/>
            <SYNONYMS>Protein kinase C inhibitor protein-1</SYNONYMS>
            <SYNONYMS>MDCR</SYNONYMS>
            <XREF>
              <unificationXref rdf:ID="unificationXref621">
                <DB>HPRD</DB>
                <ID>05457</ID>
              </unificationXref>
            </XREF>
            <SYNONYMS>MDS</SYNONYMS>
          </protein>
        </PHYSICAL-ENTITY>
      </sequenceParticipant>
    </PARTICIPANTS>
    <XREF rdf:resource="#publicationXref386"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence343">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <XREF rdf:resource="#publicationXref386"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
      </evidence>
    </EVIDENCE>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between MST1R and 14-3-3-epsilon</COMMENT>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >MST1R-YWHAE</SHORT-NAME>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >MST1R-YWHAE</NAME>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant156">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary660"/>
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein257">
        <SYNONYMS>Tumor protein p73</SYNONYMS>
        <SEQUENCE>MAQSTATSPDGGTTFEHLWSSLEPDSTYFDLPQSSRGNNEVVGGTDSSMDVFHLEGMTTSVMAQFNLLSSTMDQMSSRAASASPYTPEHAASVPTHSPYAQPSSTFDTMSPAPVIPSNTDYPGPHHFEVTFQQSSTAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDVVKRCPNHELGRDFNEGQSAPASHLIRVEGNNLSQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIITLEMRDGQVLGRRSFEGRICACPGRDRKADEDHYREQQALNESSAKNGAASKRAFKQSPPAVPALGAGVKKRRHGDEDTYYLQVRGRENFEILMKLKESLELMELVPQPLVDSYRQQQQLLQRPSHLQPPSYGPVLSPMNKVHGGMNKLPSVNQLVGQPPPHSSAATPNLGPVGPGMLNNHGHAVPANGEMSSSHSAQSMVSGSHCTPPPPYHADPSLVSFLTGLGCPNCIEYFTSQGLQSIYHLQNLTIEDLGALKIPEQYRMTIWRGLQDLKQGHDYSTAQQLLRSSNAATISIGGSGELQRQRVMEAVHFRVRHTITIPNRGGPGGGPDEWADFGFDLPDCKARKQPIKEEFTEAEIH</SEQUENCE>
        <ORGANISM rdf:resource="#bioSource44"/>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref505">
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
            <ID>601990</ID>
            <DB>OMIM</DB>
          </relationshipXref>
        </XREF>
        <SYNONYMS>TP73</SYNONYMS>
        <SYNONYMS>p53 related protein</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref451">
            <DB>Pubmed</DB>
            <ID>10391251</ID>
          </publicationXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref452">
            <DB>Pubmed</DB>
            <ID>12070014</ID>
          </publicationXref>
        </XREF>
        <XREF>
          <unificationXref rdf:ID="unificationXref615">
            <DB>HPRD</DB>
            <ID>03587</ID>
          </unificationXref>
        </XREF>
        <NAME>TP73</NAME>
        <SYNONYMS>p53 related protein p73</SYNONYMS>
        <SYNONYMS>p53 like transcription factor</SYNONYMS>
        <SHORT-NAME>TP73</SHORT-NAME>
        <XREF>
          <unificationXref rdf:ID="unificationXref614">
            <ID>NP_005418</ID>
            <DB>refseq</DB>
          </unificationXref>
        </XREF>
      </protein>
    </PHYSICAL-ENTITY>
  </sequenceParticipant>
  <evidence rdf:ID="evidence285">
    <XREF rdf:resource="#publicationXref386"/>
  </evidence>
  <unificationXref rdf:ID="unificationXref627">
    <ID>03183</ID>
    <DB>HPRD</DB>
  </unificationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant83">
    <PHYSICAL-ENTITY rdf:resource="#protein221"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
  </sequenceParticipant>
  <protein rdf:ID="protein265">
    <ORGANISM rdf:resource="#bioSource44"/>
    <XREF rdf:resource="#publicationXref426"/>
    <NAME>DSP</NAME>
    <XREF>
      <unificationXref rdf:ID="unificationXref631">
        <ID>00513</ID>
        <DB>HPRD</DB>
      </unificationXref>
    </XREF>
    <SYNONYMS>DSP</SYNONYMS>
    <XREF>
      <relationshipXref rdf:ID="relationshipXref513">
        <DB>OMIM</DB>
        <ID>125647</ID>
        <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
      </relationshipXref>
    </XREF>
    <SYNONYMS>Desmoplakin I</SYNONYMS>
    <SYNONYMS>DP1</SYNONYMS>
    <SEQUENCE>MSCNGGSHPRINTLGRMIRAESGPDLRYEVTSGGGGTSRMYYSRRGVITDQNSDGYCQTGTMSRHQNQNTIQELLQNCSDCLMRAELIVQPELKYGDGIQLTRSRELDECFAQANDQMEILDSLIREMRQMGQPCDAYQKRLLQLQEQMRALYKAISVPRVRRASSKGGGGYTCQSGSGWDEFTKHVTSECLGWMRQQRAEMDMVAWGVDLASVEQHINSHRGIHNSIGDYRWQLDKIKADLREKSAIYQLEEEYENLLKASFERMDHLRQLQNIIQATSREIMWINDCEEEELLYDWSDKNTNIAQKQEAFSIRMSQLEVKEKELNKLKQESDQLVLNQHPASDKIEAYMDTLQTQWSWILQITKCIDVHLKENAAYFQFFEEAQSTEAYLKGLQDSIRKKYPCDKNMPLQHLLEQIKELEKEREKILEYKRQVQNLVNKSKKIVQLKPRNPDYRSNKPIILRALCDYKQDQKIVHKGDECILKDNNERSKWYVTGPGGVDMLVPSVGLIIPPPNPLAVDLSCKIEQYYEAILALWNQLYINMKSLVSWHYCMIDIEKIRAMTIAKLKTMRQEDYMKTIADLELHYQEFIRNSQGSEMFGDDDKRKIQSQFTDAQKHYQTLVIQLPGYPQHQTVTTTEITHHGTCQDVNHNKVIETNRENDKQETWMLMELQKIRRQIEHCEGRMTLKNLPLADQGSSHHITVKINELKSVQNDSQAIAEVLNQLKDMLANFRGSEKYCYLQNEVFGLFQKLENINGVTDGYLNSLCTVRALLQAILQTEDMLKVYEARLTEEETVCLDLDKVEAYRCGLKKIKNDLNLKKSLLATMKTELQKAQQIHSQTSQQYPLYDLDLGKFGEKVTQLTDRWQRIDKQIDFRLWDLEKQIKQLRNYRDNYQAFCKWLYDRKRRQDSLESMKFGDSNTVMRFLNEQKNLHSEISGKRDKSEEVQKIAELCANSIKDYELQLASYTSGLETLLNIPIKRTMIQSPSGVILQEAADVHARYIELLTRSGDYYRFLSEMLKSLEDLKLKNTKIEVLEEELRLARDANSENCNKNKFLDQNLQKYQAECSQFKAKLASLEELKRQAELDGKSAKQNLDKCYGQIKELNEKITRLTYEIEDEKRRRKSVEDRFDQQKNDYDQLQKARQCEKENLGWQKLESEKAIKEKEYEIERLRVLLQEEGTRKREYENELAKVRNHYNEEMSNLRNKYETEINITKTTIKEISMQKEDDSKNLRNQLDRLSRENRDLKDEIVRLNDSILQATEQRRRAEENALQQKACGSEIMQKKQHLEIELKQVMQQRSEDNARHKQSLEEAAKTIQDKNKEIERLKAEFQEEAKRRWEYENELSKVRNNYDEEIISLKNQFETEINITKTTIHQLTMQKEEDTSGYRAQIDNLTRENRSLSEEIKRLKNTLTQTTENLRRVEEDIQQQKATGSEVSQRKQQLEVELRQVTQMRTEESVRYKQSLDDAAKTIQDKNKEIERLKQLIDKETNDRKCLEDENARLQRVQYDLQKANSSATETINKLKVQEQELTRLRIDYERVSQERTVKDQDITRFQNSLKELQLQKQKVEEELNRLKRTASEDSCKRKKLEEELEGMRRSLKEQAIKITNLTQQLEQASIVKKRSEDDLRQQRDVLDGHLREKQRTQEELRRLSSEVEALRRQLLQEQESVKQAHLRNEHFQKAIEDKSRSLNESKIEIERLQSLTENLTKEHLMLEEELRNLRLEYDDLRRGRSEADSDKNATILELRSQLQISNNRTLELQGLINDLQRERENLRQEIEKFQKQALEASNRIQESKNQCTQVVQERESLLVKIKVLEQDKARLQRLEDELNRAKSTLEAETRVKQRLECEKQQIQNDLNQWKTQYSRKEEAIRKIESEREKSEREKNSLRSEIERLQAEIKRIEERCRRKLEDSTRETQSQLETERSRYQREIDKLRQRPYGSHRETQTECEWTVDTSKLVFDGLRKKVTAMQLYECQLIDKTTLDKLLKGKKSVEEVASEIQPFLRGAGSIAGASASPKEKYSLVEAKRKKLISPESTVMLLEAQAATGGIIDPHRNEKLTVDSAIARDLIDFDDRQQIYAAEKAITGFDDPFSGKTVSVSEAIKKNLIDRETGMRLLEAQIASGGVVDPVNSVFLPKDVALARGLIDRDLYRSLNDPRDSQKNFVDPVTKKKVSYVQLKERCRIEPHTGLLLLSVQKRSMSFQGIRQPVTVTELVDSGILRPSTVNELESGQISYDEVGERIKDFLQGSSCIAGIYNETTKQKLGIYEAMKIGLVRPGTALELLEAQAATGFIVDPVSNLRLPVEEAYKRGLVGIEFKEKLLSAERAVTGYNDPETGNIISLFQAMNKELIEKGHGIRLLEAQIATGGIIDPKESHRLPVDIAYKRGYFNEELSEILSDPSDDTKGFFDPNTEENLTYLQLKERCIKDEETGLCLLPLKEKKKQVQTSQKNTLRKRRVVIVDPETNKEMSVQEAYKKGLIDYETFKELCEQECEWEEITITGSDGSTRVVLVDRKTGSQYDIQDAIDKGLVDRKFFDQYRSGSLSLTQFADMISLKNGVGTSSSMGSGVSDDVFSSSRHESVSKISTISSVRNLTIRSSSFSDTLEESSPIAAIFDTENLEKISITEGIERGIVDSITGQRLLEAQACTGGIIHPTTGQKLSLQDAVSQGVIDQDMATSVKPAQKAFIGFEGVKGKKKMSAAEAVKEKWLPYEAGQRFLEFQYLTGGLVDPEVHGRISTEEAIRKGFIDGRAAQRLQDTSSYAKILTCPKTKLKISYKDAINRSMVEDITGLRLLEAASVSSKGLPSPYNMSSAPGSRSGSRSGSRSGSRSGSRSGSRRGSFDATGNSSYSYSYSFSSSSIGH</SEQUENCE>
    <SHORT-NAME>DSP</SHORT-NAME>
    <XREF rdf:resource="#unificationXref630"/>
    <SYNONYMS>250 kDa paraneoplastic pemphigus antigen</SYNONYMS>
    <XREF>
      <publicationXref rdf:ID="publicationXref459">
        <ID>11132762</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
  </protein>
  <physicalInteraction rdf:ID="physicalInteraction688">
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant106">
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6Beta4-Laminin1</SHORT-NAME>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6Beta4-Laminin1</NAME>
    <XREF rdf:resource="#publicationXref399"/>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant107">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
        <PHYSICAL-ENTITY rdf:resource="#protein237"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between Alpha6Beta4 and Laminin1</COMMENT>
    <EVIDENCE>
      <evidence rdf:ID="evidence305">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <XREF rdf:resource="#publicationXref399"/>
      </evidence>
    </EVIDENCE>
  </physicalInteraction>
  <biochemicalReaction rdf:ID="biochemicalReaction26">
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary656"/>
    <LEFT>
      <sequenceParticipant rdf:ID="sequenceParticipant63">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein226"/>
      </sequenceParticipant>
    </LEFT>
    <XREF rdf:resource="#publicationXref386"/>
    <NAME>Phosphorylation</NAME>
    <RIGHT>
      <sequenceParticipant rdf:ID="sequenceParticipant64">
        <PHYSICAL-ENTITY rdf:resource="#protein226"/>
        <SEQUENCE-FEATURE-LIST>
          <sequenceFeature rdf:ID="sequenceFeature668">
            <FEATURE-LOCATION>
              <sequenceSite rdf:ID="sequenceSite679">
                <POSITION-STATUS>EQUAL</POSITION-STATUS>
                <SEQUENCE-POSITION>1394</SEQUENCE-POSITION>
              </sequenceSite>
            </FEATURE-LOCATION>
            <FEATURE-TYPE rdf:resource="#openControlledVocabulary658"/>
          </sequenceFeature>
        </SEQUENCE-FEATURE-LIST>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </RIGHT>
    <EVIDENCE>
      <evidence rdf:ID="evidence282">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <XREF rdf:resource="#publicationXref386"/>
      </evidence>
    </EVIDENCE>
    <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
  </biochemicalReaction>
  <sequenceParticipant rdf:ID="sequenceParticipant110">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein221"/>
  </sequenceParticipant>
  <unificationXref rdf:ID="unificationXref591">
    <DB>HPRD</DB>
    <ID>01899</ID>
  </unificationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant140">
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein253">
        <XREF>
          <publicationXref rdf:ID="publicationXref438">
            <ID>9602068</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <SYNONYMS>CD151</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref440">
            <DB>Pubmed</DB>
            <ID>10811835</ID>
          </publicationXref>
        </XREF>
        <SYNONYMS>SFA1</SYNONYMS>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref502">
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
            <ID>602243</ID>
            <DB>OMIM</DB>
          </relationshipXref>
        </XREF>
        <SEQUENCE>MGEFNEKKTTCGTVCLKYLLFTYNCCFWLAGLAVMAVGIWTLALKSDYISLLASGTYLATAYILVVAGTVVMVTGVLGCCATFKERRNLLRLYFILLLIIFLLEIIAGILAYAYYQQLNTELKENLKDTMTKRYHQPGHEAVTSAVDQLQQEFHCCGSNNSQDWRDSEWIRSQEAGGRVVPDSCCKTVVALCGQRDHASNIYKVEGGCITKLETFIQEHLRVIGAVGIGIACVQVFGMIFTCCLYRSLKLEHY</SEQUENCE>
        <ORGANISM rdf:resource="#bioSource44"/>
        <SYNONYMS>Platelet surface glycoprotein gp27</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref437">
            <DB>Pubmed</DB>
            <ID>8627808</ID>
          </publicationXref>
        </XREF>
        <SYNONYMS>PETA3</SYNONYMS>
        <XREF rdf:resource="#publicationXref439"/>
        <XREF>
          <unificationXref rdf:ID="unificationXref607">
            <DB>refseq</DB>
            <ID>NP_004348</ID>
          </unificationXref>
        </XREF>
        <SYNONYMS>GP27</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref608">
            <DB>HPRD</DB>
            <ID>03763</ID>
          </unificationXref>
        </XREF>
        <SHORT-NAME>CD151</SHORT-NAME>
        <NAME>CD151</NAME>
      </protein>
    </PHYSICAL-ENTITY>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant114">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein221"/>
  </sequenceParticipant>
  <catalysis rdf:ID="catalysis2">
    <CONTROLLER>
      <sequenceParticipant rdf:ID="sequenceParticipant50">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
        <PHYSICAL-ENTITY rdf:resource="#protein220"/>
      </sequenceParticipant>
    </CONTROLLER>
    <CONTROLLED>
      <biochemicalReaction rdf:ID="biochemicalReaction22">
        <LEFT>
          <sequenceParticipant rdf:ID="sequenceParticipant51">
            <PHYSICAL-ENTITY rdf:resource="#protein221"/>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
          </sequenceParticipant>
        </LEFT>
        <EVIDENCE>
          <evidence rdf:ID="evidence278">
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
            <XREF rdf:resource="#publicationXref375"/>
          </evidence>
        </EVIDENCE>
        <XREF rdf:resource="#publicationXref375"/>
        <NAME>Phosphorylation</NAME>
        <RIGHT>
          <sequenceParticipant rdf:ID="sequenceParticipant52">
            <SEQUENCE-FEATURE-LIST>
              <sequenceFeature rdf:ID="sequenceFeature664">
                <FEATURE-TYPE rdf:resource="#openControlledVocabulary658"/>
              </sequenceFeature>
            </SEQUENCE-FEATURE-LIST>
            <PHYSICAL-ENTITY rdf:resource="#protein221"/>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
          </sequenceParticipant>
        </RIGHT>
        <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary656"/>
      </biochemicalReaction>
    </CONTROLLED>
    <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
    <NAME>P-FYN-ITGB4</NAME>
    <COMMENT>Phosphorylation of ITGB4 by FYN.N terminus of FYN interacts with  cytoplasmic domain of �4 (854-1183).Fyn mediates EGFR induced phosphorylation of �4 and disruption of hemidesmosomes</COMMENT>
    <EVIDENCE rdf:resource="#evidence278"/>
    <XREF rdf:resource="#publicationXref375"/>
  </catalysis>
  <physicalInteraction rdf:ID="physicalInteraction691">
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant112">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between Alpha6Beta4 and Laminin2</COMMENT>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <XREF rdf:resource="#publicationXref399"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6Beta4-Laminin2</NAME>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6Beta4-Laminin2</SHORT-NAME>
    <EVIDENCE rdf:resource="#evidence308"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant113">
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein245">
            <SHORT-NAME>VIM</SHORT-NAME>
            <NAME>VIM</NAME>
            <XREF>
              <publicationXref rdf:ID="publicationXref418">
                <ID>11911279</ID>
                <DB>Pubmed</DB>
              </publicationXref>
            </XREF>
            <XREF rdf:resource="#publicationXref379"/>
            <SEQUENCE>MSTRSVSSSSYRRMFGGPGTASRPSSSRSYVTTSTRTYSLGSALRPSTSRSLYASSPGGVYATRSSAVRLRSSVPGVRLLQDSVDFSLADAINTEFKNTRTNEKVELQELNDRFANYIDKVRFLEQQNKILLAELEQLKGQGKSRLGDLYEEEMRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKLQEEMLQREEAENTLQSFRQDVDNASLARLDLERKVESLQEEIAFLKKLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVRQQYESVAAKNLQEAEEWYKSKFADLSEAANRNNDALRQAKQESTEYRRQVQSLTCEVDALKGTNESLERQMREMEENFAVEAANYQDTIGRLQDEIQNMKEEMARHLREYQDLLNVKMALDIEIATYRKLLEGEESRISLPLPNFSSLNLRETNLDSLPLVDTHSKRTFLIKTVETRDGQVINETSQHHDDLE</SEQUENCE>
            <SYNONYMS>VIM</SYNONYMS>
            <XREF rdf:resource="#unificationXref591"/>
            <XREF>
              <relationshipXref rdf:ID="relationshipXref494">
                <ID>193060</ID>
                <DB>OMIM</DB>
                <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
              </relationshipXref>
            </XREF>
            <SYNONYMS>Vimentin</SYNONYMS>
            <ORGANISM rdf:resource="#bioSource44"/>
            <XREF>
              <unificationXref rdf:ID="unificationXref590">
                <ID>NP_003371</ID>
                <DB>refseq</DB>
              </unificationXref>
            </XREF>
          </protein>
        </PHYSICAL-ENTITY>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
      </sequenceParticipant>
    </PARTICIPANTS>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant109">
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein244">
        <SEQUENCE>MSGALDVLQMKEEDVLKFLAAGTHLGGTNLDFQMEQYIYKRKSDGIYIINLKRTWEKLLLAARAIVAIENPADVSVISSRNTGQRAVLKFAAATGATPIAGRFTPGTFTNQIQAAFREPRLLVVTDPRADHQPLTEASYVNLPTIALCNTDSPLRYVDIAIPCNNKGAHSVGLMWWMLAREVLRMRGTISREHPWEVMPDLYFYRDPEEIEKEEQAAAEKAVTKEEFQGEWTAPAPEFTATQPEVADWSEGVQVPSVPIQQFPTEDWSAQPATEDWSAAPTAQATEWVGATTDWS</SEQUENCE>
        <ORGANISM rdf:resource="#bioSource44"/>
        <NAME>LAMR1</NAME>
        <SYNONYMS>p40</SYNONYMS>
        <SYNONYMS>Laminin receptor, 67-KD</SYNONYMS>
        <SHORT-NAME>LAMR1</SHORT-NAME>
        <SYNONYMS>LAMBR</SYNONYMS>
        <SYNONYMS>RPSA</SYNONYMS>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref493">
            <ID>150370</ID>
            <DB>OMIM</DB>
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
          </relationshipXref>
        </XREF>
        <SYNONYMS>67kD, Ribosomal protein SA</SYNONYMS>
        <SYNONYMS>LAMR1</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref589">
            <ID>01038</ID>
            <DB>HPRD</DB>
          </unificationXref>
        </XREF>
        <SYNONYMS>Laminin receptor 1</SYNONYMS>
        <XREF rdf:resource="#publicationXref416"/>
        <SYNONYMS>LRP</SYNONYMS>
        <SYNONYMS>67LR</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref417">
            <ID>8999943</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <XREF>
          <unificationXref rdf:ID="unificationXref588">
            <DB>refseq</DB>
            <ID>NP_002286</ID>
          </unificationXref>
        </XREF>
        <SYNONYMS>37LRP</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <unificationXref rdf:ID="unificationXref582">
    <DB>HPRD</DB>
    <ID>04221</ID>
  </unificationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant98">
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein238">
        <XREF>
          <unificationXref rdf:ID="unificationXref576">
            <DB>HPRD</DB>
            <ID>01323</ID>
          </unificationXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref406">
            <DB>Pubmed</DB>
            <ID>10648558</ID>
          </publicationXref>
        </XREF>
        <NAME>RHOA</NAME>
        <SYNONYMS>RHO12</SYNONYMS>
        <SYNONYMS>RHOA</SYNONYMS>
        <SYNONYMS>Ras homolog gene family member A</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref575">
            <DB>refseq</DB>
            <ID>NP_001655</ID>
          </unificationXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref407">
            <ID>12466390</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <SYNONYMS>Aplysia ras related homolog 12</SYNONYMS>
        <SHORT-NAME>RHOA</SHORT-NAME>
        <SYNONYMS>ARH12</SYNONYMS>
        <SYNONYMS>Oncogene rho H12</SYNONYMS>
        <SEQUENCE>MAAIRKKLVIVGDGACGKTCLLIVFSKDQFPEVYVPTVFENYVADIEVDGKQVELALWDTAGQEDYDRLR
PLSYPDTDVILMCFSIDSPDSLENIPEKWTPEVKHFCPNVPIILVGNKKDLRNDEHTRRELAKMKQEPVK
PEEGRDMANRIGAFGYMECSAKTKDGVREVFEMATRAALQARRGKKKSGCLVL</SEQUENCE>
        <SYNONYMS>Transforming protein RhoA</SYNONYMS>
        <ORGANISM rdf:resource="#bioSource44"/>
        <SYNONYMS>ARHA</SYNONYMS>
        <SYNONYMS>RHOH12</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <relationshipXref rdf:ID="relationshipXref472">
    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
    <DB>OMIM</DB>
    <ID>600636</ID>
  </relationshipXref>
  <evidence rdf:ID="evidence299">
    <XREF rdf:resource="#publicationXref406"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
  </evidence>
  <evidence rdf:ID="evidence333">
    <XREF>
      <publicationXref rdf:ID="publicationXref444">
        <ID>12867433</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
  </evidence>
  <physicalInteraction rdf:ID="physicalInteraction698">
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-ERBIN</SHORT-NAME>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <XREF rdf:resource="#publicationXref429"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant127">
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein249">
            <NAME>ERBIN</NAME>
            <XREF>
              <unificationXref rdf:ID="unificationXref600">
                <ID>06090</ID>
                <DB>HPRD</DB>
              </unificationXref>
            </XREF>
            <XREF rdf:resource="#unificationXref599"/>
            <SYNONYMS>Densin 180 like protein</SYNONYMS>
            <XREF>
              <relationshipXref rdf:ID="relationshipXref498">
                <ID>606944</ID>
                <DB>OMIM</DB>
                <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
              </relationshipXref>
            </XREF>
            <ORGANISM rdf:resource="#bioSource44"/>
            <SYNONYMS>Erbb2 interacting protein</SYNONYMS>
            <SYNONYMS>ERBIN</SYNONYMS>
            <SEQUENCE>MTTKRSLFVRLVPCRCLRGEEETVTTLDYSHCSLEQVPKEIFTFEKTLEELYLDANQIEELPKQLFNCQSLHKLSLPDNDLTTLPASIANLINLRELDVSKNGIQEFPENIKNCKVLTIVEASVNPISKLPDGFSQLLNLTQLYLNDAFLEFLPANFGRLTKLQILELRENQLKMLPKTMNRLTQLERLDLGSNEFTEVPEVLEQLSGLKEFWMDANRLTFIPGFIGSLKQLTYLDVSKNNIEMVEEGISTCENLQDLLLSSNSLQQLPETIGSLKNITTLKIDENQLMYLPDSIGGLISVEELDCSFNEVEALPSSIGQLTNLRTFAADHNYLQQLPPEIGSWKNITVLFLHSNKLETLPEEMGDMQKLKVINLSDNRLKNLPFSFTKLQQLTAMWLSDNQSKPLIPLQKETDSETQKMVLTNYMFPQQPRTEDVMFISDNESFNPSLWEEQRKQRAQVAFECDEDKDEREAPPREGNLKRYPTPYPDELKNMVKTVQTIVHRLKDEETNEDSGRDLKPHEDQQDINKDVGVKTSESTTTVKSKVDEREKYMIGNSVQKISEPEAEISPGSLPVTANMKASENLKHIVNHDDVFEESEELSSDEEMKMAEMRPPLIETSINQPKVVALSNNKKDDTKETDSLSDEVTHNSNQNNSNCSSPSRMSDSVSLNTDSSQDTSLCSPVKQTHIDINSKIRQEDENFNSLLQNGDILNSSTEEKFKAHDKKDFNLPEYDLNVEERLVLIEKSVDSTATADDTHKLDHINMNLNKLITNDTFQPEIMERSKTQDIVLGTSFLSINSKEETEHLENGNKCPNLESVNKVNGHSEETSQSPNRTEPHDSDCSVDLGISKSTEDLSPQKSGPVGSVVKSHSITNMEIGGLKIYDILSDNGPQQPSTTVKITSAVDGKNIVRSKSATLLYDQPLQVFTGSSSSSDLISGTKAIFKFDSNHNPEEPNIIRGPTSGPQSAPQIYGPPQYNIQYSSSAAVKDTLWHSKQNPQIDHASFPPQLLPRSESTENQSYAKHSANMNFSNHNNVRANTAYHLHQRLGPARHGEMWAISPNDRLIPAVTRSTIQRQSSVSSTASVNLGDPGSTRRAQIPEGDYLSYREFHSAGRTPPMMPGSQRPLSARTYSIDGPNASRPQSARPSINEIPERTMSVSDFNYSRTSPSKRPNARVGSEHSLLDPPGKSKVPRDWREQVLRHIEAKKLEKKHPQTSSSGDPCQDGIFISGQQNYSSATLSHKDVPPDSLMKMPLSNGQMGQPLRPQANYSQIHHPPQASVARHPSREQLIDYLMLKVAHQPPYTQPHCSPRQGHELAKQEIRVRVEKDPELGFSISGGVGGRGNPFRPDDDGIFVTRVQPEGPASKLLQPGDKIIQANGYSFINIEHGQAVSLLKTFQNTVELIIVREVSS</SEQUENCE>
            <SHORT-NAME>ERBIN</SHORT-NAME>
            <XREF rdf:resource="#publicationXref429"/>
            <XREF>
              <publicationXref rdf:ID="publicationXref428">
                <ID>11279080</ID>
                <DB>Pubmed</DB>
              </publicationXref>
            </XREF>
            <SYNONYMS>ERBB2IP</SYNONYMS>
          </protein>
        </PHYSICAL-ENTITY>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <EVIDENCE>
      <evidence rdf:ID="evidence317">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
        <XREF rdf:resource="#publicationXref429"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
      </evidence>
    </EVIDENCE>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGB4 and ERBIN.</COMMENT>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant126">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-ERBIN</NAME>
  </physicalInteraction>
  <unificationXref rdf:ID="unificationXref570">
    <ID>01525</ID>
    <DB>HPRD</DB>
  </unificationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant175">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein250"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant68">
    <PHYSICAL-ENTITY rdf:resource="#protein228"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary660"/>
  </sequenceParticipant>
  <unificationXref rdf:ID="unificationXref529">
    <ID>MI:0194</ID>
    <DB>PSIMI</DB>
  </unificationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant128">
    <PHYSICAL-ENTITY rdf:resource="#protein234"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <biochemicalReaction rdf:ID="biochemicalReaction33">
    <INTERACTION-TYPE>
      <openControlledVocabulary rdf:ID="openControlledVocabulary653">
        <TERM>proteolytic cleavage reaction</TERM>
        <XREF rdf:resource="#unificationXref529"/>
      </openControlledVocabulary>
    </INTERACTION-TYPE>
    <XREF>
      <publicationXref rdf:ID="publicationXref402">
        <ID>9344615</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
    <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
    <RIGHT>
      <sequenceParticipant rdf:ID="sequenceParticipant84">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
        <SEQUENCE-FEATURE-LIST rdf:resource="#sequenceFeature675"/>
      </sequenceParticipant>
    </RIGHT>
    <LEFT rdf:resource="#sequenceParticipant83"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence293">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <XREF rdf:resource="#publicationXref402"/>
      </evidence>
    </EVIDENCE>
    <NAME>Proteolytic Cleavage</NAME>
  </biochemicalReaction>
  <sequenceParticipant rdf:ID="sequenceParticipant179">
    <PHYSICAL-ENTITY rdf:resource="#protein265"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <catalysis rdf:ID="catalysis11">
    <COMMENT>Phosphorylation of ITGA6 by PRKCD.PMID 12919677 states human ITGA6 and PRKCD. Exp-vtPMID 11389095 states about mouse ITGA6. Exp-- vv, vt. Host orgn- MouseITGA6 is phosphorylated at Serine  residues</COMMENT>
    <EVIDENCE>
      <evidence rdf:ID="evidence290">
        <XREF rdf:resource="#publicationXref386"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
      </evidence>
    </EVIDENCE>
    <CONTROLLER>
      <sequenceParticipant rdf:ID="sequenceParticipant77">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein232">
            <XREF>
              <unificationXref rdf:ID="unificationXref564">
                <DB>HPRD</DB>
                <ID>01501</ID>
              </unificationXref>
            </XREF>
            <NAME>PRKCD</NAME>
            <SYNONYMS>PKC delta</SYNONYMS>
            <SYNONYMS>PRKCD</SYNONYMS>
            <XREF rdf:resource="#publicationXref386"/>
            <XREF>
              <publicationXref rdf:ID="publicationXref397">
                <ID>11571229</ID>
                <DB>Pubmed</DB>
              </publicationXref>
            </XREF>
            <ORGANISM rdf:resource="#bioSource44"/>
            <SYNONYMS>Protein kinase C delta</SYNONYMS>
            <XREF>
              <unificationXref rdf:ID="unificationXref563">
                <ID>NP_006245</ID>
                <DB>refseq</DB>
              </unificationXref>
            </XREF>
            <XREF rdf:resource="#relationshipXref485"/>
            <SEQUENCE>MAPFLRIAFNSYELGSLQAEDEANQPFCAVKMKEALSTERGKTLVQKKPTMYPEWKSTFDAHIYEGRVIQIVLMRAAEEPVSEVTVGVSVLAERCKKNNGKAEFWLDLQPQAKVLMSVQYFLEDVDCKQSMRSEDEAKFPTMNRRGAIKQAKIHYIKNHEFIATFFGQPTFCSVCKDFVWGLNKQGYKCRQCNAAIHKKCIDKIIGRCTGTAANSRDTIFQKERFNIDMPHRFKVHNYMSPTFCDHCGSLLWGLVKQGLKCEDCGMNVHHKCREKVANLCGINQKLLAEALNQVTQRASRRSDSASSEPVGIYQGFEKKTGVAGEDMQDNSGTYGKIWEGSSKCNINNFIFHKVLGKGSFGKVLLGELKGRGEYFAIKALKKDVVLIDDDVECTMVEKRVLTLAAENPFLTHLICTFQTKDHLFFVMEFLNGGDLMYHIQDKGRFELYRATFYAAEIMCGLQFLHSKGIIYRDLKLDNVLLDRDGHIKIADFGMCKENIFGESRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFEREPTKRLGVTGNIKIHPFFKTINWTLLEKRRLEPPFRPKVKSPRDYSNFDQEFLNEKARLSYSDKNLIDSMDQSAFAGFSFVNPKFEHLLED</SEQUENCE>
            <SHORT-NAME>PRKCD</SHORT-NAME>
          </protein>
        </PHYSICAL-ENTITY>
      </sequenceParticipant>
    </CONTROLLER>
    <XREF rdf:resource="#publicationXref396"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence291">
        <XREF rdf:resource="#publicationXref396"/>
      </evidence>
    </EVIDENCE>
    <NAME>P-PRKCD-ITGA6</NAME>
    <XREF rdf:resource="#publicationXref386"/>
    <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
    <CONTROLLED>
      <biochemicalReaction rdf:ID="biochemicalReaction31">
        <NAME>Phosphorylation</NAME>
        <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
        <LEFT>
          <sequenceParticipant rdf:ID="sequenceParticipant78">
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
            <PHYSICAL-ENTITY rdf:resource="#protein233"/>
          </sequenceParticipant>
        </LEFT>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary656"/>
        <XREF rdf:resource="#publicationXref396"/>
        <XREF rdf:resource="#publicationXref386"/>
        <EVIDENCE rdf:resource="#evidence291"/>
        <RIGHT rdf:resource="#sequenceParticipant79"/>
      </biochemicalReaction>
    </CONTROLLED>
  </catalysis>
  <physicalInteraction rdf:ID="physicalInteraction721">
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant172">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <XREF rdf:resource="#publicationXref375"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-YES</NAME>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between Beta4 and YES</COMMENT>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-YES</SHORT-NAME>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant173">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein264">
            <XREF>
              <unificationXref rdf:ID="unificationXref628">
                <ID>NP_005424</ID>
                <DB>refseq</DB>
              </unificationXref>
            </XREF>
            <XREF>
              <relationshipXref rdf:ID="relationshipXref512">
                <ID>164880</ID>
                <DB>OMIM</DB>
                <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
              </relationshipXref>
            </XREF>
            <SYNONYMS>YES1</SYNONYMS>
            <SHORT-NAME>YES</SHORT-NAME>
            <SYNONYMS>c-Yes</SYNONYMS>
            <XREF>
              <unificationXref rdf:ID="unificationXref629">
                <DB>HPRD</DB>
                <ID>01285</ID>
              </unificationXref>
            </XREF>
            <ORGANISM rdf:resource="#bioSource44"/>
            <XREF rdf:resource="#publicationXref375"/>
            <SYNONYMS>YES</SYNONYMS>
            <SEQUENCE>MGCIKSKENKSPAIKYRPENTPEPVSTSVSHYGAEPTTVSPCPSSSAKGTAVNFSSLSMTPFGGSSGVTPFGGASSSFSVVPSSYPAGLTGGVTIFVALYDYEARTTEDLSFKKGERFQIINNTEGDWWEARSIATGKNGYIPSNYVAPADSIQAEEWYFGKMGRKDAERLLLNPGNQRGIFLVRESETTKGAYSLSIRDWDEIRGDNVKHYKIRKLDNGGYYITTRAQFDTLQKLVKHYTEHADGLCHKLTTVCPTVKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMSKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGENLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILQTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMNLCWKKDPDERPTFEYIQSFLEDYFTATEPQYQPGENL</SEQUENCE>
            <XREF>
              <publicationXref rdf:ID="publicationXref456">
                <DB>Pubmed</DB>
                <ID>2067846</ID>
              </publicationXref>
            </XREF>
            <SYNONYMS>Yamaguchi sarcoma oncogene</SYNONYMS>
            <NAME>YES1</NAME>
          </protein>
        </PHYSICAL-ENTITY>
      </sequenceParticipant>
    </PARTICIPANTS>
    <EVIDENCE>
      <evidence rdf:ID="evidence348">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <XREF rdf:resource="#publicationXref375"/>
      </evidence>
    </EVIDENCE>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant95">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary660"/>
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein241">
        <SHORT-NAME>ITGB4BP</SHORT-NAME>
        <SYNONYMS>ITGB4BP</SYNONYMS>
        <SYNONYMS>p27BBP</SYNONYMS>
        <XREF rdf:resource="#unificationXref582"/>
        <ORGANISM rdf:resource="#bioSource44"/>
        <NAME>ITGB4BP</NAME>
        <XREF rdf:resource="#publicationXref412"/>
        <XREF>
          <unificationXref rdf:ID="unificationXref581">
            <DB>refseq</DB>
            <ID>NP_002203</ID>
          </unificationXref>
        </XREF>
        <SEQUENCE>MAVRASFENNCEIGCFAKLTNTYCLVAIGGSENFYSVFEGELSDTIPVVHASIAGCRIIGRMCVGNRHGL
LVPNNTTDQELQHIRNSLPDTVQIRRVEERLSALGNVTTCNDYVALVHPDLDRETEEILADVLKVEVFRQ
TVADQVLVGSYCVFSNQGGLVHPKTSIEDQDELSSLLQVPLVAGTVNRGSEVIAAGMVVNDWCAFCGLDT
TSTELSVVESVFKLNEAQPSTIATSMRDSLIDSLT</SEQUENCE>
        <SYNONYMS>p27 beta 4 binding protein</SYNONYMS>
        <SYNONYMS>B4 integrin interactor</SYNONYMS>
        <SYNONYMS>EIF3A</SYNONYMS>
        <SYNONYMS>EIF6</SYNONYMS>
        <SYNONYMS>CAB</SYNONYMS>
        <SYNONYMS>Eukaryotic translation initiation factor 6</SYNONYMS>
        <SYNONYMS>Eukaryotic translation initiation factor 3A</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
  </sequenceParticipant>
  <physicalInteraction rdf:ID="physicalInteraction683">
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >RHOA-RTKN</SHORT-NAME>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >RHOA-RTKN</NAME>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant97">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein242">
            <XREF>
              <relationshipXref rdf:ID="relationshipXref491">
                <DB>OMIM</DB>
                <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                <ID>602288</ID>
              </relationshipXref>
            </XREF>
            <SYNONYMS>Rhotekin</SYNONYMS>
            <XREF rdf:resource="#publicationXref406"/>
            <SYNONYMS>RTKN</SYNONYMS>
            <SHORT-NAME>RTKN</SHORT-NAME>
            <XREF>
              <publicationXref rdf:ID="publicationXref413">
                <ID>10940294</ID>
                <DB>Pubmed</DB>
              </publicationXref>
            </XREF>
            <XREF>
              <unificationXref rdf:ID="unificationXref583">
                <ID>AAH04558</ID>
                <DB>genbank</DB>
              </unificationXref>
            </XREF>
            <NAME>Rhotekin</NAME>
            <ORGANISM rdf:resource="#bioSource44"/>
            <XREF>
              <unificationXref rdf:ID="unificationXref584">
                <DB>HPRD</DB>
                <ID>03795</ID>
              </unificationXref>
            </XREF>
            <SEQUENCE>MFSRNHRSRVTVARGSALEMEFKRGRFRLSLFSDLPEDTELQRKLDHEIRMREGACKLLAACSQREQALEATKSLLVCNSRILSYMGELQRRKEAQVLGKTSRRPSDSGPPAERSPCRGRVCISDLRIPLMWKDTEYFKNKGDLHRWAVFLLLQLGEHIQDTEMILVDRTLTDISFQSNVLFAEAGPDFELRLELYGACVEEEGALTGGPKRLATKLSSSLGRSSGRRVRASLDSAGGSGSSPILLPTPVVGGPRYHLLAHTTLTLAAVQDGFRTHDLTLASHEENPAWLPLYGSVCCRLAAQPLCMTQPTASGTLRVQQAGEMQNWAQVHGVLKGTNLFCYRQPEDADTGEEPLLTIAVNKETRVRAGELDQALGRPFTLSISNQYGDDEVTHTLQTESREALQSWMEALWQLFFDMSQWKQCCDEIMKIETPAPRKPPQALAKQGSLYHEMAIEPLDDIAAVTDILTQREGARLETPPPWLAMFTDQPALPNPCSPASVAPAPDWTHPLPWGRPRTFSLDAVPPDHSPRARSVAPLPPQRSPRTRGLCSKGQPRTWLQSPV</SEQUENCE>
          </protein>
        </PHYSICAL-ENTITY>
      </sequenceParticipant>
    </PARTICIPANTS>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant96">
        <PHYSICAL-ENTITY rdf:resource="#protein238"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <XREF rdf:resource="#publicationXref406"/>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between RHOA and RTKN</COMMENT>
    <EVIDENCE rdf:resource="#evidence299"/>
  </physicalInteraction>
  <biochemicalReaction rdf:ID="biochemicalReaction21">
    <XREF>
      <publicationXref rdf:ID="publicationXref372">
        <ID>10579725</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
    <RIGHT>
      <sequenceParticipant rdf:ID="sequenceParticipant49">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein219">
            <SYNONYMS>RAC ALPHA</SYNONYMS>
            <SYNONYMS>PRKBA</SYNONYMS>
            <SYNONYMS>RAC PK alpha</SYNONYMS>
            <SYNONYMS>PKB</SYNONYMS>
            <SEQUENCE>MNDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQRESPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWATAIQTVADGLKRQEEETMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPTQRLGGGSEDAKEIMQHRFFANIVWQDVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA</SEQUENCE>
            <SYNONYMS>RAC</SYNONYMS>
            <XREF rdf:resource="#publicationXref372"/>
            <XREF rdf:resource="#relationshipXref473"/>
            <SYNONYMS>AKT1</SYNONYMS>
            <XREF rdf:resource="#publicationXref374"/>
            <XREF rdf:resource="#unificationXref531"/>
            <SYNONYMS>RAC alpha serine/threonine protein kinase</SYNONYMS>
            <NAME>AKT1</NAME>
            <ORGANISM>
              <bioSource rdf:ID="bioSource45">
                <TAXON-XREF rdf:resource="#unificationXref532"/>
                <NAME>Mus musculus</NAME>
              </bioSource>
            </ORGANISM>
            <SHORT-NAME>AKT1</SHORT-NAME>
            <SYNONYMS>Protein kinase B</SYNONYMS>
            <SYNONYMS>v-akt murine thymoma viral oncogene homolog 1</SYNONYMS>
            <SYNONYMS>C-AKT</SYNONYMS>
            <XREF>
              <unificationXref rdf:ID="unificationXref530">
                <DB>refseq</DB>
                <ID>NP_033782</ID>
              </unificationXref>
            </XREF>
            <SYNONYMS>Murine thymoma viral (v-akt) oncogene homolog 1</SYNONYMS>
          </protein>
        </PHYSICAL-ENTITY>
        <SEQUENCE-FEATURE-LIST rdf:resource="#sequenceFeature663"/>
      </sequenceParticipant>
    </RIGHT>
    <NAME>Proteolytic Cleavage</NAME>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary653"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence277">
        <XREF rdf:resource="#publicationXref372"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
      </evidence>
    </EVIDENCE>
    <LEFT>
      <sequenceParticipant rdf:ID="sequenceParticipant48">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
        <PHYSICAL-ENTITY rdf:resource="#protein219"/>
      </sequenceParticipant>
    </LEFT>
    <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
  </biochemicalReaction>
  <sequenceFeature rdf:ID="sequenceFeature671">
    <FEATURE-TYPE rdf:resource="#openControlledVocabulary658"/>
  </sequenceFeature>
  <sequenceParticipant rdf:ID="sequenceParticipant91">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary660"/>
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein239">
        <SEQUENCE>MSSILPFTPPVVKRLLGWKKSAGGSGGAGGGEQNGQEEKWCEKAVKSLVKKLKKTGRLDELEKAITTQNC
NTKCVTIPSTCSEIWGLSTPNTIDQWDTTGLYSFSEQTRSLDGRLQVSHRKGLPHVIYCRLWRWPDLHSH
HELKAIENCEYAFNLKKDEVCVNPYHYQRVETPVLPPVLVPRHTEILTELPPLDDYTHSIPENTNFPAGI
EPQSNYIPETPPPGYISEDGETSDQQLNQSMDTGSPAELSPTTLSPVNHSLDLQPVTYSEPAFWCSIAYY
ELNQRVGETFHASQPSLTVDGFTDPSNSERFCLGLLSNVNRNATVEMTRRHIGRGVRLYYIGGEVFAECL
SDSAIFVQSPNCNQRYGWHPATVCKIPPGCNLKIFNNQEFAALLAQSVNQGFEAVYQLTRMCTIRMSFVK
GWGAEYRRQTVTSTPCWIELHLNGPLQWLDKVLTQMGSPSVRCSSMS</SEQUENCE>
        <NAME>MADH2</NAME>
        <SHORT-NAME>SMAD2</SHORT-NAME>
        <SYNONYMS>MADR2</SYNONYMS>
        <SYNONYMS>MADH2</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref409">
            <ID>9006934</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <SYNONYMS>SMA and MAD related protein 2</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref577">
            <DB>refseq</DB>
            <ID>NP_005892</ID>
          </unificationXref>
        </XREF>
        <XREF>
          <unificationXref rdf:ID="unificationXref578">
            <DB>HPRD</DB>
            <ID>03221</ID>
          </unificationXref>
        </XREF>
        <ORGANISM rdf:resource="#bioSource44"/>
        <SYNONYMS>JV18</SYNONYMS>
        <SYNONYMS>SMAD2</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
  </sequenceParticipant>
  <evidence rdf:ID="evidence346">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <XREF rdf:resource="#publicationXref386"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
  </evidence>
  <unificationXref rdf:ID="unificationXref648">
    <DB>refseq</DB>
    <ID>NP_006133</ID>
  </unificationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant196">
    <PHYSICAL-ENTITY rdf:resource="#protein268"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary659"/>
  </sequenceParticipant>
  <protein rdf:ID="protein230">
    <XREF>
      <publicationXref rdf:ID="publicationXref394">
        <ID>12089369</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
    <XREF>
      <unificationXref rdf:ID="unificationXref559">
        <ID>NP_002567</ID>
        <DB>refseq</DB>
      </unificationXref>
    </XREF>
    <SYNONYMS>Alpha PAK</SYNONYMS>
    <XREF rdf:resource="#publicationXref393"/>
    <SYNONYMS>PAK</SYNONYMS>
    <SYNONYMS>PAK1</SYNONYMS>
    <SYNONYMS>Serine/threonine kinase PAK 1</SYNONYMS>
    <SYNONYMS>P65 PAK</SYNONYMS>
    <ORGANISM rdf:resource="#bioSource44"/>
    <SYNONYMS>p21/CDC42/RAC1 activated kinase 1</SYNONYMS>
    <NAME>PAK1</NAME>
    <XREF>
      <unificationXref rdf:ID="unificationXref560">
        <DB>HPRD</DB>
        <ID>03995</ID>
      </unificationXref>
    </XREF>
    <SEQUENCE>MSNNGLDIQDKPPAPPMRNTSTMIGAGSKDAGTLNHGSKPLPPNPEEKKKKDRFYRSILPGDKTNKKKEKERPEISLPSDFEHTIHVGFDAVTGEFTGMPEQWARLLQTSNITKSEQKKNPQAVLDVLEFYNSKKTSNSQKYMSFTDKSAEDYNSSNALNVKAVSETPAVPPVSEDEDDDDDDATPPPVIAPRPEHTKSVYTRSVIEPLPVTPTRDVATSPISPTENNTTPPDALTRNTEKQKKKPKMSDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNH</SEQUENCE>
    <SHORT-NAME>PAK1</SHORT-NAME>
    <XREF>
      <relationshipXref rdf:ID="relationshipXref483">
        <ID>602590</ID>
        <DB>OMIM</DB>
        <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
      </relationshipXref>
    </XREF>
    <SYNONYMS>p21 activated kinase 1</SYNONYMS>
  </protein>
  <evidence rdf:ID="evidence295">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <XREF rdf:resource="#publicationXref406"/>
  </evidence>
  <protein rdf:ID="protein261">
    <SYNONYMS>Protein AS1</SYNONYMS>
    <SEQUENCE>MGDREQLLQRARLAEQAERYDDMASAMKAVTELNEPLSNEDRNLLSVAYKNVVGARRSSWRVISSIEQKTMADGNEKKLEKVKAYREKIEKELETVCNDVLSLLDKFLIKNCNDFQYESKVFYLKMKGDYYRYLAEVASGEKKNSVVEASEAAYKEAFEISKEQMQPTHPIRLGLALNFSVFYYEIQNAPEQACLLAKQAFDDAIAELDTLNEDSYKDSTLIMQLLRDNLTLWTSDQQDEEAGEGN</SEQUENCE>
    <NAME>YWHAH</NAME>
    <XREF>
      <relationshipXref rdf:ID="relationshipXref509">
        <ID>113508</ID>
        <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
        <DB>OMIM</DB>
      </relationshipXref>
    </XREF>
    <SYNONYMS>YWHAH</SYNONYMS>
    <XREF rdf:resource="#publicationXref386"/>
    <SYNONYMS>14-3-3-eta</SYNONYMS>
    <XREF rdf:resource="#unificationXref623"/>
    <ORGANISM rdf:resource="#bioSource44"/>
    <SHORT-NAME>14-3-3-eta</SHORT-NAME>
    <SYNONYMS>Brain protein 14-3-3, eta isoform</SYNONYMS>
    <SYNONYMS>Tyrosine 3-monooxygenase/Tryptophan 5-monooxygenase activation protein 1</SYNONYMS>
    <SYNONYMS>YWHA1</SYNONYMS>
    <XREF>
      <unificationXref rdf:ID="unificationXref622">
        <DB>refseq</DB>
        <ID>NP_003396</ID>
      </unificationXref>
    </XREF>
    <XREF rdf:resource="#publicationXref455"/>
  </protein>
  <evidence rdf:ID="evidence362">
    <XREF rdf:resource="#publicationXref444"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
  </evidence>
  <publicationXref rdf:ID="publicationXref389">
    <ID>15121854</ID>
    <DB>Pubmed</DB>
  </publicationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant171">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein263">
        <SYNONYMS>14-3-3-zeta</SYNONYMS>
        <XREF rdf:resource="#publicationXref386"/>
        <SYNONYMS>Brain protein 14-3-3, zeta isoform</SYNONYMS>
        <NAME>YWHAZ</NAME>
        <XREF>
          <unificationXref rdf:ID="unificationXref626">
            <DB>refseq</DB>
            <ID>NP_003397</ID>
          </unificationXref>
        </XREF>
        <SHORT-NAME>14-3-3-zeta</SHORT-NAME>
        <SEQUENCE>MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTEGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDTQGDEAEAGEGGEN</SEQUENCE>
        <SYNONYMS>Tyrosine 3 monooxygenase/tryptophan 5 monooxygenase activation protein, zeta isoform</SYNONYMS>
        <ORGANISM rdf:resource="#bioSource44"/>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref511">
            <DB>OMIM</DB>
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
            <ID>601288</ID>
          </relationshipXref>
        </XREF>
        <XREF>
          <publicationXref rdf:ID="publicationXref454">
            <ID>8037685</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <XREF rdf:resource="#unificationXref627"/>
        <SYNONYMS>YWHAZ</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
  </sequenceParticipant>
  <physicalInteraction rdf:ID="physicalInteraction702">
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant135">
        <PHYSICAL-ENTITY rdf:resource="#protein252"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-PLEC1</SHORT-NAME>
    <XREF rdf:resource="#publicationXref436"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence322">
        <XREF rdf:resource="#publicationXref435"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
      </evidence>
    </EVIDENCE>
    <XREF rdf:resource="#publicationXref434"/>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-PLEC1</NAME>
    <EVIDENCE>
      <evidence rdf:ID="evidence323">
        <XREF rdf:resource="#publicationXref427"/>
      </evidence>
    </EVIDENCE>
    <EVIDENCE>
      <evidence rdf:ID="evidence324">
        <XREF rdf:resource="#publicationXref434"/>
      </evidence>
    </EVIDENCE>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant134">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <XREF rdf:resource="#publicationXref427"/>
    <EVIDENCE rdf:resource="#evidence325"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGB4 and PLEC1 N149 also Q131 and R138 in the plectin-ABD are important for binding to ITGB4</COMMENT>
    <XREF rdf:resource="#publicationXref435"/>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant203">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein269"/>
  </sequenceParticipant>
  <unificationXref rdf:ID="unificationXref649">
    <DB>HPRD</DB>
    <ID>03185</ID>
  </unificationXref>
  <physicalInteraction rdf:ID="physicalInteraction729">
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between Alpha6Beta4 and laminin5</COMMENT>
    <XREF rdf:resource="#publicationXref399"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant194">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <XREF>
      <publicationXref rdf:ID="publicationXref465">
        <ID>8143784</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
    <PARTICIPANTS>
      <physicalEntityParticipant rdf:ID="physicalEntityParticipant37">
        <PHYSICAL-ENTITY>
          <complex rdf:ID="complex41">
            <NAME>PIK3R2-Human_PIK3R3-Human_PIK3CA-Human_PIK3CB-Human_PIK3CD-Human_PIK3CG-Human</NAME>
            <COMPONENTS>
              <sequenceParticipant rdf:ID="sequenceParticipant198">
                <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary659"/>
                <PHYSICAL-ENTITY rdf:resource="#protein270"/>
              </sequenceParticipant>
            </COMPONENTS>
            <ORGANISM rdf:resource="#bioSource44"/>
            <COMPONENTS>
              <sequenceParticipant rdf:ID="sequenceParticipant199">
                <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
                <PHYSICAL-ENTITY rdf:resource="#protein271"/>
              </sequenceParticipant>
            </COMPONENTS>
            <COMPONENTS>
              <sequenceParticipant rdf:ID="sequenceParticipant197">
                <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
                <PHYSICAL-ENTITY rdf:resource="#protein269"/>
              </sequenceParticipant>
            </COMPONENTS>
            <COMPONENTS>
              <sequenceParticipant rdf:ID="sequenceParticipant200">
                <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
                <PHYSICAL-ENTITY rdf:resource="#protein272"/>
              </sequenceParticipant>
            </COMPONENTS>
            <COMPONENTS rdf:resource="#sequenceParticipant195"/>
            <COMPONENTS rdf:resource="#sequenceParticipant196"/>
          </complex>
        </PHYSICAL-ENTITY>
      </physicalEntityParticipant>
    </PARTICIPANTS>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6Beta4-Laminin5</NAME>
    <EVIDENCE>
      <evidence rdf:ID="evidence361">
        <XREF rdf:resource="#publicationXref399"/>
      </evidence>
    </EVIDENCE>
    <EVIDENCE>
      <evidence rdf:ID="evidence360">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <XREF rdf:resource="#publicationXref465"/>
      </evidence>
    </EVIDENCE>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6Beta4-Laminin5</SHORT-NAME>
  </physicalInteraction>
  <evidence rdf:ID="evidence359">
    <XREF rdf:resource="#publicationXref380"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
  </evidence>
  <unificationXref rdf:ID="unificationXref586">
    <DB>refseq</DB>
    <ID>NP_001276</ID>
  </unificationXref>
  <evidence rdf:ID="evidence307">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
    <XREF rdf:resource="#publicationXref379"/>
  </evidence>
  <unificationXref rdf:ID="unificationXref618">
    <ID>NP_003395</ID>
    <DB>refseq</DB>
  </unificationXref>
  <publicationXref rdf:ID="publicationXref453">
    <ID>11509666</ID>
    <DB>Pubmed</DB>
  </publicationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant146">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein221"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant207">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein233"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant73">
    <SEQUENCE-FEATURE-LIST rdf:resource="#sequenceFeature671"/>
    <PHYSICAL-ENTITY rdf:resource="#protein231"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
  </sequenceParticipant>
  <evidence rdf:ID="evidence288">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <XREF rdf:resource="#publicationXref386"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
  </evidence>
  <sequenceParticipant rdf:ID="sequenceParticipant119">
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein246">
        <XREF rdf:resource="#unificationXref593"/>
        <XREF rdf:resource="#publicationXref415"/>
        <NAME>CLCA5</NAME>
        <SHORT-NAME>CLCA5</SHORT-NAME>
        <XREF rdf:resource="#publicationXref419"/>
        <SYNONYMS>CLCA5</SYNONYMS>
        <SEQUENCE>MTHRDSTGPVIGLKLVTLLFTLSPELLFLGAGLKLKENGYDGLLVAINPRVPEDLKLITNIKEMITEASFYLFNATKRRVFFRNVQILVPATWTDHNYSRVRQESYDKANVIVAEQSEEHGDDPYTLQHRGCGQEGRYIHFTPSFLLNDELAAGYGARGRVFVHEWAHLRWGVFDEYNNDKPFYVNGRNEIQVTRCSSDITGVFVCEKGLCPHEDCIISKIFREGCTFLYNSTQNATGSIMFMPSLPSVVEFCNESTHNQEAPNLQNQVCSLRSTWDVITASSDLNHSLPVHGVGLPAPPTFSLLQAGDRVVCLVIDVSRKMAEGDRLLRLQQAAELYLMQVVEAHTFVGIVTFDSKGEIRASLQQIYSDDDRKLLVSYLPTAVSTDAETNICAGVKKGFEVVEERNGRADGSVLILVTSGADEHIANCLLTSMNSGSTIHSMALGSSAARKVGELSRLTGGLKFFIPDKFTSNGMTEAFVRISSGTGDIFQQSLQVESVCETVQPQHQLADTMTVDSAVGNDTLFLVTWQTGGPPEIALLDPSGRKYNTGDFIINLAFRTASLKIPGTAKHGHWTYTLNNTHHSPQALKVTVASRASSLAMSPATLEAFVERDSTYFPQPVIIYANVRKGLHPILNATVVATVEPEAGDPVVLQLLDGGAGADVIRNDGIYSRYFSSFAVSGSYSLTVHVRHSPSTSTLALPVPGNHAMYVPGYITNDNIQMNAPKNLGHRPVKERWGFSRVSSGGSFSVLGVPDGPHPDMFPPCKITDLEAMKVEDDVVLSWTAPGEDFDQGQTTSYEIRMSRSLWNIRDDFDNAILVNSSELVPQHAGTRETFTFSPKLVTHELDHELAEDAQEPYIVYVALRAMDRSSLRSAVSNIALVSMSLPPNSSPVVSRDDLILKGVLTTVGLIAILCLIMVVAHCIFNRKKRPSRKENETKFL</SEQUENCE>
        <ORGANISM rdf:resource="#bioSource45"/>
        <XREF>
          <unificationXref rdf:ID="unificationXref592">
            <ID>NP_848812</ID>
            <DB>refseq</DB>
          </unificationXref>
        </XREF>
        <XREF rdf:resource="#relationshipXref495"/>
      </protein>
    </PHYSICAL-ENTITY>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary659"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant56">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein223"/>
  </sequenceParticipant>
  <publicationXref rdf:ID="publicationXref411">
    <DB>Pubmed</DB>
    <ID>11058129</ID>
  </publicationXref>
  <relationshipXref rdf:ID="relationshipXref503">
    <ID>131550</ID>
    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
    <DB>OMIM</DB>
  </relationshipXref>
  <sequenceParticipant rdf:ID="sequenceParticipant94">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
    <PHYSICAL-ENTITY rdf:resource="#protein241"/>
  </sequenceParticipant>
  <physicalInteraction rdf:ID="physicalInteraction707">
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between Alpha6Beta4 and NTN1</COMMENT>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6Beta4-NTN1</SHORT-NAME>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant145">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary659"/>
        <PHYSICAL-ENTITY rdf:resource="#protein254"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant144">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <EVIDENCE>
      <evidence rdf:ID="evidence331">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <XREF rdf:resource="#publicationXref442"/>
      </evidence>
    </EVIDENCE>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6Beta4-NTN1</NAME>
    <XREF rdf:resource="#publicationXref442"/>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant100">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein221"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant125">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein249"/>
  </sequenceParticipant>
  <evidence rdf:ID="evidence298">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <XREF rdf:resource="#publicationXref412"/>
  </evidence>
  <physicalInteraction rdf:ID="physicalInteraction713">
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence339">
        <XREF rdf:resource="#publicationXref451"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
      </evidence>
    </EVIDENCE>
    <XREF rdf:resource="#publicationXref451"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence340">
        <XREF rdf:resource="#publicationXref452"/>
      </evidence>
    </EVIDENCE>
    <PARTICIPANTS rdf:resource="#sequenceParticipant156"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >TP73-ABL1</NAME>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between TP73 and ABL1</COMMENT>
    <XREF rdf:resource="#publicationXref452"/>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >TP73-ABL1</SHORT-NAME>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant157">
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein258">
            <ORGANISM rdf:resource="#bioSource44"/>
            <SYNONYMS>JTK7</SYNONYMS>
            <XREF rdf:resource="#publicationXref453"/>
            <XREF>
              <relationshipXref rdf:ID="relationshipXref506">
                <DB>OMIM</DB>
                <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                <ID>189980</ID>
              </relationshipXref>
            </XREF>
            <SYNONYMS>c-ABL</SYNONYMS>
            <SYNONYMS>Proto-oncogene tyrosine-protein kinase ABL1</SYNONYMS>
            <SYNONYMS>v-abl</SYNONYMS>
            <NAME>ABL1</NAME>
            <SYNONYMS>ABL</SYNONYMS>
            <SYNONYMS>p150</SYNONYMS>
            <XREF>
              <unificationXref rdf:ID="unificationXref616">
                <ID>NP_005148</ID>
                <DB>refseq</DB>
              </unificationXref>
            </XREF>
            <SHORT-NAME>ABL1</SHORT-NAME>
            <XREF rdf:resource="#publicationXref452"/>
            <SEQUENCE>MLEICLKLVGCKSKKGLSSSSSCYLEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYPLSSGINGSFLVRESESSPSQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDRSQVYELLEKDYRMKRPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGVRGAVTTLLQAPELPTKTRTSRRAAEHRDTTDVPEMPHSKGQGESDPLDHEPAVSPLLPRKERGPPEGGLNEDERLLPKDKKTNLFSALIKKKKKTAPTPPKRSSSFREMDGQPERRGAGEEEGRDISNGALAFTPLDTADPAKSPKPSNGAGVPNGALRESGGSGFRSPHLWKKSSTLTSSRLATGEEEGGGSSSKRFLRSCSVSCVPHGAKDTEWRSVTLPRDLQSTGRQFDSSTFGGHKSEKPALPRKRAGENRSDQVTRGTVTPPPRLVKKNEEAADEVFKDIMESSPGSSPPNLTPKPLRRQVTVAPASGLPHKEEAWKGSALGTPAAAEPVTPTSKAGSGAPRGTSKGPAEESRVRRHKHSSESPGRDKGKLSKLKPAPPPPPAASAGKAGGKPSQRPGQEAAGEAVLGAKTKATSLVDAVNSDAAKPSQPAEGLKKPVLPATPKPHPAKPSGTPISPAPVPLSTLPSASSALAGDQPSSTAFIPLISTRVSLRKTRQPPERASGAITKGVVLDSTEALCLAISGNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNKFAFREAINKLENNLRELQICPASAGSGPAATQDFSKLLSSVKEISDIVQR</SEQUENCE>
            <XREF rdf:resource="#unificationXref617"/>
            <SYNONYMS>ABL1</SYNONYMS>
          </protein>
        </PHYSICAL-ENTITY>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
      </sequenceParticipant>
    </PARTICIPANTS>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant104">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein221"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant212">
    <PHYSICAL-ENTITY rdf:resource="#protein247"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant185">
    <PHYSICAL-ENTITY rdf:resource="#protein241"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant167">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein262">
        <NAME>YWHAQ</NAME>
        <SEQUENCE>MEKTELIQKAKLAEQAERYDDMATCMKAVTEQGAELSNEERNLLSVAYKNVVGGRRSAWRVISSIEQKTDTSDKKLQLIKDYREKVESELRSICTTVLELLDKYLIANATNPESKVFYLKMKGDYFRYLAEVACGDDRKQTIDNSQGAYQEAFDISKKEMQPTHPIRLGLALNFSVFYYEILNNPELACTLAKTAFDEAIAELDTLNEDSYKDSTLIMQLLRDNLTLWTSDSAGEECDAAEGAEN</SEQUENCE>
        <XREF rdf:resource="#publicationXref386"/>
        <SYNONYMS>1C5</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref625">
            <ID>00886</ID>
            <DB>HPRD</DB>
          </unificationXref>
        </XREF>
        <ORGANISM rdf:resource="#bioSource44"/>
        <SYNONYMS>14-3-3 protein tau</SYNONYMS>
        <SYNONYMS>HS1</SYNONYMS>
        <SHORT-NAME>14-3-3 tau</SHORT-NAME>
        <SYNONYMS>YWHAQ</SYNONYMS>
        <XREF>
          <unificationXref rdf:ID="unificationXref624">
            <ID>NP_006817</ID>
            <DB>refseq</DB>
          </unificationXref>
        </XREF>
        <SYNONYMS>14-3-3 tau</SYNONYMS>
        <XREF rdf:resource="#relationshipXref510"/>
        <SYNONYMS>Tyrosine 3/tryptophan 5 -monooxygenase activation protein, theta polypeptide</SYNONYMS>
        <XREF rdf:resource="#publicationXref455"/>
      </protein>
    </PHYSICAL-ENTITY>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant115">
    <PHYSICAL-ENTITY rdf:resource="#protein245"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <physicalInteraction rdf:ID="physicalInteraction735">
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant216">
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein274">
            <XREF rdf:resource="#unificationXref649"/>
            <SEQUENCE>MERASLIQKAKLAEQAERYEDMAAFMKGAVEKGEELSCEERNLLSVAYKNVVGGQRAAWRVLSSIEQKSNEEGSEEKGPEVREYREKVETELQGVCDTVLGLLDSHLIKEAGDAESRVFYLKMKGDYYRYLAEVATGDDKKRIIDSARSAYQEAMDISKKEMPPTNPIRLGLALNFSVFHYEIANSPEEAISLAKTTFDEAMADLHTLSEDSYKDSTLIMQLLRDNLTLWTADNAGEEGGEAPQEPQS</SEQUENCE>
            <SYNONYMS>Stratifin</SYNONYMS>
            <XREF rdf:resource="#publicationXref386"/>
            <XREF>
              <publicationXref rdf:ID="publicationXref470">
                <ID>10524633</ID>
                <DB>Pubmed</DB>
              </publicationXref>
            </XREF>
            <XREF rdf:resource="#unificationXref648"/>
            <XREF>
              <relationshipXref rdf:ID="relationshipXref522">
                <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                <DB>OMIM</DB>
                <ID>601290</ID>
              </relationshipXref>
            </XREF>
            <ORGANISM rdf:resource="#bioSource44"/>
            <SHORT-NAME>SFN</SHORT-NAME>
            <NAME>SFN</NAME>
            <SYNONYMS>SFN</SYNONYMS>
            <SYNONYMS>14-3-3-sigma</SYNONYMS>
          </protein>
        </PHYSICAL-ENTITY>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >MST1R-SFN</SHORT-NAME>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >MST1R-SFN</NAME>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant215">
        <PHYSICAL-ENTITY rdf:resource="#protein226"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <EVIDENCE rdf:resource="#evidence370"/>
    <XREF rdf:resource="#publicationXref386"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between MST1R and 14-3-3-sigma</COMMENT>
  </physicalInteraction>
  <evidence rdf:ID="evidence352">
    <XREF rdf:resource="#publicationXref426"/>
  </evidence>
  <evidence rdf:ID="evidence303">
    <XREF rdf:resource="#publicationXref403"/>
  </evidence>
  <transport rdf:ID="transport17">
    <NAME>CY-NU-SMAD2</NAME>
    <LEFT rdf:resource="#sequenceParticipant91"/>
    <COMMENT>Transport of SMAD2 from cytoplasm to nucleus.Aalpha6�4 does not inhibit TGF�-mediated Smad2 phosphorylation  but prevents translocation of phosphoSmad2 to the nucleus.</COMMENT>
    <EVIDENCE>
      <evidence rdf:ID="evidence296">
        <XREF>
          <publicationXref rdf:ID="publicationXref408">
            <ID>12902406</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
      </evidence>
    </EVIDENCE>
    <RIGHT>
      <sequenceParticipant rdf:ID="sequenceParticipant90">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
        <PHYSICAL-ENTITY rdf:resource="#protein239"/>
      </sequenceParticipant>
    </RIGHT>
    <XREF rdf:resource="#publicationXref408"/>
  </transport>
  <physicalInteraction rdf:ID="physicalInteraction696">
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGB4 and BPAG1.Dystonin-ABD domain interacts with ITGB4.</COMMENT>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant122">
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <EVIDENCE>
      <evidence rdf:ID="evidence314">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
        <XREF rdf:resource="#publicationXref426"/>
      </evidence>
    </EVIDENCE>
    <XREF rdf:resource="#publicationXref426"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant123">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein248"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence315">
        <XREF rdf:resource="#publicationXref427"/>
      </evidence>
    </EVIDENCE>
    <XREF rdf:resource="#publicationXref427"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-BPAG1</NAME>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-BPAG1</SHORT-NAME>
  </physicalInteraction>
  <physicalInteraction rdf:ID="physicalInteraction703">
    <XREF rdf:resource="#publicationXref440"/>
    <PARTICIPANTS rdf:resource="#sequenceParticipant137"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between CD151 and ITGA6.</COMMENT>
    <EVIDENCE>
      <evidence rdf:ID="evidence326">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <XREF rdf:resource="#publicationXref440"/>
      </evidence>
    </EVIDENCE>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >CD151-ITGA6</SHORT-NAME>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant136">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein253"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >CD151-ITGA6</NAME>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
  </physicalInteraction>
  <unificationXref rdf:ID="unificationXref552">
    <DB>refseq</DB>
    <ID>NP_002728</ID>
  </unificationXref>
  <relationshipXref rdf:ID="relationshipXref507">
    <DB>OMIM</DB>
    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
    <ID>601289</ID>
  </relationshipXref>
  <relationshipXref rdf:ID="relationshipXref489">
    <ID>190090</ID>
    <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
    <DB>OMIM</DB>
  </relationshipXref>
  <publicationXref rdf:ID="publicationXref457">
    <ID>9500991</ID>
    <DB>Pubmed</DB>
  </publicationXref>
  <catalysis rdf:ID="catalysis6">
    <XREF rdf:resource="#publicationXref386"/>
    <NAME>P-AKT1-MST1R</NAME>
    <CONTROLLED rdf:resource="#biochemicalReaction26"/>
    <EVIDENCE rdf:resource="#evidence282"/>
    <COMMENT>Phosphorylation of MST1R by AKT1.MST1R S1394 phosphorylation is induced by MSP through a receptor mediated PI3K and Akt activation.pubmed : 12919677</COMMENT>
    <CONTROLLER>
      <sequenceParticipant rdf:ID="sequenceParticipant62">
        <PHYSICAL-ENTITY rdf:resource="#protein224"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
      </sequenceParticipant>
    </CONTROLLER>
    <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
  </catalysis>
  <sequenceFeature rdf:ID="sequenceFeature666">
    <FEATURE-TYPE rdf:resource="#openControlledVocabulary658"/>
  </sequenceFeature>
  <evidence rdf:ID="evidence337">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
    <XREF rdf:resource="#publicationXref449"/>
  </evidence>
  <physicalInteraction rdf:ID="physicalInteraction718">
    <XREF rdf:resource="#publicationXref386"/>
    <PARTICIPANTS rdf:resource="#sequenceParticipant167"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGB4 and 14-3-3 tau</COMMENT>
    <EVIDENCE>
      <evidence rdf:ID="evidence345">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
        <XREF rdf:resource="#publicationXref386"/>
      </evidence>
    </EVIDENCE>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-YWHAQ</SHORT-NAME>
    <PARTICIPANTS rdf:resource="#sequenceParticipant166"/>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-YWHAQ</NAME>
  </physicalInteraction>
  <biochemicalReaction rdf:ID="biochemicalReaction34">
    <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
    <EVIDENCE>
      <evidence rdf:ID="evidence294">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <XREF rdf:resource="#publicationXref403"/>
      </evidence>
    </EVIDENCE>
    <RIGHT rdf:resource="#sequenceParticipant87"/>
    <NAME>Phosphorylation</NAME>
    <XREF rdf:resource="#publicationXref403"/>
    <LEFT>
      <sequenceParticipant rdf:ID="sequenceParticipant86">
        <PHYSICAL-ENTITY rdf:resource="#protein237"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
      </sequenceParticipant>
    </LEFT>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary656"/>
  </biochemicalReaction>
  <evidence rdf:ID="evidence284">
    <XREF rdf:resource="#publicationXref389"/>
  </evidence>
  <publicationXref rdf:ID="publicationXref467">
    <ID>9856810</ID>
    <DB>Pubmed</DB>
  </publicationXref>
  <physicalInteraction rdf:ID="physicalInteraction697">
    <EVIDENCE rdf:resource="#evidence316"/>
    <XREF rdf:resource="#publicationXref429"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >BPAG1-ERBIN</NAME>
    <PARTICIPANTS rdf:resource="#sequenceParticipant124"/>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >BPAG1-ERBIN</SHORT-NAME>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <PARTICIPANTS rdf:resource="#sequenceParticipant125"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between BPAG1 and ERBIN.</COMMENT>
  </physicalInteraction>
  <catalysis rdf:ID="catalysis7">
    <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
    <NAME>P-PRKCA-ITGB4</NAME>
    <COMMENT>Phosphorylation of ITGB4 by PRKCA.Mobilization of alpha6beta4 occurs by a protein kinase C (PKC) dependent mechanism, and that it involves the phosphorylation of the �4 integrin subunit on serine residues.Pubmed : 10477766Combination of biochemical and mutational analyses, demonstrate that EGF induces the phosphorylation of three specific serine residues (S1356, S1360, and S1364) located within the connecting segment of the beta4 subunit.Protein kinase C alpha is the kinase responsible for phosphorylating at least two of these serines, based on in vitro kinase assays, peptide mapping, and mutational analysis.Most likely S1360 and S1364 are known to be phosphorylated, because they are located within a consensus PKC sitePubmed : 15121854</COMMENT>
    <CONTROLLED>
      <biochemicalReaction rdf:ID="biochemicalReaction27">
        <XREF>
          <publicationXref rdf:ID="publicationXref388">
            <DB>Pubmed</DB>
            <ID>10477766</ID>
          </publicationXref>
        </XREF>
        <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
        <NAME>Phosphorylation</NAME>
        <RIGHT>
          <sequenceParticipant rdf:ID="sequenceParticipant67">
            <SEQUENCE-FEATURE-LIST>
              <sequenceFeature rdf:ID="sequenceFeature669">
                <FEATURE-TYPE rdf:resource="#openControlledVocabulary658"/>
              </sequenceFeature>
            </SEQUENCE-FEATURE-LIST>
            <PHYSICAL-ENTITY rdf:resource="#protein221"/>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
          </sequenceParticipant>
        </RIGHT>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary656"/>
        <XREF rdf:resource="#publicationXref386"/>
        <EVIDENCE rdf:resource="#evidence285"/>
        <XREF rdf:resource="#publicationXref389"/>
        <LEFT>
          <sequenceParticipant rdf:ID="sequenceParticipant66">
            <PHYSICAL-ENTITY rdf:resource="#protein221"/>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
          </sequenceParticipant>
        </LEFT>
      </biochemicalReaction>
    </CONTROLLED>
    <XREF rdf:resource="#publicationXref386"/>
    <EVIDENCE rdf:resource="#evidence284"/>
    <XREF rdf:resource="#publicationXref388"/>
    <EVIDENCE rdf:resource="#evidence285"/>
    <XREF rdf:resource="#publicationXref389"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence283">
        <XREF rdf:resource="#publicationXref388"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
      </evidence>
    </EVIDENCE>
    <CONTROLLER>
      <sequenceParticipant rdf:ID="sequenceParticipant65">
        <PHYSICAL-ENTITY>
          <protein rdf:ID="protein227">
            <SYNONYMS>PRKACA</SYNONYMS>
            <XREF>
              <publicationXref rdf:ID="publicationXref390">
                <ID>12135703</ID>
                <DB>Pubmed</DB>
              </publicationXref>
            </XREF>
            <XREF rdf:resource="#unificationXref553"/>
            <XREF>
              <relationshipXref rdf:ID="relationshipXref480">
                <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
                <ID>176960</ID>
                <DB>OMIM</DB>
              </relationshipXref>
            </XREF>
            <NAME>PRKCA</NAME>
            <SYNONYMS>Protein kinase C, alpha</SYNONYMS>
            <XREF rdf:resource="#unificationXref552"/>
            <XREF rdf:resource="#publicationXref386"/>
            <SYNONYMS>PKC alpha</SYNONYMS>
            <ORGANISM rdf:resource="#bioSource44"/>
            <SYNONYMS>PKCA</SYNONYMS>
            <XREF rdf:resource="#publicationXref388"/>
            <SYNONYMS>PRKCA</SYNONYMS>
            <XREF rdf:resource="#publicationXref389"/>
            <SEQUENCE>MADVFPGNDSTASQDVANRFARKGALRQKNVHEVKDHKFIARFFKQPTFCSHCTDFIWGFGKQGFQCQVCCFVVHKRCHEFVTFSCPGADKGPDTDDPRSKHKFKIHTYGSPTFCDHCGSLLYGLIHQGMKCDTCDMNVHKQCVINVPSLCGMDHTEKRGRIYLKAEVADEKLHVTVRDAKNLIPMDPNGLSDPYVKLKLIPDPKNESKQKTKTIRSTLNPQWNESFTFKLKPSDKDRRLSVEIWDWDRTTRNDFMGSLSFGVSELMKMPASGWYKLLNQEEGEYYNVPIPEGDEEGNMELRQKFEKAKLGPAGNKVISPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPAKRLGCGPEGERDVREHAFFRRIDWEKLENREIQPPFKPKVCGKGAENFDKFFTRGQPVLTPPDQLVIANIDQSDFEGFSYVNPQFVHPILQSAV</SEQUENCE>
            <SHORT-NAME>PRKCA</SHORT-NAME>
          </protein>
        </PHYSICAL-ENTITY>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary660"/>
      </sequenceParticipant>
    </CONTROLLER>
  </catalysis>
  <physicalInteraction rdf:ID="physicalInteraction730">
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGB4 and laminin5</COMMENT>
    <PARTICIPANTS>
      <physicalEntityParticipant rdf:ID="physicalEntityParticipant38">
        <PHYSICAL-ENTITY>
          <complex rdf:ID="complex42">
            <COMPONENTS rdf:resource="#sequenceParticipant203"/>
            <COMPONENTS>
              <sequenceParticipant rdf:ID="sequenceParticipant205">
                <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
                <PHYSICAL-ENTITY rdf:resource="#protein271"/>
              </sequenceParticipant>
            </COMPONENTS>
            <COMPONENTS>
              <sequenceParticipant rdf:ID="sequenceParticipant206">
                <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
                <PHYSICAL-ENTITY rdf:resource="#protein272"/>
              </sequenceParticipant>
            </COMPONENTS>
            <COMPONENTS>
              <sequenceParticipant rdf:ID="sequenceParticipant204">
                <PHYSICAL-ENTITY rdf:resource="#protein270"/>
                <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary659"/>
              </sequenceParticipant>
            </COMPONENTS>
            <NAME>PIK3R3-Human_PIK3CA-Human_PIK3CB-Human_PIK3CD-Human_PIK3CG-Human</NAME>
            <ORGANISM rdf:resource="#bioSource44"/>
            <COMPONENTS>
              <sequenceParticipant rdf:ID="sequenceParticipant202">
                <PHYSICAL-ENTITY rdf:resource="#protein268"/>
                <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary659"/>
              </sequenceParticipant>
            </COMPONENTS>
          </complex>
        </PHYSICAL-ENTITY>
      </physicalEntityParticipant>
    </PARTICIPANTS>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant201">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-Laminin5</NAME>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <EVIDENCE rdf:resource="#evidence362"/>
    <XREF rdf:resource="#publicationXref444"/>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-Laminin5</SHORT-NAME>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant132">
    <PHYSICAL-ENTITY rdf:resource="#protein230"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <protein rdf:ID="protein235">
    <SEQUENCE>MRLTVLCAVCLLPGSLALPLPQEAGGMSELQWEQAQDYLKRFYLYDSETKNANSLEAKLKEMQKFFGLPITGMLNSRVIEIMQKPRCGVPDVAEYSLFPNSPKWTSKVVTYRIVSYTRDLPHITVDRLVSKALNMWGKEIPLHFRKVVWGTADIMIGFARGAHGDSYPFDGPGNTLAHAFAPGTGLGGDAHFDEDERWTDGSSLGINFLYAATHELGHSLGMGHSSDPNAVMYPTYGNGDPQNFKLSQDDIKGIQKLYGKRSNSRKK</SEQUENCE>
    <SYNONYMS>Matrilysin, Uterine</SYNONYMS>
    <XREF>
      <unificationXref rdf:ID="unificationXref569">
        <DB>refseq</DB>
        <ID>NP_002414</ID>
      </unificationXref>
    </XREF>
    <ORGANISM rdf:resource="#bioSource44"/>
    <XREF rdf:resource="#publicationXref402"/>
    <SYNONYMS>Matrix metalloproteinase 7</SYNONYMS>
    <SHORT-NAME>MMP7</SHORT-NAME>
    <SYNONYMS>Matrin</SYNONYMS>
    <XREF>
      <relationshipXref rdf:ID="relationshipXref488">
        <DB>OMIM</DB>
        <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
        <ID>178990</ID>
      </relationshipXref>
    </XREF>
    <XREF rdf:resource="#unificationXref570"/>
    <NAME>MMP7</NAME>
    <SYNONYMS>Putative metalloproteinase I</SYNONYMS>
    <SYNONYMS>MMP7</SYNONYMS>
    <SYNONYMS>PUMP1</SYNONYMS>
  </protein>
  <physicalInteraction rdf:ID="physicalInteraction692">
    <EVIDENCE>
      <evidence rdf:ID="evidence310">
        <XREF rdf:resource="#publicationXref401"/>
      </evidence>
    </EVIDENCE>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6Beta4-ERBB2</SHORT-NAME>
    <XREF rdf:resource="#publicationXref401"/>
    <PARTICIPANTS rdf:resource="#sequenceParticipant115"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6Beta4-ERBB2</NAME>
    <XREF rdf:resource="#publicationXref384"/>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence309">
        <XREF rdf:resource="#publicationXref384"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
      </evidence>
    </EVIDENCE>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction of Alpha6Beta4 and ERBB2</COMMENT>
    <PARTICIPANTS rdf:resource="#sequenceParticipant114"/>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant129">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein223"/>
  </sequenceParticipant>
  <biochemicalReaction rdf:ID="biochemicalReaction29">
    <NAME>Phosphorylation</NAME>
    <XREF rdf:resource="#publicationXref393"/>
    <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
    <RIGHT rdf:resource="#sequenceParticipant73"/>
    <LEFT rdf:resource="#sequenceParticipant72"/>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary656"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence287">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <XREF rdf:resource="#publicationXref393"/>
      </evidence>
    </EVIDENCE>
  </biochemicalReaction>
  <catalysis rdf:ID="catalysis3">
    <CONTROLLED>
      <biochemicalReaction rdf:ID="biochemicalReaction23">
        <NAME>Phosphorylation</NAME>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary656"/>
        <XREF rdf:resource="#publicationXref380"/>
        <RIGHT>
          <sequenceParticipant rdf:ID="sequenceParticipant55">
            <SEQUENCE-FEATURE-LIST>
              <sequenceFeature rdf:ID="sequenceFeature665">
                <FEATURE-TYPE rdf:resource="#openControlledVocabulary658"/>
              </sequenceFeature>
            </SEQUENCE-FEATURE-LIST>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
            <PHYSICAL-ENTITY rdf:resource="#protein221"/>
          </sequenceParticipant>
        </RIGHT>
        <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
        <EVIDENCE>
          <evidence rdf:ID="evidence279">
            <XREF rdf:resource="#publicationXref380"/>
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
          </evidence>
        </EVIDENCE>
        <LEFT>
          <sequenceParticipant rdf:ID="sequenceParticipant54">
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
            <PHYSICAL-ENTITY rdf:resource="#protein221"/>
          </sequenceParticipant>
        </LEFT>
      </biochemicalReaction>
    </CONTROLLED>
    <EVIDENCE rdf:resource="#evidence279"/>
    <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
    <COMMENT>Phosphorylation of ITGB4 by MET.Met Activation Induces Tyrosine Phosphorylation of the beta4 Integrin, and promotes Shc and PI3K dependent pathways.Interaction between ITGB4 and MET occurs at the plasma membrane.</COMMENT>
    <NAME>P-MET-ITGB4</NAME>
    <XREF rdf:resource="#publicationXref380"/>
    <CONTROLLER rdf:resource="#sequenceParticipant53"/>
  </catalysis>
  <evidence rdf:ID="evidence280">
    <XREF rdf:resource="#publicationXref382"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
  </evidence>
  <physicalInteraction rdf:ID="physicalInteraction689">
    <XREF rdf:resource="#publicationXref417"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant108">
        <PHYSICAL-ENTITY rdf:resource="#protein233"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGA6-LAMR1</NAME>
    <EVIDENCE>
      <evidence rdf:ID="evidence306">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <XREF rdf:resource="#publicationXref417"/>
      </evidence>
    </EVIDENCE>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGA6-LAMR1</SHORT-NAME>
    <PARTICIPANTS rdf:resource="#sequenceParticipant109"/>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGA6 and LAMR1</COMMENT>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant99">
    <PHYSICAL-ENTITY rdf:resource="#protein242"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <physicalInteraction rdf:ID="physicalInteraction731">
    <XREF rdf:resource="#publicationXref467"/>
    <PARTICIPANTS rdf:resource="#sequenceParticipant208"/>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGA6-BPAG2</SHORT-NAME>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGA6-BPAG2</NAME>
    <EVIDENCE>
      <evidence rdf:ID="evidence363">
        <XREF>
          <publicationXref rdf:ID="publicationXref466">
            <ID>7790367</ID>
            <DB>Pubmed</DB>
          </publicationXref>
        </XREF>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
      </evidence>
    </EVIDENCE>
    <XREF rdf:resource="#publicationXref466"/>
    <PARTICIPANTS rdf:resource="#sequenceParticipant207"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence364">
        <XREF rdf:resource="#publicationXref467"/>
      </evidence>
    </EVIDENCE>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGA6 and BPAG2</COMMENT>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant174">
    <PHYSICAL-ENTITY rdf:resource="#protein221"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant111">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
    <PHYSICAL-ENTITY rdf:resource="#protein245"/>
  </sequenceParticipant>
  <physicalInteraction rdf:ID="physicalInteraction724">
    <PARTICIPANTS rdf:resource="#sequenceParticipant179"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence354">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
        <XREF rdf:resource="#publicationXref426"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
      </evidence>
    </EVIDENCE>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >BPAG2-DSP</SHORT-NAME>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >BPAG2-DSP</NAME>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between BPAG2 and DSP</COMMENT>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant178">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein250"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <XREF rdf:resource="#publicationXref426"/>
  </physicalInteraction>
  <catalysis rdf:ID="catalysis12">
    <XREF rdf:resource="#publicationXref384"/>
    <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
    <COMMENT>Phosphorylation of ERBB2 by ERBB2.</COMMENT>
    <CONTROLLED>
      <biochemicalReaction rdf:ID="biochemicalReaction32">
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary656"/>
        <XREF rdf:resource="#publicationXref384"/>
        <NAME>Phosphorylation</NAME>
        <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
        <EVIDENCE>
          <evidence rdf:ID="evidence292">
            <XREF rdf:resource="#publicationXref384"/>
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
          </evidence>
        </EVIDENCE>
        <RIGHT>
          <sequenceParticipant rdf:ID="sequenceParticipant81">
            <PHYSICAL-ENTITY rdf:resource="#protein234"/>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
            <SEQUENCE-FEATURE-LIST>
              <sequenceFeature rdf:ID="sequenceFeature674">
                <FEATURE-TYPE rdf:resource="#openControlledVocabulary658"/>
              </sequenceFeature>
            </SEQUENCE-FEATURE-LIST>
          </sequenceParticipant>
        </RIGHT>
        <LEFT>
          <sequenceParticipant rdf:ID="sequenceParticipant80">
            <PHYSICAL-ENTITY rdf:resource="#protein234"/>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
          </sequenceParticipant>
        </LEFT>
      </biochemicalReaction>
    </CONTROLLED>
    <CONTROLLER rdf:resource="#sequenceParticipant80"/>
    <EVIDENCE rdf:resource="#evidence292"/>
    <NAME>AP-ERBB2-ERBB2</NAME>
  </catalysis>
  <physicalInteraction rdf:ID="physicalInteraction728">
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <PARTICIPANTS rdf:resource="#sequenceParticipant186"/>
    <EVIDENCE rdf:resource="#evidence359"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-PIK3R1_PIK3R2_PIK3R3_PIK3CA_PIK3CB_PIK3CD_PIK3CG</NAME>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGB4 and PI3K</COMMENT>
    <PARTICIPANTS rdf:resource="#physicalEntityParticipant36"/>
    <XREF rdf:resource="#publicationXref380"/>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-PIK3R1_PIK3R2_PIK3R3_PIK3CA_PIK3CB_PIK3CD_PIK3CG</SHORT-NAME>
  </physicalInteraction>
  <unificationXref rdf:ID="unificationXref571">
    <DB>refseq</DB>
    <ID>NP_005408</ID>
  </unificationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant164">
    <PHYSICAL-ENTITY rdf:resource="#protein226"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
  </sequenceParticipant>
  <sequenceFeature rdf:ID="sequenceFeature672">
    <FEATURE-TYPE rdf:resource="#openControlledVocabulary658"/>
  </sequenceFeature>
  <publicationXref rdf:ID="publicationXref441">
    <DB>Pubmed</DB>
    <ID>10671376</ID>
  </publicationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant69">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
    <PHYSICAL-ENTITY rdf:resource="#protein229"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant82">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
    <PHYSICAL-ENTITY rdf:resource="#protein235"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant170">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein226"/>
  </sequenceParticipant>
  <evidence rdf:ID="evidence349">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <XREF>
      <publicationXref rdf:ID="publicationXref443">
        <ID>9660880</ID>
        <DB>Pubmed</DB>
      </publicationXref>
    </XREF>
  </evidence>
  <biochemicalReaction rdf:ID="biochemicalReaction30">
    <EVIDENCE rdf:resource="#evidence289"/>
    <RIGHT>
      <sequenceParticipant rdf:ID="sequenceParticipant76">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
        <SEQUENCE-FEATURE-LIST rdf:resource="#sequenceFeature672"/>
      </sequenceParticipant>
    </RIGHT>
    <LEFT>
      <sequenceParticipant rdf:ID="sequenceParticipant75">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
      </sequenceParticipant>
    </LEFT>
    <NAME>Phosphorylation</NAME>
    <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary656"/>
    <XREF rdf:resource="#publicationXref396"/>
    <XREF rdf:resource="#publicationXref386"/>
  </biochemicalReaction>
  <physicalInteraction rdf:ID="physicalInteraction720">
    <PARTICIPANTS rdf:resource="#sequenceParticipant170"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >MST1R-YWHAZ</NAME>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence347">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
        <XREF rdf:resource="#publicationXref386"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
      </evidence>
    </EVIDENCE>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between MST1R and 14-3-3-zeta</COMMENT>
    <PARTICIPANTS rdf:resource="#sequenceParticipant171"/>
    <XREF rdf:resource="#publicationXref386"/>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >MST1R-YWHAZ</SHORT-NAME>
  </physicalInteraction>
  <physicalInteraction rdf:ID="physicalInteraction684">
    <PARTICIPANTS rdf:resource="#sequenceParticipant99"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between Alpha6beta4 and EGFR</COMMENT>
    <PARTICIPANTS rdf:resource="#sequenceParticipant98"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6beta4-EGFR</NAME>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence300">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <XREF rdf:resource="#publicationXref375"/>
      </evidence>
    </EVIDENCE>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6beta4-EGFR</SHORT-NAME>
    <XREF rdf:resource="#publicationXref375"/>
  </physicalInteraction>
  <unificationXref rdf:ID="unificationXref587">
    <DB>HPRD</DB>
    <ID>04880</ID>
  </unificationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant74">
    <PHYSICAL-ENTITY rdf:resource="#protein232"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <evidence rdf:ID="evidence327">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <XREF rdf:resource="#publicationXref441"/>
  </evidence>
  <sequenceParticipant rdf:ID="sequenceParticipant139">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein233"/>
  </sequenceParticipant>
  <unificationXref rdf:ID="unificationXref580">
    <DB>HPRD</DB>
    <ID>04380</ID>
  </unificationXref>
  <evidence rdf:ID="evidence344">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
    <XREF rdf:resource="#publicationXref386"/>
  </evidence>
  <physicalInteraction rdf:ID="physicalInteraction727">
    <EVIDENCE>
      <evidence rdf:ID="evidence358">
        <XREF rdf:resource="#publicationXref412"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
      </evidence>
    </EVIDENCE>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-ITGB4BP</SHORT-NAME>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-ITGB4BP</NAME>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Molecular Association between ITGB4 and ITGB4BP.</COMMENT>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <PARTICIPANTS rdf:resource="#sequenceParticipant185"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant184">
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <XREF rdf:resource="#publicationXref412"/>
  </physicalInteraction>
  <catalysis rdf:ID="catalysis10">
    <EVIDENCE rdf:resource="#evidence288"/>
    <COMMENT>Phosphorylation of ITGB4 by PRKCD.PMID 12919677 states human ITGB4 and PRKCD. Exp-vtPMID 11389095 states about mouse ITGB4. Exp-- vv, vt. Host orgn- MouseITGB4 is phosphorylated at Serine and Tyrosine residues</COMMENT>
    <CONTROLLER rdf:resource="#sequenceParticipant74"/>
    <XREF rdf:resource="#publicationXref396"/>
    <EVIDENCE rdf:resource="#evidence289"/>
    <CONTROLLED rdf:resource="#biochemicalReaction30"/>
    <XREF rdf:resource="#publicationXref386"/>
    <NAME>P-PRKCD-ITGB4</NAME>
    <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
  </catalysis>
  <physicalInteraction rdf:ID="physicalInteraction708">
    <XREF rdf:resource="#publicationXref444"/>
    <PARTICIPANTS rdf:resource="#sequenceParticipant146"/>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-ITGA6</SHORT-NAME>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGB4 and ITGA6.</COMMENT>
    <EVIDENCE rdf:resource="#evidence334"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence332">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <XREF rdf:resource="#publicationXref443"/>
      </evidence>
    </EVIDENCE>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <XREF rdf:resource="#publicationXref443"/>
    <XREF rdf:resource="#publicationXref445"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-ITGA6</NAME>
    <PARTICIPANTS rdf:resource="#sequenceParticipant147"/>
    <EVIDENCE rdf:resource="#evidence333"/>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant151">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein233"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant103">
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein243">
        <SYNONYMS>CaCC</SYNONYMS>
        <NAME>CLCA1</NAME>
        <SYNONYMS>CLCA1</SYNONYMS>
        <ORGANISM rdf:resource="#bioSource44"/>
        <XREF rdf:resource="#publicationXref415"/>
        <SYNONYMS>Calcium activated chloride channel 1</SYNONYMS>
        <XREF rdf:resource="#unificationXref587"/>
        <XREF rdf:resource="#publicationXref403"/>
        <SHORT-NAME>CLCA1</SHORT-NAME>
        <XREF rdf:resource="#unificationXref586"/>
        <XREF>
          <publicationXref rdf:ID="publicationXref414">
            <DB>Pubmed</DB>
            <ID>9828122</ID>
          </publicationXref>
        </XREF>
        <SEQUENCE>MGPFKSSVFILILHLLEGALSNSLIQLNNNGYEGIVVAIDPNVPEDETLIQQIKDMVTQASLYLFEATGKRFYFKNVAILIPETWKTKADYVRPKLETYKNADVLVAESTPPGNDEPYTEQMGNCGEKGERIHLTPDFIAGKKLAEYGPQGKAFVHEWAHLRWGVFDEYNNDEKFYLSNGRIQAVRCSAGITGTNVVKKCQGGSCYTKRCTFNKVTGLYEKGCEFVLQSRQTEKASIMFAQHVDSIVEFCTEQNHNKEAPNKQNQKCNLRSTWEVIRDSEDFKKTTPMTTQPPNPTFSLLQIGQRIVCLVLDKSGSMATGNRLNRLNQAGQLFLLQTVELGSWVGMVTFDSAAHVQSELIQINSGSDRDTLAKRLPAAASGGTSICSGLRSAFTVIRKKYPTDGSEIVLLTDGEDNTISGCFNEVKQSGAIIHTVALGPSAAQELEELSKMTGGLQTYASDQVQNNGLIDAFGALSSGNGAVSQRSIQLESKGLTLQNSQWMNGTVIVDSTVGKDTLFLITWTTQPPQILLWDPSGQKQGGFVVDKNTKMAYLQIPGIAKVGTWKYSLQASSQTLTLTVTSRASNATLPPITVTSKTNKDTSKFPSPLVVYANIRQGASPILRASVTALIESVNGKTVTLELLDNGAGADATKDDGVYSRYFTTYDTNGRYSVKVRALGGVNAARRRVIPQQSGALYIPGWIENDEIQWNPPRPEINKDDVQHKQVCFSRTSSGGSFVASDVPNAPIPDLFPPGQITDLKAEIHGGSLINLTWTAPGDDYDHGTAHKYIIRISTSILDLRDKFNESLQVNTTALIPKEANSEEVFLFKPENITFENGTDLFIAIQAVDKVDLKSEISNIARVSLFIPPQTPPETPSPDETSAPCPNIHINSTIPGIHILKIMWKWIGELQLSIA</SEQUENCE>
        <XREF>
          <relationshipXref rdf:ID="relationshipXref492">
            <DB>OMIM</DB>
            <ID>603906</ID>
            <RELATIONSHIP-TYPE>Gene</RELATIONSHIP-TYPE>
          </relationshipXref>
        </XREF>
      </protein>
    </PHYSICAL-ENTITY>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary659"/>
  </sequenceParticipant>
  <unificationXref rdf:ID="unificationXref619">
    <DB>HPRD</DB>
    <ID>03184</ID>
  </unificationXref>
  <publicationXref rdf:ID="publicationXref410">
    <DB>Pubmed</DB>
    <ID>10846168</ID>
  </publicationXref>
  <sequenceParticipant rdf:ID="sequenceParticipant47">
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein218">
        <SYNONYMS>SREBP cleavage activity 1</SYNONYMS>
        <XREF rdf:resource="#publicationXref372"/>
        <XREF>
          <unificationXref rdf:ID="unificationXref525">
            <ID>NP_004337</ID>
            <DB>refseq</DB>
          </unificationXref>
        </XREF>
        <SEQUENCE>MENTENSVDSKSIKNLEPKIIHGSESMDSGISLDNSYKMDYPEMGLCIIINNKNFHKSTGMTSRSGTDVDAANLRETFRNLKYEVRNKNDLTREEIVELMRDVSKEDHSKRSSFVCVLLSHGEEGIIFGTNGPVDLKKITNFFRGDRCRSLTGKPKLFIIQACRGTELDCGIETDSGVDDDMACHKIPVEADFLYAYSTAPGYYSWRNSKDGSWFIQSLCAMLKQYADKLEFMHILTRVNRKVATEFESFSFDATFHAKKQIPCIVSMLTKELYFYH</SEQUENCE>
        <SYNONYMS>APOPAIN</SYNONYMS>
        <SHORT-NAME>CASP3</SHORT-NAME>
        <ORGANISM rdf:resource="#bioSource44"/>
        <NAME>CASP3</NAME>
        <SYNONYMS>SCA1</SYNONYMS>
        <SYNONYMS>CPP32B</SYNONYMS>
        <SYNONYMS>cysteine protease CPP32</SYNONYMS>
        <XREF rdf:resource="#unificationXref526"/>
        <SYNONYMS>Caspase 3 preproprotein</SYNONYMS>
        <SYNONYMS>Yama</SYNONYMS>
        <SYNONYMS>CPP32</SYNONYMS>
        <SYNONYMS>PARP cleavage protease</SYNONYMS>
        <XREF>
          <publicationXref rdf:ID="publicationXref373">
            <DB>Pubmed</DB>
            <ID>9708895</ID>
          </publicationXref>
        </XREF>
        <SYNONYMS>CASP3</SYNONYMS>
        <XREF rdf:resource="#relationshipXref472"/>
      </protein>
    </PHYSICAL-ENTITY>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant149">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein233"/>
  </sequenceParticipant>
  <evidence rdf:ID="evidence297">
    <XREF rdf:resource="#publicationXref408"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
  </evidence>
  <sequenceParticipant rdf:ID="sequenceParticipant160">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein226"/>
  </sequenceParticipant>
  <evidence rdf:ID="evidence351">
    <XREF rdf:resource="#publicationXref458"/>
  </evidence>
  <physicalInteraction rdf:ID="physicalInteraction704">
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6Beta4-Laminin10</NAME>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between Alpha6Beta4 and Laminin10</COMMENT>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Alpha6Beta4-Laminin10</SHORT-NAME>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <PARTICIPANTS rdf:resource="#sequenceParticipant139"/>
    <EVIDENCE rdf:resource="#evidence327"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant138">
        <PHYSICAL-ENTITY rdf:resource="#protein253"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <XREF rdf:resource="#publicationXref441"/>
  </physicalInteraction>
  <evidence rdf:ID="evidence302">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <XREF rdf:resource="#publicationXref415"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
  </evidence>
  <physicalInteraction rdf:ID="physicalInteraction710">
    <XREF rdf:resource="#publicationXref445"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant150">
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <PARTICIPANTS rdf:resource="#sequenceParticipant151"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >PI3K-IRS1</NAME>
    <EVIDENCE>
      <evidence rdf:ID="evidence336">
        <XREF rdf:resource="#publicationXref445"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
      </evidence>
    </EVIDENCE>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >PI3K-IRS1</SHORT-NAME>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Intercation of PI3K with IRS1</COMMENT>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant211">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
    <PHYSICAL-ENTITY rdf:resource="#protein273"/>
  </sequenceParticipant>
  <physicalInteraction rdf:ID="physicalInteraction717">
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant165">
        <PHYSICAL-ENTITY rdf:resource="#protein261"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <XREF rdf:resource="#publicationXref386"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between MST1R and 14-3-3-eta</COMMENT>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <EVIDENCE rdf:resource="#evidence344"/>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >MST1R-YWHAH</SHORT-NAME>
    <PARTICIPANTS rdf:resource="#sequenceParticipant164"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >MST1R-YWHAH</NAME>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant168">
    <PHYSICAL-ENTITY rdf:resource="#protein226"/>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
  </sequenceParticipant>
  <sequenceParticipant rdf:ID="sequenceParticipant59">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
    <PHYSICAL-ENTITY rdf:resource="#protein224"/>
  </sequenceParticipant>
  <transport rdf:ID="transport16">
    <LEFT>
      <sequenceParticipant rdf:ID="sequenceParticipant89">
        <PHYSICAL-ENTITY rdf:resource="#protein238"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </LEFT>
    <EVIDENCE rdf:resource="#evidence295"/>
    <COMMENT>Translocation of RHOA from cytoplasm to plasma membrane.</COMMENT>
    <XREF rdf:resource="#publicationXref406"/>
    <RIGHT>
      <sequenceParticipant rdf:ID="sequenceParticipant88">
        <PHYSICAL-ENTITY rdf:resource="#protein238"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
      </sequenceParticipant>
    </RIGHT>
    <NAME>CY-PM-RHOA</NAME>
  </transport>
  <evidence rdf:ID="evidence318">
    <XREF rdf:resource="#publicationXref384"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
  </evidence>
  <physicalInteraction rdf:ID="physicalInteraction693">
    <XREF rdf:resource="#publicationXref415"/>
    <EVIDENCE>
      <evidence rdf:ID="evidence311">
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
        <XREF rdf:resource="#publicationXref415"/>
        <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
      </evidence>
    </EVIDENCE>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant117">
        <PHYSICAL-ENTITY rdf:resource="#protein246"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary659"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Molecular association of ITGB4 and CLCA5</COMMENT>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-CLCA5</NAME>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant116">
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-CLCA5</SHORT-NAME>
  </physicalInteraction>
  <catalysis rdf:ID="catalysis8">
    <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
    <CONTROLLER rdf:resource="#sequenceParticipant68"/>
    <CONTROLLED>
      <biochemicalReaction rdf:ID="biochemicalReaction28">
        <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
        <NAME>Phosphorylation</NAME>
        <LEFT rdf:resource="#sequenceParticipant69"/>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary656"/>
        <EVIDENCE>
          <evidence rdf:ID="evidence286">
            <XREF rdf:resource="#publicationXref391"/>
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
          </evidence>
        </EVIDENCE>
        <RIGHT>
          <sequenceParticipant rdf:ID="sequenceParticipant70">
            <SEQUENCE-FEATURE-LIST>
              <sequenceFeature rdf:ID="sequenceFeature670">
                <FEATURE-LOCATION>
                  <sequenceSite rdf:ID="sequenceSite680">
                    <POSITION-STATUS>EQUAL</POSITION-STATUS>
                    <SEQUENCE-POSITION>65</SEQUENCE-POSITION>
                  </sequenceSite>
                </FEATURE-LOCATION>
                <FEATURE-TYPE rdf:resource="#openControlledVocabulary658"/>
              </sequenceFeature>
            </SEQUENCE-FEATURE-LIST>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
            <PHYSICAL-ENTITY rdf:resource="#protein229"/>
          </sequenceParticipant>
        </RIGHT>
        <XREF rdf:resource="#publicationXref391"/>
      </biochemicalReaction>
    </CONTROLLED>
    <COMMENT>Phosphorylation of 4EBP1 by FRAP1.Alpha6Beta4 integrin activates the PI-3K-Akt pathway and, consequently, the rapamycin-sensitive kinase mTOR(FRAP1)which then phosphorylates and inactivates 4E-BP1 (a translational repressor) and promotes VEGF translation.</COMMENT>
    <NAME>P-FRAP1-4EBP1</NAME>
    <XREF rdf:resource="#publicationXref391"/>
    <EVIDENCE rdf:resource="#evidence286"/>
  </catalysis>
  <catalysis rdf:ID="catalysis4">
    <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
    <NAME>P-PIK3R1-AKT1</NAME>
    <EVIDENCE rdf:resource="#evidence280"/>
    <COMMENT>Phosphorylation of AKT1 by PIK3R1.</COMMENT>
    <XREF rdf:resource="#publicationXref382"/>
    <CONTROLLED>
      <biochemicalReaction rdf:ID="biochemicalReaction24">
        <NAME>Phosphorylation</NAME>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary656"/>
        <LEFT rdf:resource="#sequenceParticipant57"/>
        <RIGHT>
          <sequenceParticipant rdf:ID="sequenceParticipant58">
            <PHYSICAL-ENTITY rdf:resource="#protein224"/>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
            <SEQUENCE-FEATURE-LIST rdf:resource="#sequenceFeature666"/>
          </sequenceParticipant>
        </RIGHT>
        <EVIDENCE rdf:resource="#evidence280"/>
        <XREF rdf:resource="#publicationXref382"/>
        <SPONTANEOUS>NOT-SPONTANEOUS</SPONTANEOUS>
      </biochemicalReaction>
    </CONTROLLED>
    <CONTROLLER rdf:resource="#sequenceParticipant56"/>
  </catalysis>
  <evidence rdf:ID="evidence365">
    <XREF rdf:resource="#publicationXref380"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
  </evidence>
  <protein rdf:ID="protein236">
    <SYNONYMS>c-Src</SYNONYMS>
    <XREF>
      <unificationXref rdf:ID="unificationXref572">
        <ID>01819</ID>
        <DB>HPRD</DB>
      </unificationXref>
    </XREF>
    <ORGANISM rdf:resource="#bioSource44"/>
    <SYNONYMS>Avian sarcoma virus protein</SYNONYMS>
    <XREF rdf:resource="#unificationXref571"/>
    <XREF rdf:resource="#relationshipXref489"/>
    <NAME>c-Src</NAME>
    <XREF rdf:resource="#publicationXref403"/>
    <SYNONYMS>ASV</SYNONYMS>
    <SYNONYMS>SRC</SYNONYMS>
    <XREF>
      <publicationXref rdf:ID="publicationXref404">
        <DB>Pubmed</DB>
        <ID>9560226</ID>
      </publicationXref>
    </XREF>
    <SEQUENCE>MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL</SEQUENCE>
    <SHORT-NAME>SRC</SHORT-NAME>
  </protein>
  <sequenceParticipant rdf:ID="sequenceParticipant85">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
    <PHYSICAL-ENTITY rdf:resource="#protein236"/>
  </sequenceParticipant>
  <protein rdf:ID="protein259">
    <SYNONYMS>Protein kinase C inhibitor protein-1</SYNONYMS>
    <ORGANISM rdf:resource="#bioSource44"/>
    <SYNONYMS>Brain protein 14-3-3, beta isoform</SYNONYMS>
    <SYNONYMS>GW128</SYNONYMS>
    <SYNONYMS>14-3-3-beta</SYNONYMS>
    <SYNONYMS>Protein 1054</SYNONYMS>
    <SYNONYMS>YWHAB</SYNONYMS>
    <XREF rdf:resource="#unificationXref618"/>
    <SYNONYMS>14-3-3 protein beta/alpha</SYNONYMS>
    <XREF rdf:resource="#publicationXref454"/>
    <SEQUENCE>MTMDKSELVQKAKLAEQAERYDDMAAAMKAVTEQGHELSNEERNLLSVAYKNVVGARRSSWRVISSIEQKTERNEKKQQMGKEYREKIEAELQDICNDVLELLDKYLIPNATQPESKVFYLKMKGDYFRYLSEVASGDNKQTTVSNSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLNEESYKDSTLIMQLLRDNLTLWTSENQGDEGDAGEGEN</SEQUENCE>
    <XREF rdf:resource="#unificationXref619"/>
    <SHORT-NAME>14-3-3-beta</SHORT-NAME>
    <SYNONYMS>Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide</SYNONYMS>
    <SYNONYMS>HS1</SYNONYMS>
    <SYNONYMS>KCIP-1</SYNONYMS>
    <XREF rdf:resource="#relationshipXref507"/>
    <XREF rdf:resource="#publicationXref386"/>
    <NAME>YWHAB</NAME>
  </protein>
  <evidence rdf:ID="evidence335">
    <XREF rdf:resource="#publicationXref445"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
  </evidence>
  <sequenceParticipant rdf:ID="sequenceParticipant93">
    <PHYSICAL-ENTITY>
      <protein rdf:ID="protein240">
        <NAME>MADH3</NAME>
        <SYNONYMS>SMA and MAD related protein 3</SYNONYMS>
        <XREF rdf:resource="#publicationXref410"/>
        <SEQUENCE>MSSILPFTPPIVKRLLGWKKGEQNGQEEKWCEKAVKSLVKKLKKTGQLDELEKAITTQNVNTKCITIPRS
LDGRLQVSHRKGLPHVIYCRLWRWPDLHSHHELRAMELCEFAFNMKKDEVCVNPYHYQRVETPVLPPVLV
PRHTEIPAEFPPLDDYSHSIPENTNFPAGIEPQSNIPETPPPGYLSEDGETSDHQMNHSMDAGSPNLSPN
PMSPAHNNLDLQPVTYCEPAFWCSISYYELNQRVGETFHASQPSMTVDGFTDPSNSERFCLGLLSNVNRN
AAVELTRRHIGRGVRLYYIGGEVFAECLSDSAIFVQSPNCNQRYGWHPATVCKIPPGCNLKIFNNQEFAA
LLAQSVNQGFEAVYQLTRMCTIRMSFVKGWGAEYRRQTVTSTPCWIELHLNGPLQWLDKVLTQMGSPSIR
CSSVS</SEQUENCE>
        <XREF rdf:resource="#publicationXref411"/>
        <XREF>
          <unificationXref rdf:ID="unificationXref579">
            <ID>NP_005893</ID>
            <DB>refseq</DB>
          </unificationXref>
        </XREF>
        <XREF rdf:resource="#unificationXref580"/>
        <SYNONYMS>JV15-2</SYNONYMS>
        <SYNONYMS>HsT17436</SYNONYMS>
        <ORGANISM rdf:resource="#bioSource44"/>
        <SYNONYMS>SMAD3</SYNONYMS>
        <SHORT-NAME>SMAD3</SHORT-NAME>
        <SYNONYMS>MADH3</SYNONYMS>
      </protein>
    </PHYSICAL-ENTITY>
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary660"/>
  </sequenceParticipant>
  <catalysis rdf:ID="catalysis13">
    <CONTROLLER rdf:resource="#sequenceParticipant82"/>
    <CONTROLLED rdf:resource="#biochemicalReaction33"/>
    <NAME>Pc-MMP7-ITGB4</NAME>
    <XREF rdf:resource="#publicationXref402"/>
    <COMMENT>Proteolytic Cleavage of ITGB4 by MMP7.</COMMENT>
    <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
    <EVIDENCE rdf:resource="#evidence293"/>
  </catalysis>
  <protein rdf:ID="protein255">
    <SYNONYMS>HER1</SYNONYMS>
    <XREF rdf:resource="#publicationXref446"/>
    <XREF>
      <unificationXref rdf:ID="unificationXref611">
        <ID>00579</ID>
        <DB>HPRD</DB>
      </unificationXref>
    </XREF>
    <XREF rdf:resource="#publicationXref375"/>
    <SHORT-NAME>EGFR</SHORT-NAME>
    <ORGANISM rdf:resource="#bioSource44"/>
    <SEQUENCE>MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCKLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA</SEQUENCE>
    <SYNONYMS>EGF receptor</SYNONYMS>
    <XREF rdf:resource="#relationshipXref503"/>
    <XREF>
      <unificationXref rdf:ID="unificationXref610">
        <DB>refseq</DB>
        <ID>NP_005219</ID>
      </unificationXref>
    </XREF>
    <NAME>EGFR</NAME>
    <SYNONYMS>ERBB1</SYNONYMS>
    <SYNONYMS>EGFR</SYNONYMS>
    <SYNONYMS>Epidermal growth factor receptor</SYNONYMS>
  </protein>
  <physicalInteraction rdf:ID="physicalInteraction686">
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Molecular association of ITGB4 and CLCA1.ITGB4 can bind bind to unprocessed 125kDa and processed 35kDa CLCA1, but not to the processed 90kDa CLCA1 protein. The binding motif for ITGB4 is not conserved in the human CLCA1.</COMMENT>
    <XREF rdf:resource="#publicationXref415"/>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <EVIDENCE rdf:resource="#evidence303"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-CLCA1</NAME>
    <XREF rdf:resource="#publicationXref403"/>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-CLCA1</SHORT-NAME>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant102">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <EVIDENCE rdf:resource="#evidence302"/>
    <PARTICIPANTS rdf:resource="#sequenceParticipant103"/>
  </physicalInteraction>
  <physicalInteraction rdf:ID="physicalInteraction714">
    <EVIDENCE rdf:resource="#evidence341"/>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-YWHAB</NAME>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-YWHAB</SHORT-NAME>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant159">
        <PHYSICAL-ENTITY rdf:resource="#protein259"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant158">
        <PHYSICAL-ENTITY rdf:resource="#protein221"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <XREF rdf:resource="#publicationXref386"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGB4 and 14-3-3-beta</COMMENT>
  </physicalInteraction>
  <sequenceParticipant rdf:ID="sequenceParticipant131">
    <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
    <PHYSICAL-ENTITY rdf:resource="#protein248"/>
  </sequenceParticipant>
  <evidence rdf:ID="evidence357">
    <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
    <XREF rdf:resource="#publicationXref391"/>
  </evidence>
  <physicalInteraction rdf:ID="physicalInteraction732">
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant210">
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
        <PHYSICAL-ENTITY rdf:resource="#protein250"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <PARTICIPANTS>
      <sequenceParticipant rdf:ID="sequenceParticipant209">
        <PHYSICAL-ENTITY rdf:resource="#protein233"/>
        <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
      </sequenceParticipant>
    </PARTICIPANTS>
    <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-PI3K</SHORT-NAME>
    <XREF rdf:resource="#publicationXref380"/>
    <EVIDENCE rdf:resource="#evidence365"/>
    <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >ITGB4-PI3K</NAME>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >Interaction between ITGB4 and PI3K</COMMENT>
    <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
  </physicalInteraction>
  <pathway rdf:ID="Alpha6Beta4Integrin_pathway_Human">
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction701">
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Molecular association of PAK1 and RAC1.</COMMENT>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <PARTICIPANTS rdf:resource="#sequenceParticipant132"/>
        <XREF rdf:resource="#publicationXref393"/>
        <PARTICIPANTS rdf:resource="#sequenceParticipant133"/>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >PAK1-RAC1</SHORT-NAME>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >PAK1-RAC1</NAME>
        <EVIDENCE rdf:resource="#evidence321"/>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction694">
        <PARTICIPANTS rdf:resource="#sequenceParticipant118"/>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Alpha6Beta4-Laminin4</SHORT-NAME>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction between Alpha6Beta4 and Laminin4</COMMENT>
        <EVIDENCE rdf:resource="#evidence312"/>
        <PARTICIPANTS rdf:resource="#sequenceParticipant119"/>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Alpha6Beta4-Laminin4</NAME>
        <XREF rdf:resource="#publicationXref399"/>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction685">
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <XREF rdf:resource="#publicationXref375"/>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >ITGB4-FYN</NAME>
        <PARTICIPANTS rdf:resource="#sequenceParticipant100"/>
        <PARTICIPANTS rdf:resource="#sequenceParticipant101"/>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >ITGB4-FYN</SHORT-NAME>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction between ITGB4 and FYN</COMMENT>
        <EVIDENCE>
          <evidence rdf:ID="evidence301">
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
            <XREF rdf:resource="#publicationXref375"/>
          </evidence>
        </EVIDENCE>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction720"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction734"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction706"/>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction24"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction728"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction695"/>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction25"/>
    <PATHWAY-COMPONENTS rdf:resource="#transport16"/>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction690">
        <XREF rdf:resource="#publicationXref379"/>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Molecular Association between ITGB4 and VIM.Takes place at cell membrane.</COMMENT>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >ITGB4-VIM</SHORT-NAME>
        <PARTICIPANTS rdf:resource="#sequenceParticipant110"/>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <EVIDENCE rdf:resource="#evidence307"/>
        <PARTICIPANTS rdf:resource="#sequenceParticipant111"/>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >ITGB4-VIM</NAME>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction29"/>
    <PATHWAY-COMPONENTS>
      <catalysis rdf:ID="catalysis9">
        <EVIDENCE rdf:resource="#evidence287"/>
        <XREF rdf:resource="#publicationXref393"/>
        <COMMENT>Phosphorylation of MBP by PAK1.</COMMENT>
        <CONTROLLER>
          <sequenceParticipant rdf:ID="sequenceParticipant71">
            <PHYSICAL-ENTITY rdf:resource="#protein230"/>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
          </sequenceParticipant>
        </CONTROLLER>
        <CONTROLLED rdf:resource="#biochemicalReaction29"/>
        <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
        <NAME>P-PAK1-MBP</NAME>
      </catalysis>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction733">
        <PARTICIPANTS rdf:resource="#sequenceParticipant212"/>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction between SHC and GRB2</COMMENT>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >SHC1-GRB2</NAME>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >SHC1-GRB2</SHORT-NAME>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <EVIDENCE>
          <evidence rdf:ID="evidence366">
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
            <XREF rdf:resource="#publicationXref421"/>
          </evidence>
        </EVIDENCE>
        <XREF rdf:resource="#publicationXref421"/>
        <PARTICIPANTS rdf:resource="#sequenceParticipant211"/>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction696"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction735"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction683"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction713"/>
    <PATHWAY-COMPONENTS rdf:resource="#catalysis8"/>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction726">
        <EVIDENCE rdf:resource="#evidence357"/>
        <PARTICIPANTS rdf:resource="#sequenceParticipant182"/>
        <PARTICIPANTS>
          <sequenceParticipant rdf:ID="sequenceParticipant183">
            <PHYSICAL-ENTITY rdf:resource="#protein266"/>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary660"/>
          </sequenceParticipant>
        </PARTICIPANTS>
        <XREF rdf:resource="#publicationXref391"/>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction of 4EBP1 and EIF4EPhosphorylation of 4EBP1 disrupts binding of EIF4E.</COMMENT>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >4EBP1-EIF4E</SHORT-NAME>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >4EBP1-EIF4E</NAME>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS>
      <catalysis rdf:ID="catalysis14">
        <NAME>P-SRC-PTK2</NAME>
        <COMMENT>Phosphorylation of PTK2 by SRC.</COMMENT>
        <CONTROLLER rdf:resource="#sequenceParticipant85"/>
        <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
        <XREF rdf:resource="#publicationXref403"/>
        <EVIDENCE rdf:resource="#evidence294"/>
        <CONTROLLED rdf:resource="#biochemicalReaction34"/>
      </catalysis>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction688"/>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction33"/>
    <PATHWAY-COMPONENTS rdf:resource="#transport17"/>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction22"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction693"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction704"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction697"/>
    <PATHWAY-COMPONENTS rdf:resource="#catalysis3"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction725"/>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction32"/>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction719">
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >MST1R-YWHAQ</SHORT-NAME>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <EVIDENCE rdf:resource="#evidence346"/>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction between MST1R and 14-3-3 tau</COMMENT>
        <XREF rdf:resource="#publicationXref386"/>
        <PARTICIPANTS rdf:resource="#sequenceParticipant168"/>
        <PARTICIPANTS>
          <sequenceParticipant rdf:ID="sequenceParticipant169">
            <PHYSICAL-ENTITY rdf:resource="#protein262"/>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
          </sequenceParticipant>
        </PARTICIPANTS>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >MST1R-YWHAQ</NAME>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction687">
        <EVIDENCE rdf:resource="#evidence304"/>
        <PARTICIPANTS rdf:resource="#sequenceParticipant104"/>
        <PARTICIPANTS rdf:resource="#sequenceParticipant105"/>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >ITGB4-PTK2</NAME>
        <XREF rdf:resource="#publicationXref403"/>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction between ITGB4 and PTK2</COMMENT>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >ITGB4-PTK2</SHORT-NAME>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction686"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction731"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction712"/>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction705">
        <PARTICIPANTS>
          <sequenceParticipant rdf:ID="sequenceParticipant141">
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
            <PHYSICAL-ENTITY rdf:resource="#protein233"/>
          </sequenceParticipant>
        </PARTICIPANTS>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction between Alpha6Beta4 and Laminin11</COMMENT>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Alpha6Beta4-Laminin11</SHORT-NAME>
        <EVIDENCE>
          <evidence rdf:ID="evidence328">
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
            <XREF rdf:resource="#publicationXref441"/>
          </evidence>
        </EVIDENCE>
        <PARTICIPANTS rdf:resource="#sequenceParticipant140"/>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Alpha6Beta4-Laminin11</NAME>
        <XREF rdf:resource="#publicationXref441"/>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction692"/>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction27"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction729"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction703"/>
    <PATHWAY-COMPONENTS>
      <catalysis rdf:ID="catalysis1">
        <XREF rdf:resource="#publicationXref372"/>
        <CONTROLLED rdf:resource="#biochemicalReaction21"/>
        <COMMENT>Proteolytic Cleavage of AKT1 by CASP3.</COMMENT>
        <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
        <EVIDENCE rdf:resource="#evidence277"/>
        <CONTROLLER rdf:resource="#sequenceParticipant47"/>
        <NAME>Pc-CASP3-AKT1</NAME>
      </catalysis>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#catalysis6"/>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction34"/>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction31"/>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction699">
        <PARTICIPANTS rdf:resource="#sequenceParticipant128"/>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <EVIDENCE rdf:resource="#evidence318"/>
        <XREF rdf:resource="#publicationXref384"/>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction of ERBB2 with PIK3R1ERBB2 activates PIK3R1</COMMENT>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >ERBB2-PIK3R1</SHORT-NAME>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >ERBB2-PIK3R1</NAME>
        <PARTICIPANTS rdf:resource="#sequenceParticipant129"/>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS>
      <catalysis rdf:ID="catalysis5">
        <COMMENT>Phosphorylation of BAD by AKT1.</COMMENT>
        <CONTROLLED rdf:resource="#biochemicalReaction25"/>
        <CONTROLLER rdf:resource="#sequenceParticipant59"/>
        <EVIDENCE rdf:resource="#evidence281"/>
        <NAME>P-AKT1-BAD</NAME>
        <XREF rdf:resource="#publicationXref382"/>
        <DIRECTION>PHYSIOL-LEFT-TO-RIGHT</DIRECTION>
      </catalysis>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS>
      <transport rdf:ID="transport18">
        <COMMENT>Transport of SMAD3 from cytoplasm to nucleus.Aalpha6�4 does not inhibit TGF�-mediated Smad3 phosphorylation  but prevents translocation of phosphoSmad2 to the nucleus.</COMMENT>
        <RIGHT>
          <sequenceParticipant rdf:ID="sequenceParticipant92">
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
            <PHYSICAL-ENTITY rdf:resource="#protein240"/>
          </sequenceParticipant>
        </RIGHT>
        <NAME>CY-NU-SMAD3</NAME>
        <XREF rdf:resource="#publicationXref408"/>
        <LEFT rdf:resource="#sequenceParticipant93"/>
        <EVIDENCE rdf:resource="#evidence297"/>
      </transport>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction691"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction717"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction689"/>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction28"/>
    <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
    >The integrins are cell membrane receptors composed of alpha and beta subunits. There are about 18 alpha subunits and 8 beta subunits.Integrins alpha6 and beta 4 heterodimerises to form the active receptor complex. Alpha6Beta4 are mainly involved with hemidesmosomes formation, cell adhesion and cell attachments. Many cytoskeletal proteins like keratins and Bullous pemphigoid antigen (BPAG) are associated with Alpha6beta4.They also associate with other receptors like Epidermal Growth factor receptor(EGFR), macrophage stimulating factor receptors. The vital ligands are Laminins, Kalinins. Various kinases (like MEKs, ERKs, PKCs, YES, FYN) and adapter molecules like (GRBs) are involved in this pathway. Alpha6beta4 modulate processes as diverse as cell proliferation, differentiation, apoptosis, migration and tissue morphogenesis.  </COMMENT>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction684"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction730"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction727"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction702"/>
    <PATHWAY-COMPONENTS rdf:resource="#catalysis13"/>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction21"/>
    <PATHWAY-COMPONENTS rdf:resource="#catalysis4"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction710"/>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction700">
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >BPAG2-BPAG1</SHORT-NAME>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <XREF rdf:resource="#publicationXref431"/>
        <PARTICIPANTS>
          <sequenceParticipant rdf:ID="sequenceParticipant130">
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
            <PHYSICAL-ENTITY rdf:resource="#protein250"/>
          </sequenceParticipant>
        </PARTICIPANTS>
        <PARTICIPANTS rdf:resource="#sequenceParticipant131"/>
        <EVIDENCE>
          <evidence rdf:ID="evidence319">
            <XREF rdf:resource="#publicationXref426"/>
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
          </evidence>
        </EVIDENCE>
        <XREF rdf:resource="#publicationXref426"/>
        <EVIDENCE rdf:resource="#evidence320"/>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction between BPAG2 and BPAG1</COMMENT>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >BPAG2-BPAG1</NAME>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#catalysis10"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction721"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction716"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction724"/>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction715">
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <EVIDENCE>
          <evidence rdf:ID="evidence342">
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary655"/>
            <XREF rdf:resource="#publicationXref386"/>
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary651"/>
            <EVIDENCE-CODE rdf:resource="#openControlledVocabulary900"/>
          </evidence>
        </EVIDENCE>
        <PARTICIPANTS>
          <sequenceParticipant rdf:ID="sequenceParticipant161">
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary652"/>
            <PHYSICAL-ENTITY rdf:resource="#protein259"/>
          </sequenceParticipant>
        </PARTICIPANTS>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >MST1R-YWHAB</SHORT-NAME>
        <XREF rdf:resource="#publicationXref386"/>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction between MST1R and 14-3-3-beta</COMMENT>
        <PARTICIPANTS rdf:resource="#sequenceParticipant160"/>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >MST1R-YWHAB</NAME>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction707"/>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction722">
        <PARTICIPANTS rdf:resource="#sequenceParticipant174"/>
        <XREF rdf:resource="#publicationXref426"/>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction between ITGB4 and BPAG2.</COMMENT>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >ITGB4-BPAG2</NAME>
        <EVIDENCE rdf:resource="#evidence351"/>
        <EVIDENCE rdf:resource="#evidence349"/>
        <XREF rdf:resource="#publicationXref457"/>
        <PARTICIPANTS rdf:resource="#sequenceParticipant175"/>
        <EVIDENCE>
          <evidence rdf:ID="evidence350">
            <XREF rdf:resource="#publicationXref457"/>
          </evidence>
        </EVIDENCE>
        <XREF rdf:resource="#publicationXref443"/>
        <EVIDENCE rdf:resource="#evidence352"/>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >ITGB4-BPAG2</SHORT-NAME>
        <XREF rdf:resource="#publicationXref458"/>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#catalysis11"/>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction711">
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >EGFR-AR</SHORT-NAME>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >EGFR-AR</NAME>
        <EVIDENCE rdf:resource="#evidence337"/>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction between EGFR and AR</COMMENT>
        <XREF rdf:resource="#publicationXref449"/>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <PARTICIPANTS rdf:resource="#sequenceParticipant153"/>
        <PARTICIPANTS>
          <sequenceParticipant rdf:ID="sequenceParticipant152">
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
            <PHYSICAL-ENTITY rdf:resource="#protein255"/>
          </sequenceParticipant>
        </PARTICIPANTS>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction26"/>
    <ORGANISM rdf:resource="#bioSource44"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction714"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction708"/>
    <PATHWAY-COMPONENTS rdf:resource="#catalysis2"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction732"/>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction723">
        <EVIDENCE rdf:resource="#evidence353"/>
        <XREF rdf:resource="#publicationXref426"/>
        <PARTICIPANTS>
          <sequenceParticipant rdf:ID="sequenceParticipant177">
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
            <PHYSICAL-ENTITY rdf:resource="#protein252"/>
          </sequenceParticipant>
        </PARTICIPANTS>
        <PARTICIPANTS rdf:resource="#sequenceParticipant176"/>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >BPAG2-PLEC1</SHORT-NAME>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction between BPAG2 and PLEC1</COMMENT>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >BPAG2-PLEC1</NAME>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction30"/>
    <PATHWAY-COMPONENTS rdf:resource="#catalysis7"/>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction698"/>
    <PATHWAY-COMPONENTS>
      <transport rdf:ID="transport19">
        <LEFT rdf:resource="#sequenceParticipant95"/>
        <XREF rdf:resource="#publicationXref412"/>
        <NAME>CY-NU-ITGB4BP</NAME>
        <COMMENT>Translocation of ITGB4BP from cytoplasm to nucleus.</COMMENT>
        <EVIDENCE rdf:resource="#evidence298"/>
        <RIGHT rdf:resource="#sequenceParticipant94"/>
      </transport>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS>
      <physicalInteraction rdf:ID="physicalInteraction709">
        <XREF rdf:resource="#publicationXref445"/>
        <NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >PI3K-IRS2</NAME>
        <SHORT-NAME rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >PI3K-IRS2</SHORT-NAME>
        <PARTICIPANTS rdf:resource="#sequenceParticipant149"/>
        <EVIDENCE rdf:resource="#evidence335"/>
        <COMMENT rdf:datatype="http://www.w3.org/2001/XMLSchema#string"
        >Interaction of PI3K with IRS2:IRS proteins contain several PI3K binding sites, and involved in the activation of PI3K.</COMMENT>
        <INTERACTION-TYPE rdf:resource="#openControlledVocabulary901_reaction"/>
        <PARTICIPANTS>
          <sequenceParticipant rdf:ID="sequenceParticipant148">
            <PHYSICAL-ENTITY rdf:resource="#protein221"/>
            <CELLULAR-LOCATION rdf:resource="#openControlledVocabulary657"/>
          </sequenceParticipant>
        </PARTICIPANTS>
      </physicalInteraction>
    </PATHWAY-COMPONENTS>
    <PATHWAY-COMPONENTS rdf:resource="#physicalInteraction718"/>
    <PATHWAY-COMPONENTS rdf:resource="#catalysis12"/>
    <NAME>Alpha6Beta4Integrin</NAME>
    <PATHWAY-COMPONENTS rdf:resource="#biochemicalReaction23"/>
  </pathway>
</rdf:RDF>
